WO2022225049A1 - Antibacterial agent, antibacterial composition using same and antiviral composition - Google Patents

Antibacterial agent, antibacterial composition using same and antiviral composition Download PDF

Info

Publication number
WO2022225049A1
WO2022225049A1 PCT/JP2022/018557 JP2022018557W WO2022225049A1 WO 2022225049 A1 WO2022225049 A1 WO 2022225049A1 JP 2022018557 W JP2022018557 W JP 2022018557W WO 2022225049 A1 WO2022225049 A1 WO 2022225049A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
acid
hydrocarbon
formula
antibacterial agent
Prior art date
Application number
PCT/JP2022/018557
Other languages
French (fr)
Japanese (ja)
Inventor
亜紀良 矢下
大介 中村
和馬 竹腰
恒太郎 金子
功治 河合
Original Assignee
ミヨシ油脂株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ミヨシ油脂株式会社 filed Critical ミヨシ油脂株式会社
Priority to JP2023515539A priority Critical patent/JPWO2022225049A1/ja
Publication of WO2022225049A1 publication Critical patent/WO2022225049A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02Amines; Quaternary ammonium compounds
    • A01N33/08Amines; Quaternary ammonium compounds containing oxygen or sulfur
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/36Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P1/00Disinfectants; Antimicrobial compounds or mixtures thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P3/00Fungicides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • the present invention relates to an antibacterial agent and an antibacterial composition and an antiviral composition using the same.
  • organic ammonium salt ionic liquid having a hydrogen-bonding functional group in the cation or anion (Patent Documents 1 to 5). It has been found that this organic ammonium salt is hydrophilic, liquid at room temperature, and has excellent water-holding and moisturizing properties.
  • the present invention has been made in view of the above circumstances, and an object of the present invention is to provide a novel antibacterial agent, antibacterial composition and antiviral composition that are highly safe and have a sustained effect.
  • the antibacterial agent of the present invention is characterized by being a blend of the following components (A) and (B).
  • B) Carboxylic acid or salt thereof The antibacterial composition of the present invention contains the above antibacterial agent.
  • the antiviral composition of the present invention contains the above antibacterial agent.
  • the antibacterial agent, antibacterial composition, and antiviral composition of the present invention are highly safe and have excellent sustained effects.
  • the antibacterial agent of the present invention is also excellent as a solvent for other ingredients.
  • the term "formulation” includes blending components (A) and (B) until the final target formulation is prepared, and components (A) and (B) are used as starting materials.
  • the formulation of the present invention may be a mixture consisting only of components (A) and (B) (including the case where they are salts), and components other than components (A) and (B) or their salts It may be a composition containing components, for example, a composition containing water, a composition to which additives are added when manufacturing a product, or a composition that is a product such as cosmetics.
  • the antibacterial agent of the present invention is a blend of the following components (A) and (B), component (A) being an amine or ammonium compound having a hydrogen-bonding functional group (excluding amino acids). ).
  • the skeleton of the amine compound of component (A) is not particularly limited, and examples include amines (ammonia, primary amines, secondary amines, tertiary amines), guanidine, imidazole, pyridine, pyrrolidine, piperidine, pyrroline, pyrazine, Cyclic amines such as triazole, isoquinoline, oxazoline, thiazoline, morpholine, pyrimidine, piperazine, triazine, quinoline, indole, quinoxaline, isoxazoline, etc.
  • amine, imidazole, pyridine, pyrrolidine, piperidine, morpholine are preferred, and amines are more preferred.
  • these may contain substituents described in the section [Substituents] below.
  • the ammonium compounds include salts of the above amine compounds and quaternary amine compounds.
  • the component (A) and the cation derived from the component (A) may have an organic group as a substituent.
  • the organic group essentially has a carbon atom and may additionally contain at least one selected from a hydrogen atom, an oxygen atom, a nitrogen atom, a sulfur atom, a phosphorus atom, and a halogen atom.
  • the atomic group contained in the organic group is not particularly limited, examples thereof include hydrocarbon groups, heterocyclic groups, and substituents described in the section [Substituents] below.
  • the substituents described in the "Substituents" column below replace hydrogen atoms of the hydrocarbon group, interrupt the hydrocarbon group, and/or are included at the base end of the hydrocarbon group, or include aromatic hydrocarbons.
  • a group forming a condensed ring with a water group is also included.
  • the number of carbon atoms in the organic group is not particularly limited, but is, for example, 1-22, 1-18, 1-12, 1-8, or 1-4.
  • the hydrocarbon group is not particularly limited, and examples include saturated or unsaturated aliphatic hydrocarbon groups, saturated or unsaturated alicyclic hydrocarbon groups, aromatic hydrocarbon groups, and combinations thereof.
  • a hydrocarbon group etc. are mentioned.
  • it may be monovalent or polyvalent, and examples of monovalent saturated or unsaturated aliphatic hydrocarbon groups include, but are not limited to, linear or branched alkyl groups, alkenyl groups and alkynyl groups. etc.
  • Alkyl groups include linear or branched chains, but are not particularly limited, and examples thereof include methyl, ethane-1-yl, propan-1-yl, 1-methylethan-1-yl, butane-1- yl group, butan-2-yl group, 2-methylpropan-1-yl group, 2-methylpropan-2-yl group, pentan-1-yl group, pentan-2-yl group, hexan-1-yl group , heptane-1-yl group, octan-1-yl group, 2-ethylhexan-1-yl group, 1,1,3,3-tetramethylbutan-1-yl group, nonan-1-yl group, decane -1-yl group, undecane-1-yl group, dodecane-1-yl group, tridecane-1-yl group, tetradecane-1-yl group, pentadecane-1-yl group, hexadecane-1-yl group,
  • Alkenyl groups include linear or branched chains, and are not particularly limited, but examples include vinyl, prop-1-en-1-yl, allyl, isopropenyl, but-1-en-1-yl. group, but-2-en-1-yl group, but-3-en-1-yl group, 2-methylprop-2-en-1-yl group, 1-methylprop-2-en-1-yl group, pent-1-en-1-yl group, pent-2-en-1-yl group, pent-3-en-1-yl group, pent-4-en-1-yl group, 3-methylbut-2- En-1-yl group, 3-methylbut-3-en-1-yl group, hex-1-en-1-yl group, hex-2-en-1-yl group, hex-3-en-1- yl group, hex-4-en-1-yl group, hex-5-en-1-yl group, 4-methylpent-3-en-1-yl group, 4-methylpent-3-en-1-yl group,
  • Alkynyl groups include straight or branched chains, and are not particularly limited and include, but are not limited to, ethynyl, prop-1-yn-1-yl, prop-2-yn-1-yl, but-1-yn- 1-yl group, but-3-yn-1-yl group, 1-methylprop-2-yn-1-yl group, pent-1-yn-1-yl group, pent-4-yn-1-yl group , hex-1-yn-1-yl group, hex-5-yn-1-yl group, hept-1-yn-1-yl group, hept-6-yn-1-yl group, octa-1-yne -1-yl group, octa-7-yn-1-yl group, non-1-yn-1-yl group, non-8-yn-1-yl group, deca-1-yn-1-yl group, Dec-9-yn-1-yl group, undec-1-yn-1-y
  • the saturated or unsaturated alicyclic hydrocarbon group is preferably a saturated alicyclic hydrocarbon group and is not particularly limited.
  • monovalent groups include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cyclo A heptyl group, a cyclooctyl group, and a group containing an alicyclic residue such as those residues are included.
  • the aromatic hydrocarbon group is not particularly limited, but includes, for example, a phenyl group, a naphthyl group, an anthracenyl group, and groups containing aromatic ring residues such as residues thereof.
  • a condensed ring may be formed together with the substituents described in [Substituent] below.
  • Examples of monovalent aromatic hydrocarbon groups include, but are not limited to, phenyl, 2-methylphenyl, 3-methylphenyl, 4-methylphenyl, 2,4-dimethylphenyl, 2,5 -dimethylphenyl group, 3,4-dimethylphenyl group, 3,5-dimethylphenyl group, 2,4,5-trimethylphenyl group, 2,4,6-trimethylphenyl group, 4-ethylphenyl group, 4-propyl phenyl group, 4-isopropylphenyl group, 4-butylphenyl group, 4-tert-butylphenyl group, 4-pentylphenyl group, 4-tert-pentylphenyl group, 2,4-bis(4-tert-pentyl)phenyl group, 1,1,3,3-tetramethylbutylphenyl group, 2-methyl-5-tert-butylphenyl group, 4-pentylphenyl group, 4-hexylphenyl group, 4-hepty
  • divalent hydrocarbon groups examples include groups obtained by removing one hydrogen atom from the above groups.
  • substituents examples include, but are not limited to, hydrocarbon groups, oxygen-containing groups, nitrogen-containing groups, sulfur-containing groups, phosphorus-containing groups, and halogens. Substituents also include groups to which these substituents are bonded.
  • hydrocarbon group examples include those listed in the above [hydrocarbon group].
  • oxygen-containing groups include, but are not limited to, hydroxyl groups, alkoxy groups, acetoxy groups, acetyl groups, aldehyde groups, carboxyl groups, carboxylate groups, urea groups, urethane groups, amide groups, imide groups, ether groups, carbonyl group, ester group, oxazole group, morpholine group, carbamate group, carbamic acid group, carbamoyl group, polyoxyethylene group, tocopheryl group, chroman group, dihydropyran group, glyceryl group, glyceryl ether group and the like.
  • nitrogen-containing groups include, but are not limited to, cyano groups, cyanato groups, isocyanate groups, nitro groups, nitroalkyl groups, amide groups, urea groups, urethane groups, imide groups, carbodiimide groups, azo groups, pyridyl groups, imidazole group, pyrrolidyl group, piperidyl group, pyrrolyl group, pyrazyl group, triazole group, isoquinolyl group, oxazolyl group, thiazolyl group, morpholyl group, guanidyl group, pyrimidyl group, piperazyl group, triazyl group, quinolyl group, indole group, quinoxalyl group , an isoxazolyl group, a primary amino group, a secondary amino group, a tertiary amino group, a quaternary ammonium group, an aminoalkyl group and the like.
  • sulfur-containing groups include, but are not limited to, sulfuric acid group, sulfonyl group, sulfonic acid group, mercapto group, thioether group, thiocarbonyl group, thiourea group, thiocarboxy group, thiocarboxylate group, dithiocarboxy group, Dithiocarboxylate group, sulfate ester, thiophene group, thiazole group, thiol group, sulfo group, sulfide group, disulfide group, thioester group, thioamide group, thiocarbamate group, dithiocarbamate group and esters thereof.
  • Examples of phosphorus-containing groups include, but are not limited to, phosphoric acid group, phosphorous acid group, phosphonic acid group, phosphinic acid group, phosphonous acid group, phosphinic acid group, pyrophosphate group, phosphate ester group, Phosphate ester group, phosphonate ester group, pyrophosphate group, ester group thereof and the like.
  • Halogen includes fluorine, chlorine, bromine, and iodine.
  • Examples of the organic group include hydrocarbon groups that may have a substituent and whose hydrocarbon portion may contain an oxygen atom.
  • hydrocarbon group the contents described in the above [Hydrocarbon group] column are referred to.
  • the hydrocarbon group is preferably an aliphatic hydrocarbon group, more preferably a saturated aliphatic hydrocarbon group (such as an alkyl group).
  • the alkyl group may be, for example, 1 to 22, 4 to 22, 8 to 22, or 12 to 22 carbon atoms, linear or branched, and may have 1 to 18, 1 to 12, or 1 to 18 carbon atoms. 4 may be linear or branched.
  • the hydrocarbon group may have a substituent, and the substituent is not particularly limited, but includes, for example, those described in the above [Substituent] column.
  • substituents those having an oxygen-containing group are preferred, and among these, a hydroxyl group, a carboxyl group, a carboxylate group, an ester group, an ether group, and an alkoxy group are preferred.
  • a hydroxyl group, a carboxyl group, a carboxylate group, an ether group, and an alkoxy group are more preferable, and a hydroxyl group is particularly preferable.
  • the hydrocarbon moiety may contain an oxygen atom.
  • the hydrocarbon moiety includes the oxygen-containing group described above, and is not particularly limited. Examples include an ether bond, a carbonyl group, a hydroxyl group, a carboxylate group and an ester bond. , amide bond, urea bond or urethane bond. Therefore, in the present invention, "the hydrocarbon moiety contains an oxygen atom” means that the hydrocarbon moiety is interrupted by a group that may also contain a heteroatom such as a nitrogen atom as an atomic group containing an oxygen atom, or the group is Including at the ends or when a hydrogen atom is substituted.
  • the component (A) has a chemical structure that is a basic skeleton, such as a site where a functional group can be introduced in the component (A) (a nitrogen site, a carbon site that forms a ring with nitrogen, etc.) contained atoms) are replaced with organic groups, one or more of which have hydrogen-bonding functional groups.
  • a hydrogen atom directly bonded to nitrogen constitutes a hydrogen-bonding functional group.
  • the hydrogen-bonding functional group is not particularly limited. Examples include a hydrogen atom, and an oxygen-containing group is preferred.
  • Hydrogen-bonding functional groups in component (A) include, from the viewpoint of affinity for water and affinity for organic and inorganic materials capable of bonding and coordinating with hydrogen-bonding functional groups, hydroxyl group, carboxyl group, and the like.
  • Groups, carboxylate groups, ester groups, ether groups, alkoxy groups, hydrogen atoms directly bonded to nitrogen are preferred.
  • a hydroxyl group, a carboxy group, a carboxylate group, an ether group, an alkoxy group, and a hydrogen atom directly bonded to nitrogen are more preferable, and a hydroxyl group, a carboxy group, a carboxylate group, and a hydrogen atom directly bonded to nitrogen are more preferable.
  • a hydrogen atom directly bonded to a hydroxyl group, a carboxy group, or nitrogen is particularly preferred, and a hydrogen atom directly bonded to a hydroxyl group or nitrogen is most preferred.
  • a preferred example of the organic group having a hydrogen-bonding functional group is a hydrocarbon group having a hydrogen-bonding functional group.
  • the organic group having a hydrogen bonding functional group includes a hydrocarbon group containing a hydroxyl group (hydroxy hydrocarbon group), a hydrocarbon group containing a carboxy group (carboxy hydrocarbon group), and a hydrocarbon group containing a hydroxyl group and a carboxy group.
  • hydroxycarboxy hydrocarbon group a hydrocarbon group containing a carboxylate group, a hydrocarbon group containing an ester group, a hydrocarbon group containing an ether group, a hydrocarbon group containing an alkoxy group, and the like.
  • the component (A) is a hydroxyhydrocarbon having one or more hydroxyl groups, a straight-chain or branched hydrocarbon moiety, and the hydrocarbon moiety may contain an oxygen atom. It is preferred to have a group.
  • the hydrocarbon group includes a saturated or unsaturated aliphatic hydrocarbon group, a saturated or unsaturated alicyclic hydrocarbon group, an aromatic hydrocarbon group, etc., and a hydrocarbon group combining them. Common hydrocarbon groups can be used as these hydrocarbon groups. Among the above hydrocarbon groups, saturated aliphatic hydrocarbon groups are preferred. Examples of the hydrocarbon group include those described in the section [Hydrocarbon group] below.
  • the hydroxy hydrocarbon group has one or more hydroxyl groups
  • the hydrocarbon moiety preferably has 1 to 22 carbon atoms, more preferably 1 to 18 carbon atoms, and still more preferably 1 to 1 carbon atoms. 12, particularly preferably straight or branched having 1 to 6 carbon atoms, and the hydrocarbon moiety may contain an oxygen atom.
  • the hydrocarbon portion contains an oxygen atom
  • the oxygen atom forms, for example, an ether bond, a carbonyl group, an ester bond, an amide bond, a urea bond, or a urethane bond with the hydrocarbon portion.
  • the hydrocarbon moiety contains an oxygen atom means that the hydrocarbon moiety is interrupted by a group that may also contain a heteroatom such as a nitrogen atom as an atomic group containing an oxygen atom, or the group is Including at the ends or when a hydrogen atom is substituted.
  • hydroxy hydrocarbon group a saturated or unsaturated aliphatic hydrocarbon group having one or more hydroxy groups, a saturated or unsaturated alicyclic hydrocarbon group, an aromatic hydrocarbon group, or a hydrocarbon combination thereof groups, preferably a saturated aliphatic hydrocarbon group having one hydroxy group (monohydroxyalkyl group, etc.), a saturated aliphatic hydrocarbon group having two or more hydroxy groups (polyhydroxyalkyl group, etc.), and the oxygen Containing groups may be included.
  • the saturated aliphatic hydrocarbon group having one hydroxy group is not particularly limited, but examples thereof include hydroxymethyl group, 1-hydroxyethyl group, 2-hydroxyethyl group, 1-hydroxypropane-1 -yl group, 2-hydroxypropan-1-yl group, 3-hydroxypropan-1-yl group, 1-hydroxypropan-2-yl group, 2-hydroxypropan-2-yl group, 2-hydroxymethylpropane- 2-yl group, 2-hydroxyethylpropan-2-yl group, 1-hydroxybutan-1-yl group, 2-hydroxybutan-1-yl group, 3-hydroxybutan-1-yl group, 4-hydroxybutane -1-yl group, 1-hydroxy-2-methylpropan-1-yl group, 2-hydroxy-2-methylpropan-1-yl group, 3-hydroxy-2-methylpropan-1-yl group, 1- Hydroxybutan-2-yl group, 2-hydroxybutan-2-yl group, 3-hydroxybutan-2-yl group, 4-hydroxybutan-2-yl group, 1-hydroxymethyl group, 2-hydroxybutan-2
  • the saturated aliphatic hydrocarbon group having two or more hydroxy groups is not particularly limited, and examples thereof include di-, tri-, tetra-, penta-, hexa-, hepta-, and octahydroxyalkyl groups. .
  • dihydroxyethyl groups such as 1,2-dihydroxyethyl group; 1,2-dihydroxypropan-1-yl group, 2,3-dihydroxypropan-1-yl group dihydroxypropan-1-yl group; 1,2-dihydroxypropan-2-yl group, dihydroxypropan-2-yl group such as 1,3-dihydroxypropan-2-yl group; trihydroxypropan-1-yl group; trihydroxypropan-2-yl group; trihydroxypropan-1-yl group; trihydroxypropan-1-yl group; trihydroxypropan-2-yl group; 1,2-dihydroxybutan-1-yl group, 1,3-dihydroxybutan-1-yl group , 1,4-dihydroxybutan-1-yl group, 2,3-dihydroxybutan-1-yl group, 2,4-dihydroxybutan-1-yl group, 3,4-dihydroxybutan-1-yl group, etc.
  • dihydroxyethyl groups such as 1,2-dihydroxyethyl group; 1,2-
  • dihydroxybutan-1-yl group 1,2,3 trihydroxybutan-1-yl group, 1,2,4 trihydroxybutan-1-yl group, 1,3,4 trihydroxybutan-1-yl group, trihydroxybutan-1-yl group such as 2,3,4 trihydroxybutan-1-yl group; tetrahydroxybutan-1-yl group; 1,2-dihydroxy-2-methylpropan-1-yl group, 1 , 3-dihydroxy-2-methylpropan-1-yl group, dihydroxy-2-methylpropan-1-yl group such as 2,3-dihydroxy-2-methylpropan-1-yl group; trihydroxy-2-methyl Propan-1-yl group; Tetrahydroxy-2-methylpropan-1-yl group; 1,2-dihydroxybutan-2-yl group, 1,3-dihydroxybutan-2-yl group, 1,4-dihydroxybutane -2-yl group, 2,3-dihydroxybutan-2-yl group, 2,4-dihydroxybutan-2-yl group, 3,4-dihydroxy
  • the polyhydroxyalkyl group preferably has 2 to 8 hydroxyl groups, more preferably 2 to 6 hydroxyl groups, and the alkyl group preferably has 1 to 22 carbon atoms, more preferably 1 to 18 carbon atoms. , those having 1 to 12 carbon atoms are more preferred, and those having 1 to 6 carbon atoms are particularly preferred.
  • a branched polyhydroxyalkyl group represented by the following formula is also preferred.
  • R 7 is a hydrogen atom, a linear alkyl group having 1 to 8 carbon atoms (preferably 1 to 4 carbon atoms), or a linear alkyl group having 1 to 8 carbon atoms (preferably 1 to 4 carbon atoms) indicates a hydroxyalkyl group.
  • the group of the above formula is not particularly limited, but examples include 1,2-dihydroxypropan-1-yl group, 2,3-dihydroxypropan-1-yl group, 1,2-dihydroxypropan-2-yl group, 1,3-dihydroxypropan-2-yl group, trihydroxypropan-1-yl group, trihydroxypropan-2-yl group, trihydroxypropan-1-yl group, trihydroxypropan-2-yl group, 1, 2-dihydroxybutan-1-yl group, 1,3-dihydroxybutan-1-yl group, 1,4-dihydroxybutan-1-yl group, 2,3-dihydroxybutan-1-yl group, 2,4- Dihydroxybutan-1-yl group, 3,4-dihydroxybutan-1-yl group, 1,2,3-trihydroxybutan-1-yl group, 1,2,4-trihydroxybutan-1-yl group 1,3 ,4-trihydroxybutan-1-yl group, 2,3,4-trihydroxybutan-1-yl group, tetrahydroxybutan
  • 2,3-dihydroxypropan-1-yl group, 1,3-dihydroxypropan-2-yl group, 1,3-dihydroxy-2-ethylpropan-2-yl group, 1 ,3-dihydroxy-2-hydroxymethylpropan-2-yl group and pentahydroxyhexan-1-yl group are preferable, and from the viewpoint of antibacterial properties, 1,3-dihydroxy-2-ethylpropan-2-yl group, 1, A 3-dihydroxy-2-hydroxymethylpropan-2-yl group is more preferred.
  • component (A) has a monohydroxyalkyl group
  • triethanolamine and diethanolamine are preferred, and triethanolamine is particularly preferred.
  • component (A) is specified in the Standards for Quasi-drug Ingredients (Quasi-drugs Ingredients), Standards for Quasi-drug Additives, Japanese Pharmacopoeia (Japanese Pharmacopoeia), Japanese Pharmacopoeia Drugs It is preferable to use compounds listed in the Standards for Quasi-Drugs (Regulations), Pharmaceutical Additives Standards (Medicine Additives), and Food Additives Standards (Food Additives) as raw materials (e.g.
  • acids, bases especially limited monoethanolamine, diethanolamine, triethanolamine, 2-amino-2-hydroxymethyl-1, 3-propanediol, 2-amino-2-methyl-1-propanol, 2-amino-2-methyl-1 , 3-propanediol, monoisopropanolamine, diisopropanolamine, triisopropanolamine, 2-acetamidoethanolamine, N-lauryldiethanolamine, and dimethyloctadecylamine are preferred.
  • triethanolamine 2- Amino-2-hydroxymethyl-1,3-propanediol is more preferred.
  • one of the moieties in component (A) into which a functional group can be introduced is The above may be substituted with an organic group that does not have a hydrogen-bonding functional group.
  • organic groups include, for example, hydrocarbon groups.
  • Hydrocarbon groups include, for example, alkyl groups. The alkyl group is preferably linear or branched with 1 to 18 carbon atoms, more preferably linear or branched with 1 to 12 carbon atoms, and even more preferably linear or branched with 1 to 8 carbon atoms. , a linear or branched chain having 1 to 4 carbon atoms is more preferable.
  • the anion is not particularly limited, but examples include hydroxide anions, halogen anions, sulfur anions, phosphorus anions, cyanide anions, and boron anions. , fluorine-based anions, nitrogen oxide-based anions, carboxylic acid-based anions, and the like, and among these, hydroxide anions are preferred.
  • component (A) is preferably an amine compound represented by the following formula (I).
  • each R 1 independently has one or more hydroxyl groups, the hydrocarbon moiety is linear or branched with 1 to 22 carbon atoms, and the hydrocarbon moiety contains an oxygen atom. represents a good hydroxy hydrocarbon group, each R 2 is independently a hydrogen atom or an organic group having 1 to 22 carbon atoms, and m is an integer of 0 to 3.
  • m is preferably an integer of 1-3.
  • R 2 are preferably hydrogen atoms.
  • the hydrocarbon in the hydrocarbon moiety that may contain an oxygen atom is preferably a saturated aliphatic hydrocarbon.
  • At least one of R 1 has one hydroxyl group, and the hydrocarbon in the hydrocarbon moiety optionally containing an oxygen atom is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group. is preferred.
  • At least one of R 1 has two or more hydroxyl groups, and the hydrocarbon in the hydrocarbon moiety which may contain an oxygen atom is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group.
  • the hydrocarbon in the hydrocarbon moiety which may contain an oxygen atom is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group.
  • At least one of R 1 has one or more hydroxyl groups
  • the hydrocarbon moiety is a branched chain having 3 to 22 carbon atoms, and the hydrocarbon moiety may contain an oxygen atom.
  • a combination of at least one of the above preferred examples shown in formula (I) can be a more preferred embodiment.
  • R 1 has one hydroxyl group, the hydrocarbon moiety is a linear hydroxy hydrocarbon group having 1 to 6 carbon atoms, R 2 is a hydrogen atom, and m is 1 to An integer of three is preferred.
  • R 1 has 2 or 3 hydroxyl groups, the hydrocarbon moiety is a branched hydroxy hydrocarbon group having 2 to 6 carbon atoms, R 2 is a hydrogen atom, and m is An integer of 1 is preferred.
  • R 1 has 2 to 6 hydroxyl groups, the hydrocarbon moiety is a linear hydroxy hydrocarbon group having 2 to 6 carbon atoms, R 2 is a hydrogen atom, and m is An integer of 1 is preferred.
  • component (A) is an ammonium compound
  • said component (A) is preferably an ammonium compound represented by the following formula (II).
  • each R 3 independently has one or more hydroxyl groups, the hydrocarbon moiety is linear or branched with 1 to 22 carbon atoms, and the hydrocarbon moiety contains an oxygen atom. represents a good hydroxy hydrocarbon group, each R 4 is independently a hydrogen atom or an organic group having 1 to 22 carbon atoms, n represents an integer of 0 to 4, and X ⁇ represents an anion.
  • the anion represented by X ⁇ is preferably a hydroxide ion.
  • n is preferably an integer of 1-4.
  • R 4 are preferably hydrogen atoms.
  • the hydrocarbon in the hydrocarbon moiety which may contain an oxygen atom is preferably a saturated aliphatic hydrocarbon.
  • At least one of R 3 has one hydroxyl group, and the hydrocarbon in the hydrocarbon moiety optionally containing an oxygen atom is preferably a hydroxy hydrocarbon group in which the hydrocarbon is a saturated aliphatic hydrocarbon.
  • At least one of R 3 has two or more hydroxyl groups, and the hydrocarbon in the hydrocarbon moiety which may contain an oxygen atom is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group.
  • the hydrocarbon in the hydrocarbon moiety which may contain an oxygen atom is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group.
  • the hydrocarbon in the hydrocarbon moiety which may contain an oxygen atom is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group.
  • At least one of R 3 has one or more hydroxyl groups
  • the hydrocarbon moiety is a branched chain having 3 to 22 carbon atoms, and the hydrocarbon moiety may contain an oxygen atom.
  • R 3 has one hydroxyl group, the hydrocarbon moiety is a hydroxy hydrocarbon group having 1 to 3 carbon atoms, R 4 is a hydrocarbon group having 1 to 3 carbon atoms, and n preferably denotes an integer of 1.
  • R 4 is a hydrocarbon group having 1 to 4 carbon atoms, and n preferably represents an integer of 0.
  • Another preferred embodiment of the antibacterial agent of the present invention is an organic ammonium salt formed by component (A) and component (B).
  • an organic ammonium salt formed by a cation derived from the component (A), which may have a cationic residue of the component (B), and an anion derived from the anionic residue of the component (B). contains The cation is preferably an ammonium cation.
  • the residue in the component (B) refers to an uncharged atom or atomic group (group), a cationic residue having a charge that becomes a cation, and an anionic residue that becomes an anion.
  • the carboxylic acid or its salt of component (B) has a cationic residue and an anionic residue.
  • the cationic residue is a hydrogen atom or a group (atomic group) that combines with the nitrogen atom of component (A) to form a hydrogen-bonding functional group or an organic group.
  • the acid of component (B) is a compound composed of protonated hydrogen and an anionic residue.
  • the organic ammonium salt includes an organic cation or NH 4 + having a nitrogen atom as the ion center, and an organic anion.
  • organic includes organic cations and organic anions.
  • organic is meant to include carbon and hydrogen as elements.
  • cations derived from component (A) include ammonium cations (NH 4 + , primary ammonium cations, secondary ammonium cations, tertiary ammonium cations), guanidinium cations, and imidazolium cations, although not particularly limited.
  • ammonium cation ammonium cation, imidazolium cation, pyridinium cation, pyrrolidinium cation, piperidinium cation, and morpholinium cation are preferred, and ammonium cation is more preferred.
  • the cation of the organic ammonium salt formed by the component (A) and the component (B) is preferably a cation represented by the following formula (III). Moreover, when the component (A) is an ammonium compound, its cation is also preferably a cation represented by the following formula (III).
  • each R 5 independently has one or more hydroxyl groups, the hydrocarbon moiety is linear or branched with 1 to 22 carbon atoms, and the hydrocarbon moiety contains an oxygen atom. represents a good hydroxy hydrocarbon group, each R 6 is independently a hydrogen atom or an organic group having 1 to 22 carbon atoms, and o represents an integer of 0 to 4.
  • o is preferably an integer of 1-4.
  • R 6 are preferably hydrogen atoms.
  • the hydrocarbon in the hydrocarbon moiety that may contain an oxygen atom is preferably a saturated aliphatic hydrocarbon.
  • At least one of R 5 has one hydroxyl group, and the hydrocarbon in the hydrocarbon moiety optionally containing an oxygen atom is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group. is preferred.
  • At least one of R 5 has two or more hydroxyl groups, and the hydrocarbon in the hydrocarbon moiety optionally containing an oxygen atom is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group.
  • the hydrocarbon in the hydrocarbon moiety optionally containing an oxygen atom is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group.
  • At least one of R 5 has one or more hydroxyl groups
  • the hydrocarbon moiety is a branched chain having 3 to 22 carbon atoms, and the hydrocarbon moiety may contain an oxygen atom.
  • R 6 of the cation represented by the formula (III) is a hydrogen atom
  • the proton corresponding to the hydrogen atom is preferably derived from the component (B).
  • a combination of at least one of the above preferred examples shown in formula (III) can be a more preferred embodiment.
  • component (B) is a carboxylic acid or its salt.
  • the carboxylic acid is an organic acid having at least one carboxy group (--COOH) in the molecule, and has an oxygen-containing group, a nitrogen-containing group, a sulfur-containing group, a phosphorus-containing group, a hydrocarbon group, and the like.
  • the carboxylic acid includes, for example, a saturated or unsaturated aliphatic hydrocarbon group, a saturated or unsaturated alicyclic hydrocarbon group, an aromatic hydrocarbon group, etc., and a hydrocarbon group combining them.
  • those having a carboxy group such as saturated aliphatic carboxylic acids, unsaturated aliphatic carboxylic acids, saturated or unsaturated alicyclic carboxylic acids, aromatic carboxylic acids, saturated aliphatic hydroxycarboxylic acids, unsaturated aliphatic hydroxycarboxylic acids, saturated or unsaturated alicyclic hydroxycarboxylic acids, aromatic hydroxycarboxylic acids, carbonylcarboxylic acids, alkyl ether carboxylic acids, halogen carboxylic acids, etc. (the number of carbon atoms in the carboxylic acids listed below is carboxy group of carbon.).
  • the saturated aliphatic carboxylic acid is composed of a linear or branched saturated aliphatic hydrocarbon group and one or more carboxy groups, and preferably has 1 to 22 carbon atoms.
  • saturated aliphatic carboxylic acids include saturated aliphatic monocarboxylic acids having one carboxy group and saturated aliphatic dicarboxylic acids having two carboxy groups.
  • the saturated aliphatic monocarboxylic acid is composed of a linear or branched saturated aliphatic hydrocarbon group and one carboxy group, and preferably has 1 to 22 carbon atoms.
  • formic acid acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, enanthic acid, caprylic acid, pelargonic acid, capric acid, lauric acid, myristic acid, pentadecyl acid, palmitic acid , margaric acid, stearic acid, arachidic acid, henicosyl acid, behenic acid, isobutyric acid, 2-methylbutyric acid, isovaleric acid, 2-ethylhexanoic acid, isononanoic acid, isopalmitic acid, isostearic acid and the like.
  • the saturated aliphatic dicarboxylic acid is composed of a linear or branched saturated aliphatic hydrocarbon group and two carboxy groups, and preferably has 2 to 22 carbon atoms. Specific examples include, but are not limited to, oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, and sebacic acid.
  • the unsaturated aliphatic carboxylic acid is composed of a linear or branched unsaturated aliphatic hydrocarbon group and one or more carboxy groups, and preferably has 3 to 22 carbon atoms.
  • unsaturated aliphatic carboxylic acids include unsaturated aliphatic monocarboxylic acids having one carboxy group and unsaturated aliphatic dicarboxylic acids having two carboxy groups.
  • the unsaturated aliphatic monocarboxylic acid is composed of a linear or branched unsaturated aliphatic hydrocarbon group and one carboxy group, and preferably has 1 to 22 carbon atoms.
  • the unsaturated aliphatic dicarboxylic acid is composed of a linear or branched unsaturated aliphatic hydrocarbon group and two carboxy groups, preferably having 1 to 22 carbon atoms. Specific examples include, but are not particularly limited to, maleic acid and fumaric acid.
  • the saturated or unsaturated alicyclic carboxylic acid is composed of a saturated or unsaturated carbocyclic ring having no aromaticity and one or more carboxy groups, and preferably has 6 to 20 carbon atoms. Among them, a saturated alicyclic carboxylic acid having a cyclohexane ring skeleton is preferred.
  • Saturated or unsaturated alicyclic carboxylic acids include saturated or unsaturated alicyclic monocarboxylic acids having one carboxy group and saturated or unsaturated alicyclic dicarboxylic acids having two carboxy groups. Examples of the saturated or unsaturated alicyclic monocarboxylic acid include, but are not particularly limited to, cyclohexanecarboxylic acid. Examples of the saturated or unsaturated alicyclic dicarboxylic acid include, but are not particularly limited to, cyclohexanedicarboxylic acid, tetrahydrophthalic acid, and the like.
  • the aromatic carboxylic acid is composed of a single ring or a plurality of aromatic rings and one or more carboxylic acids, and preferably has 6 to 20 carbon atoms. Among them, aromatic carboxylic acids having a benzene ring skeleton are preferred. Examples of aromatic carboxylic acids include aromatic monocarboxylic acids having one carboxy group, aromatic dicarboxylic acids having two carboxy groups, and aromatic tricarboxylic acids having three carboxy groups.
  • aromatic monocarboxylic acids include, but are not limited to, benzoic acid, cinnamic acid, toluic acid, xyllic acid, hemellitic acid, mesitylene acid, prenityl acid, mesitic acid, cumic acid, anisic acid, and veratrum acid. mentioned.
  • aromatic dicarboxylic acid include, but are not limited to, phthalic acid, isophthalic acid, terephthalic acid, and the like.
  • aromatic tricarboxylic acid include, but are not limited to, trimesic acid, hemimellitic acid, and trimellitic acid.
  • the saturated aliphatic hydroxycarboxylic acid is composed of a linear or branched saturated aliphatic hydrocarbon group, one or more carboxyl groups and one or more hydroxyl groups, and preferably has 2 to 24 carbon atoms. Among them, saturated aliphatic hydroxycarboxylic acids having 2 to 7 carbon atoms and having 1 to 5 hydroxyl groups are preferred. Examples of saturated aliphatic hydroxycarboxylic acids include saturated aliphatic hydroxymonocarboxylic acids having one carboxy group and saturated aliphatic hydroxydi- or tricarboxylic acids having two or three carboxy groups.
  • the saturated aliphatic hydroxymonocarboxylic acid preferably has 2 to 20 carbon atoms, more preferably 2 to 7 carbon atoms.
  • the number of hydroxyl groups is preferably 1-5.
  • the saturated aliphatic hydroxydicarboxylic acid is composed of a linear or branched saturated aliphatic hydrocarbon group, two carboxy groups and one or more hydroxyl groups, and preferably has 4 to 24 carbon atoms.
  • saturated aliphatic hydroxycarboxylic acids having 2 to 7 carbon atoms and having 1 to 4 hydroxyl groups are preferred. Specific examples include, but are not particularly limited to, tartronic acid, malic acid, tartaric acid, citramalic acid, and the like.
  • the saturated aliphatic hydroxytricarboxylic acid is composed of a linear or branched saturated aliphatic hydrocarbon group, three carboxy groups and one or more hydroxyl groups, and preferably has 4 to 24 carbon atoms. Among them, saturated aliphatic hydroxycarboxylic acids having 2 to 7 carbon atoms and having 1 to 4 hydroxyl groups are preferred. Specific examples include, but are not particularly limited to, citric acid, isocitric acid, and the like.
  • the unsaturated aliphatic hydroxycarboxylic acid is composed of a linear or branched saturated aliphatic hydrocarbon group, one or more carboxyl groups and one or more hydroxyl groups, and preferably has 3 to 22 carbon atoms. Specific examples include, but are not particularly limited to, ricinoleic acid, ricinoleic acid, ricineraidic acid, and the like.
  • the saturated or unsaturated alicyclic hydroxycarboxylic acid comprises a saturated or unsaturated carbocyclic ring having no aromaticity, one or more carboxyl groups and one or more hydroxyl groups, and preferably has 4 to 20 carbon atoms. .
  • saturated alicyclic hydroxycarboxylic acids having a 6-membered ring skeleton having 1 to 4 hydroxyl groups are preferable, and specifically, although not particularly limited, examples include hydroxycyclohexanecarboxylic acid, dihydroxycyclohexanecarboxylic acid, quinic acid ( 1,3,4,5-tetrahydroxycyclohexanecarboxylic acid), shikimic acid, glucuronic acid, galacturonic acid, mannuronic acid, iduronic acid, guluronic acid and the like.
  • a cyclic lactone having a hydroxyl group can also be preferably used, and specific examples thereof include, but are not limited to, ascorbic acid and erythorbic acid.
  • the aromatic hydroxycarboxylic acid is composed of an aromatic single ring or multiple rings, one or more carboxyl groups and one or more hydroxyl groups, and preferably has 6 to 20 carbon atoms.
  • aromatic carboxylic acids having a benzene ring skeleton having 1 to 5 hydroxyl groups are preferred, and specific examples include, but are not limited to, salicylic acid, hydroxybenzoic acid, dihydroxybenzoic acid, trihydroxybenzoic acid, and hydroxymethyl.
  • Benzoic acid vanillic acid, syringic acid, protocatechuic acid, gentisic acid, orceric acid, mandelic acid, benzilic acid, atrolactic acid, phloretic acid, coumaric acid, umberic acid, caffeic acid, ferulic acid, sinapic acid, cresotic acid, chlorogen acid, rosmarinic acid and the like.
  • the carbonylcarboxylic acid is a carboxylic acid having 3 to 22 carbon atoms and having a carbonyl group in the molecule, preferably a carbonylcarboxylic acid having 3 to 7 carbon atoms and having 1 to 2 carbonyl groups. Specific examples include, but are not particularly limited to, pyruvic acid, ketobutyric acid, and the like.
  • the alkyl ether carboxylic acid is a carboxylic acid having 2 to 22 carbon atoms and having an ether group in the molecule, including a polyoxyalkylene alkyl ether carboxylic acid, and a carboxylic acid having 2 to 12 carbon atoms and having 1 to 2 ether groups.
  • Alkyl carboxylic acids are preferred. Specific examples include, but are not particularly limited to, methoxyacetic acid, ethoxyacetic acid, methoxybutyric acid, ethoxybutyric acid, and the like.
  • halogen carboxylic acid a halogen carboxylic acid having 2 to 22 carbon atoms is preferable. Specifically, but not particularly limited, for example, trifluoroacetic acid, trichloroacetic acid, tribromoacetic acid, pentafluoropropionic acid, pentachloropropionic acid, pentabromopropionic acid, perfluorononanoic acid, perchlorononanoic acid, perbromonanoic acid, etc. and halogen-substituted halogen carboxylic acids.
  • carboxylic acid salt in component (B) examples include salts of the above carboxylic acid anions and cations (alkali metal cations, alkaline earth metal cations, ammonium cations, etc.).
  • carboxylic acids or salts thereof of component (B) are preferred, and carboxylic acids having a carboxy group and a hydroxyl group are more preferred from the viewpoint of antibacterial properties, and those having two or more carboxy groups and a hydroxyl group are preferred. More preferred.
  • a carboxylic acid having a hydroxyl group is one of the preferred embodiments in terms of affinity with organic materials and inorganic materials.
  • component (B) is specified in the Standards for Quasi-drug Ingredients (Quasi-drugs Ingredients), Standards for Quasi-drugs Additives, Japanese Pharmacopoeia (Japanese Pharmacopoeia), Japanese Pharmacopoeia It is preferable to use compounds listed in the Standards for Quasi-Drugs (Regulations), Standards for Pharmaceutical Additives (Medicine Additives), and Food Additives Standards (Food Additives) as raw materials.
  • Caprylic acid capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, lactic acid, glycolic acid, succinic acid, citric acid, hydrochloric acid, fumaric acid, phosphoric acid, ascorbic acid, malic acid, tartaric acid etc. and salts thereof.
  • the antibacterial agent of the present invention may contain only components (A) and (B), or may be a composition containing components (A) and (B).
  • the blending molar ratio of component (A) and component (B) is not particularly limited, and can be 1:99 to 99:1, preferably 1:9 to 9:1. , more preferably 1:5 to 5:1, still more preferably 1:3 to 3:1, particularly preferably 1:2 to 2:1, most preferably 1:1.
  • the blending of the component (A) and the component (B) is such that the valence of the component (A) is equal to or less than the valence of the component (B).
  • the component (B) when the component (B) is a polybasic acid, it may be a partially neutralized salt or a completely neutralized salt.), preferably less than equivalent in terms of antibacterial performance.
  • component (B) is a dibasic acid and component (A) has a valence of 1
  • the blending molar ratio of component (A) and component (B) can be 1:1 mol to 2:1 mol. can.
  • Two or more kinds of components (A) may be used. From the point of view of antibacterial performance, it is preferable to use an unneutralized carboxyl group, and the molar ratio of component (A) to component (B) is preferably 1:1.
  • the ratio of the total number of amino groups to the total number of carboxy groups (total number of amino groups / total number of carboxy groups) of components (A) and (B) is less than 1. is preferably
  • component (A) and component (B) form an organic ammonium salt, in addition to the carboxylate group generated by the dissociation of hydrogen ions from the carboxy group of component (A) or component (B), it participates in the formation of the salt.
  • Component (A) or component (B) preferably has one or more carboxy groups that do not participate in salt formation, and more preferably component (B) has one or more carboxy groups that do not participate in salt formation.
  • a mixture of component (A) and component (B) or a salt of component (A) and component (B) may be in an anhydrous state (anhydrous), and can absorb moisture in the air. It may be an absorbed hydrate.
  • a hydrate refers to a compound that, when left in the air at 25°C, absorbs water and has a saturated moisture content. Compounds that do not absorb water when left in air at 25° C. are non-hydrated and anhydrous.
  • the antibacterial agent of the present invention is a mixture of components (A) and (B) or a salt of (A) and (B), anhydrides and hydrates at 25 ° C. Whether liquid or solid However, for example, if it is liquid at 25 ° C., it will remain as a liquid when the solvent evaporates after spraying or applying the liquid containing the antibacterial agent of the present invention to the part to be used, and the effect will be exhibited in a wide range, and crystals will precipitate. There are no problems in use such as coagulation or agglomeration and solidification. Moreover, when it is liquid at 25° C., it can be used as a solvent or base having antibacterial properties when used with other additives. From these points of view, the anhydride and/or hydrate are preferably liquid at 25°C.
  • the surface of the object on which the antibacterial agent of the present invention is used has functional groups that interact and bond with hydrogen-bonding functional groups such as oxygen-containing groups, nitrogen-containing groups, sulfur-containing groups, phosphorus-containing groups, and metals. In this case, it interacts and bonds with the hydrogen-bonding functional groups of component (A) and/or component (B), and the antibacterial agent of the present invention adheres well to the object for a long time and can exhibit its effect. be.
  • component (A) is preferably a saturated aliphatic compound having one or more linear or branched hydroxy groups.
  • An amine compound having a hydrocarbon group, more preferably a monohydroxyalkyl group or a polyhydroxyalkyl group having 1 to 6 carbon atoms, more preferably triethanolamine, 2-amino-2-hydroxymethyl-1, 3-propanediol, 2-amino-2-ethyl-1,3-propanediol, and component (B) is preferably a saturated aliphatic hydroxycarboxylic acid (lactic acid, malic acid, citric acid, tartaric acid, etc.) and more preferably saturated aliphatic hydroxy di- or tricarboxylic acids (malic acid, citric acid, tartaric acid, etc.).
  • component (A) is a saturated aliphatic hydrocarbon having one or more linear or branched hydroxy groups from the viewpoint of antibacterial properties and safety. It is an amine compound having a group, and component (B) is a saturated aliphatic hydroxycarboxylic acid (lactic acid, malic acid, citric acid, tartaric acid, etc.).
  • component (A) is an amine having a monohydroxyalkyl group or a polyhydroxyalkyl group having 1 to 6 carbon atoms from the viewpoint of antibacterial properties and safety.
  • component (B) is a saturated aliphatic hydroxy di- or tricarboxylic acid (malic acid, citric acid, tartaric acid, etc.).
  • component (A) is triethanolamine, 2-amino-2-hydroxymethyl-1,3-propane from the viewpoint of antibacterial properties and safety.
  • diol or 2-amino-2-ethyl-1,3-propanediol and component (B) is malic acid, citric acid or tartaric acid.
  • the antibacterial agent of the present invention is a salt of components (A) and (B), it is preferable from the viewpoint of maintaining the antibacterial effect over a long period of time without volatilizing even in a low-humidity environment.
  • the form of the antibacterial agent is not particularly limited, but can be, for example, liquid, solid, gel, or cream.
  • the antibacterial agent of the present invention may contain a solvent and other components in addition to components (A) and (B).
  • solvents include, but are not limited to, water, methanol, ethanol, propanol, isopropanol, butanol, ethylene glycol, propylene glycol, 1,3-butylene glycol, diethylene glycol, dipropylene glycol, isoprene glycol, hexylene glycol, glycerin.
  • benzyl alcohol oleyl alcohol, methyl acetate, ethyl acetate, isopropyl acetate, butyl acetate, ethyl ether, acetone, toluene, hexane, heptane, paraffin, acetonitrile, etc. These may be used alone, You may use it in combination of 2 or more types.
  • Antibacterial composition antibacterial composition, antiviral composition
  • the antibacterial composition or antiviral composition of the present invention is obtained by adding the antibacterial agent of the present invention explained above.
  • the antibacterial composition or antiviral composition of the present invention can be produced by mixing the antibacterial agent of the present invention, in which the components (A) and (B) have been blended in advance, with a solvent, other ingredients, etc. Others include blending components (A) and (B) prior to making the antimicrobial composition.
  • the properties of the antibacterial composition of the present invention are not particularly limited, but may be, for example, liquid, solid, gel, or the like. can do.
  • the form of the antibacterial composition is not particularly limited, but examples thereof include a solution obtained by diluting the components (A) and (B) in a solvent, a mixture with other components, and the like. Additives and the like added at the time of production of these, and solvents such as existing antibacterial agents, antiviral agents, disinfectants, and the like can be mentioned.
  • the antibacterial composition or antiviral composition of the present invention contains the antibacterial agent of the present invention as an essential ingredient, and other ingredients may be added to the extent that the effects of the present invention are not impaired.
  • Other ingredients are not particularly limited, but for example, the above solvents, existing antibacterial agents other than the antibacterial agent of the present invention, antiviral agents, bacteria such as disinfectants, agents having an effect on viruses, surfactants ( anionic surfactants, cationic surfactants, nonionic surfactants, amphoteric surfactants, etc.), resins, UV absorbers (including organic and inorganic), fragrances, moisturizers, metal oxides , neutralizers, pH adjusters, coloring agents, antioxidants, corrosion inhibitors, rust inhibitors, metal deactivators, antifoaming agents and the like. These may be used individually by 1 type, and may be used in combination of 2 or more type.
  • the content of components (A) and (B) in the antibacterial composition or antiviral composition of the present invention is not particularly limited, but is, for example, 1 to 100% by mass relative to the total amount of the composition, or 10 to 90% by mass.
  • organic ammonium salts are non-volatile, and liquid compounds in particular can be uniformly coated in a high-concentration state after the volatile components evaporate, providing effective and long-lasting antibacterial properties.
  • it also exerts an effect as a solvent for drugs that are effective against bacteria and viruses, such as existing antibacterial agents, antiviral agents, and disinfectants.
  • existing antibacterial agents, antiviral agents, disinfectants, etc. can be blended at higher concentrations.
  • even a solid drug can be maintained in a dissolved state and uniformly coat the surface of the object. Therefore, in addition to the antibacterial properties of the antibacterial agent of the present invention, it is possible to sufficiently exhibit the effects of existing antibacterial agents, antiviral agents, disinfectants, and the like.
  • a synergistic effect can be expected between the formulation of the present invention and existing antibacterial agents, antiviral agents, and disinfectants, and antibacterial and antiviral properties can be obtained at lower concentrations.
  • Examples of the existing antibacterial agents include, but are not limited to, paraoxybenzoic acid esters such as methylparaben and sodium salts thereof, benzoic acid and salts thereof, salicylic acid and salts thereof, sorbic acid and salts thereof, dehydroacetic acid and salts thereof, Chlorcresol, resorcinol, pantothenyl ethyl benzoate, isopropylmethylphenol (cymen-5-ol), cetylpyridinium chloride, photosensitizer, phenol, sodium lauryldiaminoethylglycinate, benzalkonium chloride, benzethonium chloride, chlorhexidine and its salts , orthophenylphenol and its salts, chloroxylenol, chlorphenesin, alkylisoquinolinium bromide, thianthol, thymol, trichlorocarbanilide, parachlorophenol, halocarbane, hinokitio
  • the drug effective against viruses is not particularly limited, but examples include sodium linear alkylbenzene sulfonate, alkyl glycoside, alkylamine oxide, benzalkonium chloride, benzethonium chloride, dialkyldimethylammonium chloride, polyoxyethylene alkyl ether, Fatty acid potassium, fatty acid sodium, chlorhexidine gluconic acid, polyhexamethylene biguanide, o-phthalaldehyde (phthalal), glutaraldehyde (glutaral), povidone iodine, sodium hypochlorite, peracetic acid and the like.
  • the amount of the above-mentioned existing antibacterial agents, antiviral agents, antiseptics, and other agents that are effective against bacteria and viruses is not particularly limited, although it depends on the compatibility with the antibacterial agent of the present invention and the solubility in the solvent. However, it can be 0.01% to 10% by weight of the antibacterial composition, and the weight ratio with the antibacterial agent of the present invention can be 1:99 to 99:1.
  • the mixture of components (A) and (B) or the salt of (A) and (B) to be incorporated into the antibacterial agent of the present invention is non-volatile. Therefore, when the antibacterial composition is used, the volatile components such as water and alcohol contained in the antibacterial composition evaporate, and the existing antibacterial agents, antiviral agents, disinfectants, etc. are effective against bacteria and viruses. higher drug concentration Therefore, the antibacterial composition can exert its effect even at a low concentration when used.
  • each of the above preferred examples shown in formula (I), each of the above preferred examples shown in formula (II), and each of the above preferred examples shown in formula (III) are at least any of them. Any combination can be a more preferable embodiment based on the results of the examples. At least one combination of all of the above preferred examples shown in formulas (I) to (III) can be a more preferred embodiment based on the results of the examples.
  • Staphylococcus aureus strain NBRC15035 NITE Potassium lactate: Medium manufactured by Fujifilm Wako Pure Chemicals Muller-Hinton broth: Medium manufactured by Becton, Dickinson and Company L-Dried product restoration medium "Daigo”: Calcium chloride manufactured by Fujifilm Wako Purechemicals: Magnesium chloride manufactured by Fujifilm Wako Pure Chemicals : Fuji Film Wako Pure Chemical Sodium Chloride : Fuji Film Wako Pure Chemical Skim Milk : Snow Brand Megmilk Meat Extract : Solabia Biokar Diagnostics Peptone : Solabia Biokar Diagnostics Sodium Chloride : Fuji Film Wako Pure Chemical Agar : Fuji Film Wako Pure Chemical Made
  • formulations (salts) The formulations (salts) of Examples 1 to 8 and 21 to 43 were prepared by the method described in JP 2019-023185, and the state at 25 ° C. was confirmed (Tables 1A to 1D). .
  • Antibacterial evaluation 1 minimum inhibitory concentration of formulation (salt) Examples 1 to 8, 21 to 43, Comparative Examples 1, 8, and 9 shown in Tables 1A to 1D, 2A, and 2B for Staphylococcus aureus minimal inhibitory concentrations (MIC) were measured by the microdilution method (Japanese Society of Chemotherapy standard (described in the law) to confirm the antibacterial activity of various compounds (salts).
  • Formulation (salt) concentrations of 250, 200, 150, 100, 50, 25, 12.5, 8, 4, 2, 0.8, 0.4, 0.2, 0.1, 0.05 mg/mL were evaluated and the MICs are shown in Tables 1A-1D. A lower MIC value indicates better antibacterial activity.
  • Antibacterial evaluation 2 of compound (salt) (halo test 1)
  • a halo test was performed using Staphylococcus aureus with reference to JISL1902.
  • Filter paper for Kiriyama funnel manufactured by Kiriyama Seisakusho
  • the filter paper was placed on the medium containing the bacterial cells, and the formulation (salt) aqueous solution (execution Examples 9 to 11 and Comparative Examples 2 to 4) were added dropwise at 100 ⁇ L. After that, culture was performed, and the presence or absence of halos was visually confirmed, and the presence or absence of halos is shown in Tables 2A and 2B.
  • Adhesion evaluation and antibacterial evaluation 3 (halo test 2) of formulation (salt) 4-1.
  • Adhesion Evaluation 100 ⁇ L of the compound (salt) aqueous solution (Examples 9 to 11) having the concentration shown in Tables 2A and 2B was dropped onto a 21 ⁇ m/m filter paper for Kiriyama funnel, and vacuum-dried at 60° C. for 8 hours. The adhesion rate of the sample was calculated from the weight change of the filter paper (Tables 2A and 2B).
  • 100 ⁇ L of water was dropped onto the filter paper and the filter paper was dried in a vacuum.
  • Weight of attached sample weight of filter paper after drying (mg) - weight of filter paper before test (mg) + correction value (1.15 mg)
  • Polyoxyethylene alkyl ether manufactured by Miyoshi Oil & Fat Co., Ltd.: Peletex 2465
  • alkyl glycoside manufactured by Tokyo Chemical Industry Co., Ltd.: n-octyl ⁇ -D-glucopyranoside
  • benzalco chloride which is an antiviral substance that is recognized to be effective against viruses
  • Nacalai Tesque benzalkonium chloride
  • benzethonium chloride manufactured by Tokyo Chemical Industry: benzethonium chloride
  • o-phthalaldehyde manufactured by Fuji Film Wako Pure Chemical: phthalaldehyde
  • the formulation (salt) of the present invention dissolves sparingly water-soluble antibacterial agents and other antiviral substances well, resulting in an antibacterial composition.
  • the compound (salt) of component (A) in which R 7 in the above formula is an alkyl group tends to have a higher solubility in parabens. did.
  • Examples 19 and 20 prepared so as to contain the same amounts of the formulations of components (A) and (B) shown in Tables 4A and B and paraben, respectively, and Comparative Example 8 containing only paraben were prepared in 2. above.
  • the paraben concentration of 1.0 mg / mL (the antibacterial composition of Examples 19 and 20 is a total of 2.0 mg / mL of antibacterial agents) was evaluated, and the presence or absence of bacterial growth The presence or absence was evaluated.
  • the effect of the additive can be imparted to the composition containing the formulation (salt) of the present invention.
  • the composition obtained by adding (dissolving) the antiviral substance in (1) is endowed with antiviral properties in addition to antibacterial properties.
  • Comparing Example 44 with Comparative Examples 10 and 11 growth of bacteria was not observed in Example 44, but growth of bacteria was confirmed in Comparative Examples 10 and 11. Further, when comparing Comparative Examples 10 and 11, it was confirmed that Comparative Example 10 proliferated a larger amount of cells. In Comparative Example 10, it was confirmed that the bacteria that had originally adhered to the filter paper and the bacteria that had adhered to the filter paper during the standing period proliferated, and in Comparative Example 11, the bacteria that had adhered to the filter paper were inactivated by the bactericidal action of ethanol. , it is considered that the adhered bacterial cells were confirmed after ethanol volatilization.
  • Example 44 since the composition of the present invention was non-volatile, the composition adhered to the paper after water evaporation in a high-concentration state, and the antibacterial effect was maintained. Conceivable. Therefore, it was suggested that the composition of the present invention is non-volatile, so that it does not volatilize while adhering to the filter paper and can exhibit antibacterial effects for a long period of time.

Abstract

Provided are a novel antibacterial agent having a high safety and long-lasting effect, an antibacterial composition and an antiviral composition. The antibacterial agent of the present invention is a formulation comprising the following components (A) and (B). (A) An amine or an ammonium compound having a hydrogen-bonding functional group (excluding an amino acid). (B) A carboxylic acid or a salt thereof.

Description

抗菌剤とそれを用いた抗菌性組成物及び抗ウイルス性組成物Antibacterial agent and antibacterial composition and antiviral composition using the same
 本発明は、抗菌剤とそれを用いた抗菌性組成物及び抗ウイルス性組成物に関する。 The present invention relates to an antibacterial agent and an antibacterial composition and an antiviral composition using the same.
 従来から細菌による汚染や腐敗の防止や、細菌による感染の予防及び治療を目的として、種々の抗菌剤が様々な分野において使用されている。近年では新規感染症の流行等から、公衆衛生に対する関心がますます高くなっている。こうした時代背景の中で、人体や人体と接触する部材の表面を清潔に保つための薬剤のニーズが高まっている。これらの用途では通常エタノールをはじめとするアルコール系の薬剤が使用されているが、体質的にアルコールに弱い人は使用し辛いことや、揮発性が高く表面へ残留しないために長期間の抗菌性に劣るという問題がある。また次亜塩素酸ナトリウム水や次亜塩素酸水といった塩素系の薬剤も使用されるが、次亜塩素酸ナトリウムは強アルカリ性で人体への使用は推奨されていないことや酸性の溶液と混合すると塩素ガスを発生するなど使用時には制約がある。また、次亜塩素酸水は保存安定性に難があることなどにより長期間の抗菌性に劣ることや使用時の有効塩素濃度の低減などが問題であった。 Conventionally, various antibacterial agents have been used in various fields for the purpose of preventing bacterial contamination and putrefaction, and preventing and treating bacterial infections. In recent years, due to the epidemic of new infectious diseases, etc., interest in public health is increasing more and more. Against this backdrop of the times, there is a growing need for chemicals to keep the surfaces of the human body and parts that come into contact with the human body clean. Alcohol-based agents such as ethanol are usually used for these applications, but it is difficult for people who are physically sensitive to alcohol to use them. There is a problem that it is inferior to Chlorine-based chemicals such as sodium hypochlorite water and hypochlorous acid water are also used. There are restrictions on use, such as the generation of chlorine gas. In addition, hypochlorous acid water has problems such as poor long-term antibacterial properties due to poor storage stability and a decrease in effective chlorine concentration during use.
 このようなことから、安全性に優れ、人体への影響も低く、揮発性が低く長時間効果が持続する抗菌剤が望まれている。 For this reason, antibacterial agents with excellent safety, low impact on the human body, low volatility, and long-lasting effects are desired.
 本出願人は、カチオンもしくはアニオンに水素結合性官能基を有する有機アンモニウム塩(イオン液体)を提案した(特許文献1~5)。この有機アンモニウム塩は親水性で常温液状であり、保水・保湿性能等に優れることを見出している。 The applicant proposed an organic ammonium salt (ionic liquid) having a hydrogen-bonding functional group in the cation or anion (Patent Documents 1 to 5). It has been found that this organic ammonium salt is hydrophilic, liquid at room temperature, and has excellent water-holding and moisturizing properties.
特開2014-131974号公報JP 2014-131974 A 特開2014-131975号公報JP 2014-131975 A 特開2019-023185号公報JP 2019-023185 A 国際公開第2020/166674号WO2020/166674 国際公開第2020/166678号WO2020/166678
 しかしながら、抗菌性能に着目した検討、特に、この課題に適したアミンもしくはアンモニウム化合物とカルボン酸もしくはその塩との配合物、有機アンモニウム塩のカチオンとなるアミン及びアニオンの組み合わせの検討はされていない。 However, studies focused on antibacterial performance, in particular, studies of combinations of amines or ammonium compounds and carboxylic acids or salts thereof suitable for this task, and combinations of amines and anions that serve as cations of organic ammonium salts have not been made.
 本発明は、以上のような事情に鑑みてなされたものであり、安全性が高く、持続的効果を持つ新規な抗菌剤、抗菌性組成物及び抗ウイルス性組成物を提供することを課題としている。 The present invention has been made in view of the above circumstances, and an object of the present invention is to provide a novel antibacterial agent, antibacterial composition and antiviral composition that are highly safe and have a sustained effect. there is
 上記の課題を解決するために、本発明の抗菌剤は、次の成分(A)及び(B)の配合物であることを特徴としている。
(A)水素結合性官能基を有するアミンもしくはアンモニウム化合物(但し、アミノ酸を除く。)
(B)カルボン酸もしくはその塩
 本発明の抗菌性組成物は、前記抗菌剤を添加したものである。
 本発明の抗ウイルス性組成物は、前記抗菌剤を添加したものである。
In order to solve the above problems, the antibacterial agent of the present invention is characterized by being a blend of the following components (A) and (B).
(A) an amine or ammonium compound having a hydrogen-bonding functional group (excluding amino acids);
(B) Carboxylic acid or salt thereof The antibacterial composition of the present invention contains the above antibacterial agent.
The antiviral composition of the present invention contains the above antibacterial agent.
 本発明の抗菌剤、抗菌性組成物及び抗ウイルス性組成物は、安全性が高く、持続的効果に優れる。また、本発明の抗菌剤は他成分の溶媒としても優れる。 The antibacterial agent, antibacterial composition, and antiviral composition of the present invention are highly safe and have excellent sustained effects. The antibacterial agent of the present invention is also excellent as a solvent for other ingredients.
 以下に、本発明を詳細に説明する。 The present invention will be described in detail below.
 本発明において「配合物」とは、最終的に目的とする配合物を調製するまでに成分(A)及び(B)を配合したことを包含し、成分(A)及び(B)を出発原料として成分(A)と(B)で形成される塩を合成し、当該塩を配合物とした場合、及び当該塩を必要に応じて水等のその他の成分と混合して配合物とした場合を包含する。本発明の配合物は、成分(A)と(B)のみからなる混合物(これらの塩である場合を含む。)であってもよく、成分(A)と(B)又はそれらの塩以外の成分を含む組成物、例えば水を含む組成物や、製品を製造する際に添加剤を添加した組成物や、化粧品等の製品である組成物であってもよい。 In the present invention, the term "formulation" includes blending components (A) and (B) until the final target formulation is prepared, and components (A) and (B) are used as starting materials. When synthesizing a salt formed by components (A) and (B) as a compound, and when the salt is mixed with other ingredients such as water as necessary to form a compound encompasses The formulation of the present invention may be a mixture consisting only of components (A) and (B) (including the case where they are salts), and components other than components (A) and (B) or their salts It may be a composition containing components, for example, a composition containing water, a composition to which additives are added when manufacturing a product, or a composition that is a product such as cosmetics.
 本発明の抗菌剤は、次の成分(A)及び(B)の配合物であって、成分(A)は、水素結合性官能基を有するアミンもしくはアンモニウム化合物である(但し、アミノ酸を除く。)。 The antibacterial agent of the present invention is a blend of the following components (A) and (B), component (A) being an amine or ammonium compound having a hydrogen-bonding functional group (excluding amino acids). ).
 成分(A)のうちアミン化合物の骨格は特に限定されず、例えば、アミン(アンモニア、1級アミン、2級アミン、3級アミン)、グアニジンや、イミダゾール、ピリジン、ピロリジン、ピペリジン、ピロリン、ピラジン、トリアゾール、イソキノリン、オキサゾリン、チアゾリン、モルホリン、ピリミジン、ピペラジン、トリアジン、キノリン、インドール、キノキサリン、イソオキサゾリン等をはじめとする環状アミン等が挙げられ、これらの中でもアミン、イミダゾール、ピリジン、ピロリジン、ピペリジン、モルホリンが好ましく、アミンがより好ましい。また、これらに後記[置換基]の欄に記載の置換基等を含んでもよい。 The skeleton of the amine compound of component (A) is not particularly limited, and examples include amines (ammonia, primary amines, secondary amines, tertiary amines), guanidine, imidazole, pyridine, pyrrolidine, piperidine, pyrroline, pyrazine, Cyclic amines such as triazole, isoquinoline, oxazoline, thiazoline, morpholine, pyrimidine, piperazine, triazine, quinoline, indole, quinoxaline, isoxazoline, etc. Among these, amine, imidazole, pyridine, pyrrolidine, piperidine, morpholine are preferred, and amines are more preferred. In addition, these may contain substituents described in the section [Substituents] below.
 成分(A)のうちアンモニウム化合物は、上記のアミン化合物の塩又は、アミン化合物を4級化したものが挙げられる。 Among the components (A), the ammonium compounds include salts of the above amine compounds and quaternary amine compounds.
 成分(A)、及び成分(A)由来のカチオンには、置換基として有機基を有していてもよい。 The component (A) and the cation derived from the component (A) may have an organic group as a substituent.
[有機基]
 本明細書において有機基は、炭素原子を必須とし、その他に水素原子、酸素原子、窒素原子、硫黄原子、リン原子、及びハロゲン原子から選ばれる少なくとも1種を含んでもよい。有機基に含まれる原子団は、特に限定されないが、例えば、炭化水素基、複素環基、及び後記[置換基]の欄に記載の置換基等が挙げられる。例えば、後記[置換基]の欄に記載の置換基等が、炭化水素基の水素原子と置換し、炭化水素基を中断し、及び/又は炭化水素基の基端に含み、あるいは芳香族炭化水基と縮合環を形成した基も含まれる。
 有機基における炭素数は、特に限定されないが、例えば、1~22、1~18、1~12、1~8、あるいは1~4である。
[Organic group]
In the present specification, the organic group essentially has a carbon atom and may additionally contain at least one selected from a hydrogen atom, an oxygen atom, a nitrogen atom, a sulfur atom, a phosphorus atom, and a halogen atom. Although the atomic group contained in the organic group is not particularly limited, examples thereof include hydrocarbon groups, heterocyclic groups, and substituents described in the section [Substituents] below. For example, the substituents described in the "Substituents" column below replace hydrogen atoms of the hydrocarbon group, interrupt the hydrocarbon group, and/or are included at the base end of the hydrocarbon group, or include aromatic hydrocarbons. A group forming a condensed ring with a water group is also included.
The number of carbon atoms in the organic group is not particularly limited, but is, for example, 1-22, 1-18, 1-12, 1-8, or 1-4.
[炭化水素基]
 本明細書において炭化水素基としては、特に限定されないが、例えば、飽和又は不飽和脂肪族炭化水素基、飽和又は不飽和脂環式炭化水素基、芳香族炭化水素基、また、それらを組み合わせた炭化水素基等が挙げられる。文脈に応じて1価でも多価でもよく、1価の飽和又は不飽和脂肪族炭化水素基としては、特に限定されないが、例えば、直鎖状もしくは分岐鎖状のアルキル基、アルケニル基、アルキニル基等が挙げられる。アルキル基は、直鎖状もしくは分岐鎖状を含み、特に限定されないが、例えばメチル基、エタン-1-イル基、プロパン-1-イル基、1-メチルエタン-1-イル基、ブタン-1-イル基、ブタン-2-イル基、2-メチルプロパン-1-イル基、2-メチルプロパン-2-イル基、ペンタン-1-イル基、ペンタン-2-イル基、ヘキサン-1-イル基、ヘプタン-1-イル基、オクタン-1-イル基、2-エチルヘキサン-1-イル基、1,1,3,3-テトラメチルブタン-1-イル基、ノナン-1-イル基、デカン-1-イル基、ウンデカン-1-イル基、ドデカン-1-イル基、トリデカン-1-イル基、テトラデカン-1-イル基、ペンタデカン-1-イル基、ヘキサデカン-1-イル基、2-ヘキシルデカン-1-イル基、ヘプタデカン-1-イル基、オクタデカン-1-イル基、ノナデカン-1-イル基、イコサン-1-イル基、ヘンイコサン-1-イル基、ドコサン-1-イル基、4,8,12-トリメチルトリデカン-1-イル基、ベンジル基、α,α-ジメチルベンジル基等が挙げられる。アルケニル基は直鎖状もしくは分岐鎖状を含み、特に限定されないが、例えば、ビニル基、プロパ-1-エン-1-イル基、アリル基、イソプロペニル基、ブタ-1-エン-1-イル基、ブタ-2-エン-1-イル基、ブタ-3-エン-1-イル基、2-メチルプロパ-2-エン-1-イル基、1-メチルプロパ-2-エン-1-イル基、ペンタ-1-エン-1-イル基、ペンタ-2-エン-1-イル基、ペンタ-3-エン-1-イル基、ペンタ-4-エン-1-イル基、3-メチルブタ-2-エン-1-イル基、3-メチルブタ-3-エン-1-イル基、ヘキサ-1-エン-1-イル基、ヘキサ-2-エン-1-イル基、ヘキサ-3-エン-1-イル基、ヘキサ-4-エン-1-イル基、ヘキサ-5-エン-1-イル基、4-メチルペンタ-3-エン-1-イル基、4-メチルペンタ-3-エン-1-イル基、ヘプタ-1-エン-1-イル基、ヘプタ-6-エン-1-イル基、オクタ-1-エン-1-イル基、オクタ-7-エン-1-イル基、ノナ-1-エン-1-イル基、ノナ-8-エン-1-イル基、デカ-1-エン-1-イル基、デカ-9-エン-1-イル基、ウンデカ-1-エン-1-イル基、ウンデカ-10-エン-1-イル基、ドデカ-1-エン-1-イル基、ドデカ-11-エン-1-イル基、トリデカ-1-エン-1-イル基、トリデカ-12-エン-1-イル基、テトラデカ-1-エン-1-イル基、テトラデカ-13-エン-1-イル基、ペンタデカ-1-エン-1-イル基、ペンタデカ-14-エン-1-イル基、ヘキサデカ-1-エン-1-イル基、ヘキサデカ-15-エン-1-イル基、ヘプタデカ-1-エン-1-イル基、ヘプタデカ-16-エン-1-イル基、オクタデカ-1-エン-1-イル基、オクタデカ-9-エン-1-イル基、オクタデカ-17-エン-1-イル基、ノナデカ-1-エン-1-イル基、イコサ-1-エン-1-イル基、ヘンイコサ-1-エン-1-イル基、ドコサ-1-エン-1-イル基等が挙げられる。アルキニル基は直鎖状もしくは分岐鎖状を含み、特に限定されないが、例えば、エチニル、プロパ-1-イン-1-イル基、プロパ-2-イン-1-イル基、ブタ-1-イン-1-イル基、ブタ-3-イン-1-イル基、1-メチルプロパ-2-イン-1-イル基、ペンタ-1-イン-1-イル基、ペンタ-4-イン-1-イル基、ヘキサ-1-イン-1-イル基、ヘキサ-5-イン-1-イル基、ヘプタ-1-イン-1-イル基、ヘプタ-6-イン-1-イル基、オクタ-1-イン-1-イル基、オクタ-7-イン-1-イル基、ノナ-1-イン-1-イル基、ノナ-8-イン-1-イル基、デカ-1-イン-1-イル基、デカ-9-イン-1-イル基、ウンデカ-1-イン-1-イル基、ウンデカ-10-イン-1-イル基、ドデカ-1-イン-1-イル基、ドデカ-11-イン-1-イル基、トリデカ-1-イン-1-イル基、トリデカ-12-イン-1-イル基、テトラデカ-1-イン-1-イル基、テトラデカ-13-イン-1-イル基、ペンタデカ-1-イン-1-イル基、ペンタデカ-14-イン-1-イル基、ヘキサデカ-1-イン-1-イル基、ヘキサデカ-15-イン-1-イル基、ヘプタデカ-1-イン-1-イル基、ヘプタデカ-16-イン-1-イル基、オクタデカ-1-イン-1-イル基、オクタデカ-17-イン-1-イル基、ノナデカ-1-イン-1-イル基、イコサ-1-イン-1-イル基、ヘンイコサ-1-イン-1-イル基、ドコサ-1-イン-1-イル基等が挙げられる。
[Hydrocarbon group]
In the present specification, the hydrocarbon group is not particularly limited, and examples include saturated or unsaturated aliphatic hydrocarbon groups, saturated or unsaturated alicyclic hydrocarbon groups, aromatic hydrocarbon groups, and combinations thereof. A hydrocarbon group etc. are mentioned. Depending on the context, it may be monovalent or polyvalent, and examples of monovalent saturated or unsaturated aliphatic hydrocarbon groups include, but are not limited to, linear or branched alkyl groups, alkenyl groups and alkynyl groups. etc. Alkyl groups include linear or branched chains, but are not particularly limited, and examples thereof include methyl, ethane-1-yl, propan-1-yl, 1-methylethan-1-yl, butane-1- yl group, butan-2-yl group, 2-methylpropan-1-yl group, 2-methylpropan-2-yl group, pentan-1-yl group, pentan-2-yl group, hexan-1-yl group , heptane-1-yl group, octan-1-yl group, 2-ethylhexan-1-yl group, 1,1,3,3-tetramethylbutan-1-yl group, nonan-1-yl group, decane -1-yl group, undecane-1-yl group, dodecane-1-yl group, tridecane-1-yl group, tetradecane-1-yl group, pentadecane-1-yl group, hexadecane-1-yl group, 2- hexyldecane-1-yl group, heptadecan-1-yl group, octadecane-1-yl group, nonadecan-1-yl group, icosan-1-yl group, henicosan-1-yl group, docosan-1-yl group, 4 , 8,12-trimethyltridecan-1-yl group, benzyl group, α,α-dimethylbenzyl group and the like. Alkenyl groups include linear or branched chains, and are not particularly limited, but examples include vinyl, prop-1-en-1-yl, allyl, isopropenyl, but-1-en-1-yl. group, but-2-en-1-yl group, but-3-en-1-yl group, 2-methylprop-2-en-1-yl group, 1-methylprop-2-en-1-yl group, pent-1-en-1-yl group, pent-2-en-1-yl group, pent-3-en-1-yl group, pent-4-en-1-yl group, 3-methylbut-2- En-1-yl group, 3-methylbut-3-en-1-yl group, hex-1-en-1-yl group, hex-2-en-1-yl group, hex-3-en-1- yl group, hex-4-en-1-yl group, hex-5-en-1-yl group, 4-methylpent-3-en-1-yl group, 4-methylpent-3-en-1-yl group , hept-1-en-1-yl group, hept-6-en-1-yl group, octa-1-en-1-yl group, octa-7-en-1-yl group, non-1-ene -1-yl group, non-8-en-1-yl group, dec-1-en-1-yl group, dec-9-en-1-yl group, undec-1-en-1-yl group, undec-10-en-1-yl group, dodec-1-en-1-yl group, dodec-11-en-1-yl group, tridec-1-en-1-yl group, tridec-12-en- 1-yl group, tetradeca-1-en-1-yl group, tetradeca-13-en-1-yl group, pentadeca-1-en-1-yl group, pentadec-14-en-1-yl group, hexadecaco -1-en-1-yl group, hexadec-15-en-1-yl group, heptadecan-1-en-1-yl group, heptadedec-16-en-1-yl group, octadec-1-en-1 -yl group, octadec-9-en-1-yl group, octadec-17-en-1-yl group, nonadecan-1-en-1-yl group, icosa-1-en-1-yl group, henicosa- 1-en-1-yl group, docos-1-en-1-yl group and the like. Alkynyl groups include straight or branched chains, and are not particularly limited and include, but are not limited to, ethynyl, prop-1-yn-1-yl, prop-2-yn-1-yl, but-1-yn- 1-yl group, but-3-yn-1-yl group, 1-methylprop-2-yn-1-yl group, pent-1-yn-1-yl group, pent-4-yn-1-yl group , hex-1-yn-1-yl group, hex-5-yn-1-yl group, hept-1-yn-1-yl group, hept-6-yn-1-yl group, octa-1-yne -1-yl group, octa-7-yn-1-yl group, non-1-yn-1-yl group, non-8-yn-1-yl group, deca-1-yn-1-yl group, Dec-9-yn-1-yl group, undec-1-yn-1-yl group, undec-10-yn-1-yl group, dodec-1-yn-1-yl group, dodec-11-yn- 1-yl group, tridec-1-yn-1-yl group, tridec-12-yn-1-yl group, tetradeca-1-yn-1-yl group, tetradeca-13-yn-1-yl group, pentadeca -1-yn-1-yl group, pentadeca-14-yn-1-yl group, hexadec-1-yn-1-yl group, hexadec-15-yn-1-yl group, heptadeca-1-yn-1 -yl group, heptadeca-16-yn-1-yl group, octadec-1-yn-1-yl group, octadec-17-yn-1-yl group, nonadeca-1-yn-1-yl group, icosa- 1-yn-1-yl group, henicosa-1-yn-1-yl group, docos-1-yn-1-yl group and the like.
 飽和又は不飽和脂環式炭化水素基としては、飽和脂環式炭化水素基が好ましく、特に限定されないが、例えば、1価の基としてはシクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基、シクロヘプチル基、シクロオクチル基、また、それらの残基等の脂環残基を含む基が挙げられる。 The saturated or unsaturated alicyclic hydrocarbon group is preferably a saturated alicyclic hydrocarbon group and is not particularly limited. Examples of monovalent groups include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cyclo A heptyl group, a cyclooctyl group, and a group containing an alicyclic residue such as those residues are included.
 芳香族炭化水素基としては、特に限定されないが、例えば、フェニル基、ナフチル基、アントラセニル基、また、それらの残基等の芳香環残基を含む基が挙げられる。後記[置換基]に記載された置換基等と一緒になって縮合環を形成してもよい。1価の芳香族炭化水素基としては、特に限定されないが、例えば、フェニル基、2-メチルフェニル基、3-メチルフェニル基、4-メチルフェニル基、2,4-ジメチルフェニル基、2,5-ジメチルフェニル基、3,4-ジメチルフェニル基、3,5-ジメチルフェニル基、2,4,5-トリメチルフェニル基、2,4,6-トリメチルフェニル基、4-エチルフェニル基、4-プロピルフェニル基、4-イソプロピルフェニル基、4-ブチルフェニル基、4-tert-ブチルフェニル基、4-ペンチルフェニル基、4-tert-ペンチルフェニル基、2,4-ビス(4-tert-ペンチル)フェニル基、1,1,3,3-テトラメチルブチルフェニル基、2-メチル-5-tert-ブチルフェニル基、4-ペンチルフェニル基、4-ヘキシルフェニル基、4-ヘプチルフェニル基、4-オクチルフェニル基、4-ノニルフェニル基、4-デカニルフェニル基、4-ウンデシルフェニル基、4-ドデシルフェニル基、4-トリデシルフェニル基、4-テトラデシルフェニル基、4-ペンタデシルフェニル基、4-ヘキサデシルフェニル基、4-ヘプタデシルフェニル基、4-オクタデシルフェニル基、4-ビフェニル基、2-メトキシフェニル基、3-メトキシフェニル基、4-メトキシフェニル基、2-エトキシフェニル基、3-エトキシフェニル基、4-エトキシフェニル基、2-クロロフェニル基、2-フルオロフェニル基、4-フルオロフェニル基、2-トリフルオロメチルフェニル基、4-トリフルオロメチルフェニル基、4-ヒドロキシフェニル基、1-ナフチル基、2-ナフチル基、1-アントラセニル基、2-アントラセニル基、9-アントラセニル基等が挙げられる。 The aromatic hydrocarbon group is not particularly limited, but includes, for example, a phenyl group, a naphthyl group, an anthracenyl group, and groups containing aromatic ring residues such as residues thereof. A condensed ring may be formed together with the substituents described in [Substituent] below. Examples of monovalent aromatic hydrocarbon groups include, but are not limited to, phenyl, 2-methylphenyl, 3-methylphenyl, 4-methylphenyl, 2,4-dimethylphenyl, 2,5 -dimethylphenyl group, 3,4-dimethylphenyl group, 3,5-dimethylphenyl group, 2,4,5-trimethylphenyl group, 2,4,6-trimethylphenyl group, 4-ethylphenyl group, 4-propyl phenyl group, 4-isopropylphenyl group, 4-butylphenyl group, 4-tert-butylphenyl group, 4-pentylphenyl group, 4-tert-pentylphenyl group, 2,4-bis(4-tert-pentyl)phenyl group, 1,1,3,3-tetramethylbutylphenyl group, 2-methyl-5-tert-butylphenyl group, 4-pentylphenyl group, 4-hexylphenyl group, 4-heptylphenyl group, 4-octylphenyl group, 4-nonylphenyl group, 4-decanylphenyl group, 4-undecylphenyl group, 4-dodecylphenyl group, 4-tridecylphenyl group, 4-tetradecylphenyl group, 4-pentadecylphenyl group, 4 -hexadecylphenyl group, 4-heptadecylphenyl group, 4-octadecylphenyl group, 4-biphenyl group, 2-methoxyphenyl group, 3-methoxyphenyl group, 4-methoxyphenyl group, 2-ethoxyphenyl group, 3- ethoxyphenyl group, 4-ethoxyphenyl group, 2-chlorophenyl group, 2-fluorophenyl group, 4-fluorophenyl group, 2-trifluoromethylphenyl group, 4-trifluoromethylphenyl group, 4-hydroxyphenyl group, 1 -naphthyl group, 2-naphthyl group, 1-anthracenyl group, 2-anthracenyl group, 9-anthracenyl group and the like.
 2価の炭化水素基としては、上記の基から水素原子を1個除いた基が挙げられる。 Examples of divalent hydrocarbon groups include groups obtained by removing one hydrogen atom from the above groups.
[置換基]
 上記置換基としては、特に限定されないが、例えば、炭化水素基、酸素含有基、窒素含有基、硫黄含有基、リン含有基、ハロゲン等が挙げられる。置換基には、これらの置換基が結合した基も含まれる。
[Substituent]
Examples of the substituent include, but are not limited to, hydrocarbon groups, oxygen-containing groups, nitrogen-containing groups, sulfur-containing groups, phosphorus-containing groups, and halogens. Substituents also include groups to which these substituents are bonded.
 炭化水素基としては、上記[炭化水素基]に挙げたものが挙げられる。 Examples of the hydrocarbon group include those listed in the above [hydrocarbon group].
 酸素含有基としては、特に限定されないが、例えば、水酸基、アルコキシ基、アセトキシ基、アセチル基、アルデヒド基、カルボキシ基、カルボシキレート基、尿素基、ウレタン基、アミド基、イミド基、エーテル基、カルボニル基、エステル基、オキサゾール基、モルホリン基、カルバメート基、カルバミン酸基、カルバモイル基、ポリオキシエチレン基、トコフェリル基、クロマン基、ジヒドロピラン基、グリセリル基、グリセリルエーテル基等が挙げられる。 Examples of oxygen-containing groups include, but are not limited to, hydroxyl groups, alkoxy groups, acetoxy groups, acetyl groups, aldehyde groups, carboxyl groups, carboxylate groups, urea groups, urethane groups, amide groups, imide groups, ether groups, carbonyl group, ester group, oxazole group, morpholine group, carbamate group, carbamic acid group, carbamoyl group, polyoxyethylene group, tocopheryl group, chroman group, dihydropyran group, glyceryl group, glyceryl ether group and the like.
 窒素含有基としては、特に限定されないが、例えば、シアノ基、シアナト基、イソシアネート基、ニトロ基、ニトロアルキル基、アミド基、尿素基、ウレタン基、イミド基、カルボジイミド基、アゾ基、ピリジル基、イミダゾール基、ピロリジル基、ピペリジル基、ピロリル基、ピラジル基、トリアゾール基、イソキノリル基、オキサゾリル基、チアゾリル基、モルホリル基、グアニジル基、ピリミジル基、ピペラジル基、トリアジル基、キノリル基、インドール基、キノキサリル基、イソオキサゾリル基、1級アミノ基、2級アミノ基、3級アミノ基、4級アンモニウム基、アミノアルキル基等が挙げられる。 Examples of nitrogen-containing groups include, but are not limited to, cyano groups, cyanato groups, isocyanate groups, nitro groups, nitroalkyl groups, amide groups, urea groups, urethane groups, imide groups, carbodiimide groups, azo groups, pyridyl groups, imidazole group, pyrrolidyl group, piperidyl group, pyrrolyl group, pyrazyl group, triazole group, isoquinolyl group, oxazolyl group, thiazolyl group, morpholyl group, guanidyl group, pyrimidyl group, piperazyl group, triazyl group, quinolyl group, indole group, quinoxalyl group , an isoxazolyl group, a primary amino group, a secondary amino group, a tertiary amino group, a quaternary ammonium group, an aminoalkyl group and the like.
 硫黄含有基としては、特に限定されないが、例えば、硫酸基、スルホニル基、スルホン酸基、メルカプト基、チオエーテル基、チオカルボニル基、チオ尿素基、チオカルボキシ基、チオカルボキシレート基、ジチオカルボキシ基、ジチオカルボキシレート基、硫酸エステル、チオフェン基、チアゾール基、チオール基、スルホ基、スルフィド基、ジスルフィド基、チオエステル基、チオアミド基、チオカルバメート基、ジチオカルバメート基やそれらのエステル等が挙げられる。 Examples of sulfur-containing groups include, but are not limited to, sulfuric acid group, sulfonyl group, sulfonic acid group, mercapto group, thioether group, thiocarbonyl group, thiourea group, thiocarboxy group, thiocarboxylate group, dithiocarboxy group, Dithiocarboxylate group, sulfate ester, thiophene group, thiazole group, thiol group, sulfo group, sulfide group, disulfide group, thioester group, thioamide group, thiocarbamate group, dithiocarbamate group and esters thereof.
 リン含有基としては、特に限定されないが、例えば、リン酸基、亜リン酸基、ホスホン酸基、ホスフィン酸基、亜ホスホン酸基、亜ホスフィン酸基、ピロホスフェート基、リン酸エステル基、亜リン酸エステル基、ホスホン酸エステル基、ピロホスファート基やそれらのエステル基等が挙げられる。 Examples of phosphorus-containing groups include, but are not limited to, phosphoric acid group, phosphorous acid group, phosphonic acid group, phosphinic acid group, phosphonous acid group, phosphinic acid group, pyrophosphate group, phosphate ester group, Phosphate ester group, phosphonate ester group, pyrophosphate group, ester group thereof and the like.
 ハロゲンとしては、フッ素、塩素、臭素、ヨウ素が挙げられる。  Halogen includes fluorine, chlorine, bromine, and iodine.
 前記有機基は、置換基を有していてもよく炭化水素部位が酸素原子を含んでいてもよい炭化水素基等が挙げられる。炭化水素基としては、上記[炭化水素基]の欄に記載した内容が参照される。炭化水素基は脂肪族炭化水素基が好ましく、飽和脂肪族炭化水素基(アルキル基等)がより好ましい。アルキル基は、例えば、炭素数1~22、4~22、8~22、あるいは12~22の直鎖状もしくは分岐状であってよく、また炭素数1~18、1~12、あるいは1~4の直鎖状もしくは分岐状であってよい。 Examples of the organic group include hydrocarbon groups that may have a substituent and whose hydrocarbon portion may contain an oxygen atom. As for the hydrocarbon group, the contents described in the above [Hydrocarbon group] column are referred to. The hydrocarbon group is preferably an aliphatic hydrocarbon group, more preferably a saturated aliphatic hydrocarbon group (such as an alkyl group). The alkyl group may be, for example, 1 to 22, 4 to 22, 8 to 22, or 12 to 22 carbon atoms, linear or branched, and may have 1 to 18, 1 to 12, or 1 to 18 carbon atoms. 4 may be linear or branched.
 上記炭化水素基は置換基を有していてもよく、ここで置換基としては、特に限定されないが、例えば、上記[置換基]の欄に記載したものが挙げられる。置換基の中でも酸素含有基を有するものが好ましく、その中でも水酸基、カルボキシ基、カルボキシレート基、エステル基、エーテル基、アルコキシ基が好ましい。これらの中でも、水酸基、カルボキシ基、カルボキシレート基、エーテル基、アルコキシ基がより好ましく、水酸基が特に好ましい。 The hydrocarbon group may have a substituent, and the substituent is not particularly limited, but includes, for example, those described in the above [Substituent] column. Among the substituents, those having an oxygen-containing group are preferred, and among these, a hydroxyl group, a carboxyl group, a carboxylate group, an ester group, an ether group, and an alkoxy group are preferred. Among these, a hydroxyl group, a carboxyl group, a carboxylate group, an ether group, and an alkoxy group are more preferable, and a hydroxyl group is particularly preferable.
 上記炭化水素部位は酸素原子を含んでいてもよく、この場合、炭化水素部位に上記の酸素含有基を含み、特に限定されないが、例えば、エーテル結合、カルボニル基、水酸基、カルボキシレート基、エステル結合、アミド結合、尿素結合又はウレタン結合を形成もしくは含有する。従って本発明において「炭化水素部位が酸素原子を含む」とは、酸素原子を含む原子団として窒素原子等のヘテロ原子をも含んでよい基によって炭化水素部位が中断されるか、当該基を基端に含むか、あるいは水素原子が置換される場合を包含する。 The hydrocarbon moiety may contain an oxygen atom. In this case, the hydrocarbon moiety includes the oxygen-containing group described above, and is not particularly limited. Examples include an ether bond, a carbonyl group, a hydroxyl group, a carboxylate group and an ester bond. , amide bond, urea bond or urethane bond. Therefore, in the present invention, "the hydrocarbon moiety contains an oxygen atom" means that the hydrocarbon moiety is interrupted by a group that may also contain a heteroatom such as a nitrogen atom as an atomic group containing an oxygen atom, or the group is Including at the ends or when a hydrogen atom is substituted.
 成分(A)は、本発明の効果を高める点において、成分(A)における官能基を導入可能な部位(窒素部位や、窒素と共に環を構成する炭素部位などの、基本骨格となる化学構造に含まれる原子)が、その1つ以上が水素結合性官能基を持つ有機基で置換される。あるいは、窒素に直接結合した水素原子が水素結合性官能基を構成する。 In terms of enhancing the effect of the present invention, the component (A) has a chemical structure that is a basic skeleton, such as a site where a functional group can be introduced in the component (A) (a nitrogen site, a carbon site that forms a ring with nitrogen, etc.) contained atoms) are replaced with organic groups, one or more of which have hydrogen-bonding functional groups. Alternatively, a hydrogen atom directly bonded to nitrogen constitutes a hydrogen-bonding functional group.
 上記水素結合性官能基を持つ有機基において、水素結合性官能基としては、特に限定されないが、例えば、上記の酸素含有基、窒素含有基、硫黄含有基、リン含有基、窒素に直接結合した水素原子等が挙げられ、酸素含有基が好ましい。 In the above organic group having a hydrogen-bonding functional group, the hydrogen-bonding functional group is not particularly limited. Examples include a hydrogen atom, and an oxygen-containing group is preferred.
 成分(A)に有する水素結合性官能基としては、水への親和性、水素結合性官能基と結合、配位等が可能な有機、無機材料等への親和性の観点から、水酸基、カルボキシ基、カルボキシレート基、エステル基、エーテル基、アルコキシ基、窒素に直接結合した水素原子が好ましい。これらの中でも、水酸基、カルボキシ基、カルボキシレート基、エーテル基、アルコキシ基、窒素に直接結合した水素原子がより好ましく、水酸基、カルボキシ基、カルボキシレート基、窒素に直接結合した水素原子が更に好ましく、水酸基、カルボキシ基、窒素に直接結合した水素原子が特に好ましく、水酸基、窒素に直接結合した水素原子が最も好ましい。水素結合性官能基を持つ有機基の好ましい例として、水素結合性官能基を有する炭化水素基が挙げられる。例えば、水素結合性官能基を持つ有機基としては、水酸基を含む炭化水素基(ヒドロキシ炭化水素基)、カルボキシ基を含む炭化水素基(カルボキシ炭化水素基)、水酸基とカルボキシ基を含む炭化水素基(ヒドロキシカルボキシ炭化水素基)、カルボキシレート基を含む炭化水素基、エステル基を含む炭化水素基、エーテル基を含む炭化水素基、アルコキシ基を含む炭化水素基等が挙げられる。 Hydrogen-bonding functional groups in component (A) include, from the viewpoint of affinity for water and affinity for organic and inorganic materials capable of bonding and coordinating with hydrogen-bonding functional groups, hydroxyl group, carboxyl group, and the like. Groups, carboxylate groups, ester groups, ether groups, alkoxy groups, hydrogen atoms directly bonded to nitrogen are preferred. Among these, a hydroxyl group, a carboxy group, a carboxylate group, an ether group, an alkoxy group, and a hydrogen atom directly bonded to nitrogen are more preferable, and a hydroxyl group, a carboxy group, a carboxylate group, and a hydrogen atom directly bonded to nitrogen are more preferable. A hydrogen atom directly bonded to a hydroxyl group, a carboxy group, or nitrogen is particularly preferred, and a hydrogen atom directly bonded to a hydroxyl group or nitrogen is most preferred. A preferred example of the organic group having a hydrogen-bonding functional group is a hydrocarbon group having a hydrogen-bonding functional group. For example, the organic group having a hydrogen bonding functional group includes a hydrocarbon group containing a hydroxyl group (hydroxy hydrocarbon group), a hydrocarbon group containing a carboxy group (carboxy hydrocarbon group), and a hydrocarbon group containing a hydroxyl group and a carboxy group. (hydroxycarboxy hydrocarbon group), a hydrocarbon group containing a carboxylate group, a hydrocarbon group containing an ester group, a hydrocarbon group containing an ether group, a hydrocarbon group containing an alkoxy group, and the like.
 前記成分(A)は、安全性の点から、水酸基を1個以上有し、炭化水素部位が直鎖状もしくは分岐鎖状で、該炭化水素部位が酸素原子を含んでいてもよいヒドロキシ炭化水素基を有することが好ましい。 From the viewpoint of safety, the component (A) is a hydroxyhydrocarbon having one or more hydroxyl groups, a straight-chain or branched hydrocarbon moiety, and the hydrocarbon moiety may contain an oxygen atom. It is preferred to have a group.
 前記炭化水素基は、飽和又は不飽和脂肪族炭化水素基、飽和又は不飽和脂環式炭化水素基、芳香族炭化水素基等、また、それらを組み合わせた炭化水素基が挙げられる。これらの炭化水素基は、一般的なものを用いることができる。前記炭化水素基の中でも、飽和脂肪族炭化水素基が好ましい。前記炭化水素基としては、後記[炭化水素基]の欄に記載のものが挙げられる。 The hydrocarbon group includes a saturated or unsaturated aliphatic hydrocarbon group, a saturated or unsaturated alicyclic hydrocarbon group, an aromatic hydrocarbon group, etc., and a hydrocarbon group combining them. Common hydrocarbon groups can be used as these hydrocarbon groups. Among the above hydrocarbon groups, saturated aliphatic hydrocarbon groups are preferred. Examples of the hydrocarbon group include those described in the section [Hydrocarbon group] below.
 例えば、特に限定されないが、上記ヒドロキシ炭化水素基は、水酸基を1個以上有し、炭化水素部位が好ましくは炭素数1~22、より好ましくは炭素数1~18、更に好ましくは炭素数1~12、特に好ましくは炭素数1~6の直鎖状もしくは分岐鎖状で、該炭化水素部位が酸素原子を含んでいてもよい。 For example, although not particularly limited, the hydroxy hydrocarbon group has one or more hydroxyl groups, and the hydrocarbon moiety preferably has 1 to 22 carbon atoms, more preferably 1 to 18 carbon atoms, and still more preferably 1 to 1 carbon atoms. 12, particularly preferably straight or branched having 1 to 6 carbon atoms, and the hydrocarbon moiety may contain an oxygen atom.
 ここで、炭化水素部位が酸素原子を含む場合、該酸素原子は、例えば、炭化水素部位にエーテル結合、カルボニル基、エステル結合、アミド結合、尿素結合又はウレタン結合を形成する。したがって本発明において「炭化水素部位が酸素原子を含む」とは、酸素原子を含む原子団として窒素原子等のヘテロ原子をも含んでよい基によって炭化水素部位が中断されるか、当該基を基端に含むか、あるいは水素原子が置換される場合を包含する。 Here, when the hydrocarbon portion contains an oxygen atom, the oxygen atom forms, for example, an ether bond, a carbonyl group, an ester bond, an amide bond, a urea bond, or a urethane bond with the hydrocarbon portion. Therefore, in the present invention, "the hydrocarbon moiety contains an oxygen atom" means that the hydrocarbon moiety is interrupted by a group that may also contain a heteroatom such as a nitrogen atom as an atomic group containing an oxygen atom, or the group is Including at the ends or when a hydrogen atom is substituted.
 上記ヒドロキシ炭化水素基としては、ヒドロキシ基を1個以上有する飽和又は不飽和脂肪族炭化水素基、飽和又は不飽和脂環式炭化水素基、芳香族炭化水素基、また、それらを組み合わせた炭化水素基が挙げられ、ヒドロキシ基を1個有する飽和脂肪族炭化水素基(モノヒドロキシアルキル基等)、ヒドロキシ基を2個以上有する飽和脂肪族炭化水素基(ポリヒドロキシアルキル基等)が好ましく、上記酸素含有基を含んでもよい。 As the hydroxy hydrocarbon group, a saturated or unsaturated aliphatic hydrocarbon group having one or more hydroxy groups, a saturated or unsaturated alicyclic hydrocarbon group, an aromatic hydrocarbon group, or a hydrocarbon combination thereof groups, preferably a saturated aliphatic hydrocarbon group having one hydroxy group (monohydroxyalkyl group, etc.), a saturated aliphatic hydrocarbon group having two or more hydroxy groups (polyhydroxyalkyl group, etc.), and the oxygen Containing groups may be included.
 ヒドロキシ基を1個有する飽和脂肪族炭化水素基(モノヒドロキシアルキル基)としては、特に限定されないが、例えば、ヒドロキシメチル基、1-ヒドロキシエチル基、2-ヒドロキシエチル基、1-ヒドロキシプロパン-1-イル基、2-ヒドロキシプロパン-1-イル基、3-ヒドロキシプロパン-1-イル基、1-ヒドロキシプロパン-2-イル基、2-ヒドロキシプロパン-2-イル基、2-ヒドロキシメチルプロパン-2-イル基、2-ヒドロキシエチルプロパン-2-イル基、1-ヒドロキシブタン-1-イル基、2-ヒドロキシブタン-1-イル基、3-ヒドロキシブタン-1-イル基、4-ヒドロキシブタン-1-イル基、1-ヒドロキシ-2-メチルプロパン-1-イル基、2-ヒドロキシ-2-メチルプロパン-1-イル基、3-ヒドロキシ-2-メチルプロパン-1-イル基、1-ヒドロキシブタン-2-イル基、2-ヒドロキシブタン-2-イル基、3-ヒドロキシブタン-2-イル基、4-ヒドロキシブタン-2-イル基、1-ヒドロキシ-2-メチルプロパン-2-イル基、5-ヒドロキシペンタン-1-イル基、2-ヒドロキシメチルペンタン-2-イル基、2-ヒドロキシエチルペンタン-2-イル基、6-ヒドロキシヘキサン-1-イル基、7-ヒドロキシヘプタン-1-イル基、8-ヒドロキシオクタン-1-イル基、9-ヒドロキシノナン-1-イル基、10-ヒドロキシデカン-1-イル基、2-メチル-1-ヒドロキシプロパン-2-イル基、2-メチル-1-プロパン-2-イル基、1-ヒドロキシ-2-メチルプロパン-2-イル基、1-ヒドロキシ-3-メチルブタン-2-イル基、2-ヒドロキシ-2-メチルプロパン-2-イル基、2-ヒドロキシ-2-メチルブタン-2-イル基、2-エチル-2-ヒドロキシブタン-2-イル基、2-ヒドロキシ-3-メチルペンタン-2-イル基、3-エチル-2-ヒドロキシペンタン-2-イル基、2-エチル-1-ヒドロキシ-3-メチルブタン-2-イル基、1-ヒドロキシ-3-メチル-2-(1-メチルエチル)ブタン-2-イル基、2-エチル-1-ヒドロキシペンタン-2-イル基、1-ヒドロキシ-2-プロピルペンタン-2-イル基、4-エチル-3-ヒドロキシヘキサン-4-イル基、3-エチル-2-ヒドロキシ-2-メチルペンタン-3-イル基、2-エチル-1-ヒドロキシヘキサン-2-イル基、1-ヒドロキシ-2-プロピルヘキサン-2-イル基、2-エチル-1-ヒドロキシヘプタン-2-イル基、2-エチル-1-ヒドロキシ-4-メチルペンタン-2-イル基、1-ヒドロキシ-2-(1-メチルエチル)ペンタン-2-イル基、3-エチル-4-ヒドロキシヘプタン-3-イル基等が挙げられる。モノヒドロキシアルキル基は、炭素数1~22のものが好ましく、炭素数1~18のものがより好ましく、炭素数1~12のものが更に好ましく、炭素数1~6のものが特に好ましい。 The saturated aliphatic hydrocarbon group having one hydroxy group (monohydroxyalkyl group) is not particularly limited, but examples thereof include hydroxymethyl group, 1-hydroxyethyl group, 2-hydroxyethyl group, 1-hydroxypropane-1 -yl group, 2-hydroxypropan-1-yl group, 3-hydroxypropan-1-yl group, 1-hydroxypropan-2-yl group, 2-hydroxypropan-2-yl group, 2-hydroxymethylpropane- 2-yl group, 2-hydroxyethylpropan-2-yl group, 1-hydroxybutan-1-yl group, 2-hydroxybutan-1-yl group, 3-hydroxybutan-1-yl group, 4-hydroxybutane -1-yl group, 1-hydroxy-2-methylpropan-1-yl group, 2-hydroxy-2-methylpropan-1-yl group, 3-hydroxy-2-methylpropan-1-yl group, 1- Hydroxybutan-2-yl group, 2-hydroxybutan-2-yl group, 3-hydroxybutan-2-yl group, 4-hydroxybutan-2-yl group, 1-hydroxy-2-methylpropan-2-yl group, 5-hydroxypentan-1-yl group, 2-hydroxymethylpentan-2-yl group, 2-hydroxyethylpentan-2-yl group, 6-hydroxyhexan-1-yl group, 7-hydroxyheptane-1 -yl group, 8-hydroxyoctan-1-yl group, 9-hydroxynonan-1-yl group, 10-hydroxydecane-1-yl group, 2-methyl-1-hydroxypropan-2-yl group, 2- methyl-1-propan-2-yl group, 1-hydroxy-2-methylpropan-2-yl group, 1-hydroxy-3-methylbutan-2-yl group, 2-hydroxy-2-methylpropan-2-yl group, 2-hydroxy-2-methylbutan-2-yl group, 2-ethyl-2-hydroxybutan-2-yl group, 2-hydroxy-3-methylpentan-2-yl group, 3-ethyl-2-hydroxy Pentan-2-yl group, 2-ethyl-1-hydroxy-3-methylbutan-2-yl group, 1-hydroxy-3-methyl-2-(1-methylethyl)butan-2-yl group, 2-ethyl -1-hydroxypentan-2-yl group, 1-hydroxy-2-propylpentan-2-yl group, 4-ethyl-3-hydroxyhexan-4-yl group, 3-ethyl-2-hydroxy-2-methyl Pentan-3-yl group, 2-ethyl-1-hydroxyhexan-2-y group, 1-hydroxy-2-propylhexan-2-yl group, 2-ethyl-1-hydroxyheptan-2-yl group, 2-ethyl-1-hydroxy-4-methylpentan-2-yl group, 1 -hydroxy-2-(1-methylethyl)pentan-2-yl group, 3-ethyl-4-hydroxyheptan-3-yl group and the like. The monohydroxyalkyl group preferably has 1 to 22 carbon atoms, more preferably 1 to 18 carbon atoms, even more preferably 1 to 12 carbon atoms, and particularly preferably 1 to 6 carbon atoms.
 ヒドロキシ基を2個以上有する飽和脂肪族炭化水素基(ポリヒドロキシアルキル基)としては、特に限定されないが、例えば、ジ、トリ、テトラ、ペンタ、ヘキサ、ヘプタ、又はオクタヒドロキシアルキル基等が挙げられる。具体的には、特に限定されないが、例えば、1,2-ジヒドロキシエチル基等のジヒドロキシエチル基;1,2-ジヒドロキシプロパン-1-イル基、2,3-ジヒドロキシプロパン-1-イル基等のジヒドロキシプロパン-1-イル基;1,2-ジヒドロキシプロパン-2-イル基、1,3-ジヒドロキシプロパン-2-イル基等のジヒドロキシプロパン-2-イル基;トリヒドロキシプロパン-1-イル基;トリヒドロキシプロパン-2-イル基;トリヒドロキシプロパン-1-イル基;トリヒドロキシプロパン-2-イル基;1,2-ジヒドロキシブタン-1-イル基、1,3-ジヒドロキシブタン-1-イル基、1,4-ジヒドロキシブタン-1-イル基、2,3-ジヒドロキシブタン-1-イル基、2,4-ジヒドロキシブタン-1-イル基、3,4-ジヒドロキシブタン-1-イル基等のジヒドロキシブタン-1-イル基;1,2,3トリヒドロキシブタン-1-イル基、1,2,4トリヒドロキシブタン-1-イル基、1,3,4トリヒドロキシブタン-1-イル基、2,3,4トリヒドロキシブタン-1-イル基等のトリヒドロキシブタン-1-イル基;テトラヒドロキシブタン-1-イル基;1,2-ジヒドロキシ-2-メチルプロパン-1-イル基、1,3-ジヒドロキシ-2-メチルプロパン-1-イル基、2,3-ジヒドロキシ-2-メチルプロパン-1-イル基等のジヒドロキシ-2-メチルプロパン-1-イル基;トリヒドロキシ-2-メチルプロパン-1-イル基;テトラヒドロキシ-2-メチルプロパン-1-イル基;1,2-ジヒドロキシブタン-2-イル基、1,3-ジヒドロキシブタン-2-イル基、1,4-ジヒドロキシブタン-2-イル基、2,3-ジヒドロキシブタン-2-イル基、2,4-ジヒドロキシブタン-2-イル基、3,4-ジヒドロキシブタン-2-イル基等のジヒドロキシブタン-2-イル基;テトラヒドロキシブタン-2-イル基;1,3-ジヒドロキシ-2-メチルプロパン-2-イル基、1,3-ジヒドロキシ-2-エチルプロパン-2-イル基、1,3-ジヒドロキシ-2-ヒドロキシメチルプロパン-2-イル基;テトラヒドロキシブタン-2-イル基;1,3-ジヒドロキシ-2-メチルプロパン-2-イル基、1,3-ジヒドロキシ-2-エチルプロパン-2-イル基、1,3-ジヒドロキシ-2-ヒドロキシメチルプロパン-2-イル基、1,2-ジヒドロキシプロパン-3-イル基、1,1-ジヒドロキシブタン-2-イル基、1,1-ジヒドロキシペンタン-2-イル基、1,1-ジヒドロキシ-5-メチルヘキサン-2-イル基、1,1-ジヒドロキシプロパン-2-イル基、1,1-ジヒドロキシ-4-(-4-ヒドロキシフェニル)ブタン-2-イル基;ジ、トリ、テトラ、又はペンタヒドロキシペンタン-1-イル基;ジ、トリ、テトラ、ペンタ、又はヘキサヒドロキシヘキサン-1-イル基;ジ、トリ、テトラ、ペンタ、ヘキサ、又はヘプタヒドロキシヘプタン-1-イル基;ジ、トリ、テトラ、ペンタ、ヘキサ、ヘプタ、又はオクタヒドロキシオクタン-1-イル基等が挙げられる。ポリヒドロキシアルキル基は、水酸基を2~8個有するものが好ましく、2~6個有するものがより好ましく、アルキル基は炭素数1~22のものが好ましく、炭素数1~18のものがより好ましく、炭素数1~12のものが更に好ましく、炭素数1~6のものが特に好ましい。また、次式で表わされる分岐鎖状のポリヒドロキシアルキル基は好ましいものとして例示される。 The saturated aliphatic hydrocarbon group having two or more hydroxy groups (polyhydroxyalkyl group) is not particularly limited, and examples thereof include di-, tri-, tetra-, penta-, hexa-, hepta-, and octahydroxyalkyl groups. . Specifically, although not particularly limited, for example, dihydroxyethyl groups such as 1,2-dihydroxyethyl group; 1,2-dihydroxypropan-1-yl group, 2,3-dihydroxypropan-1-yl group dihydroxypropan-1-yl group; 1,2-dihydroxypropan-2-yl group, dihydroxypropan-2-yl group such as 1,3-dihydroxypropan-2-yl group; trihydroxypropan-1-yl group; trihydroxypropan-2-yl group; trihydroxypropan-1-yl group; trihydroxypropan-2-yl group; 1,2-dihydroxybutan-1-yl group, 1,3-dihydroxybutan-1-yl group , 1,4-dihydroxybutan-1-yl group, 2,3-dihydroxybutan-1-yl group, 2,4-dihydroxybutan-1-yl group, 3,4-dihydroxybutan-1-yl group, etc. dihydroxybutan-1-yl group; 1,2,3 trihydroxybutan-1-yl group, 1,2,4 trihydroxybutan-1-yl group, 1,3,4 trihydroxybutan-1-yl group, trihydroxybutan-1-yl group such as 2,3,4 trihydroxybutan-1-yl group; tetrahydroxybutan-1-yl group; 1,2-dihydroxy-2-methylpropan-1-yl group, 1 , 3-dihydroxy-2-methylpropan-1-yl group, dihydroxy-2-methylpropan-1-yl group such as 2,3-dihydroxy-2-methylpropan-1-yl group; trihydroxy-2-methyl Propan-1-yl group; Tetrahydroxy-2-methylpropan-1-yl group; 1,2-dihydroxybutan-2-yl group, 1,3-dihydroxybutan-2-yl group, 1,4-dihydroxybutane -2-yl group, 2,3-dihydroxybutan-2-yl group, 2,4-dihydroxybutan-2-yl group, 3,4-dihydroxybutan-2-yl group and other dihydroxybutan-2-yl groups ; tetrahydroxybutan-2-yl group; 1,3-dihydroxy-2-methylpropan-2-yl group, 1,3-dihydroxy-2-ethylpropan-2-yl group, 1,3-dihydroxy-2- hydroxymethylpropan-2-yl group; tetrahydroxybutan-2-yl group; 1,3-dihydroxy-2-methylpropan-2-yl group, 1,3-dihydroxy-2-ethylpropan-2-yl group, 1,3-dihydroxy-2-hydroxymethylpropan-2-yl group, 1 , 2-dihydroxypropan-3-yl group, 1,1-dihydroxybutan-2-yl group, 1,1-dihydroxypentan-2-yl group, 1,1-dihydroxy-5-methylhexan-2-yl group , 1,1-dihydroxypropan-2-yl group, 1,1-dihydroxy-4-(-4-hydroxyphenyl)butan-2-yl group; di-, tri-, tetra-, or pentahydroxypentan-1-yl group di, tri, tetra, penta, or hexahydroxyhexan-1-yl group; di, tri, tetra, penta, hexa, or heptahydroxyheptan-1-yl group; di, tri, tetra, penta, hexa, hepta , or an octahydroxyoctan-1-yl group. The polyhydroxyalkyl group preferably has 2 to 8 hydroxyl groups, more preferably 2 to 6 hydroxyl groups, and the alkyl group preferably has 1 to 22 carbon atoms, more preferably 1 to 18 carbon atoms. , those having 1 to 12 carbon atoms are more preferred, and those having 1 to 6 carbon atoms are particularly preferred. A branched polyhydroxyalkyl group represented by the following formula is also preferred.
Figure JPOXMLDOC01-appb-C000004
Figure JPOXMLDOC01-appb-C000004
(式中、R7は水素原子、炭素数1~8(好ましくは炭素数1~4)の直鎖状のアルキル基、又は炭素数1~8(好ましくは炭素数1~4)の直鎖状のヒドロキシアルキル基を示す。) (Wherein, R 7 is a hydrogen atom, a linear alkyl group having 1 to 8 carbon atoms (preferably 1 to 4 carbon atoms), or a linear alkyl group having 1 to 8 carbon atoms (preferably 1 to 4 carbon atoms) indicates a hydroxyalkyl group.)
 上記式の基としては、特に限定されないが、例えば、1,2-ジヒドロキシプロパン-1-イル基、2,3-ジヒドロキシプロパン-1-イル基、1,2-ジヒドロキシプロパン-2-イル基、1,3-ジヒドロキシプロパン-2-イル基、トリヒドロキシプロパン-1-イル基、トリヒドロキシプロパン-2-イル基、トリヒドロキシプロパン-1-イル基、トリヒドロキシプロパン-2-イル基、1,2-ジヒドロキシブタン-1-イル基、1,3-ジヒドロキシブタン-1-イル基、1,4-ジヒドロキシブタン-1-イル基、2,3-ジヒドロキシブタン-1-イル基、2,4-ジヒドロキシブタン-1-イル基、3,4-ジヒドロキシブタン-1-イル基、1,2,3トリヒドロキシブタン-1-イル基、1,2,4トリヒドロキシブタン-1-イル基1,3,4トリヒドロキシブタン-1-イル基、2,3,4トリヒドロキシブタン-1-イル基、テトラヒドロキシブタン-1-イル基、1,2-ジヒドロキシ-2-メチルプロパン-1-イル基、1,3-ジヒドロキシ-2-メチルプロパン-1-イル基、2,3-ジヒドロキシ-2-メチルプロパン-1-イル基、トリヒドロキシ-2-メチルプロパン-1-イル基、テトラヒドロキシ-2-メチルプロパン-1-イル基、1,2-ジヒドロキシブタン-2-イル基、1,3-ジヒドロキシブタン-2-イル基、1,4-ジヒドロキシブタン-2-イル基、2,3-ジヒドロキシブタン-2-イル基、2,4-ジヒドロキシブタン-2-イル基、3,4-ジヒドロキシブタン-2-イル基、テトラヒドロキシブタン-2-イル基、1,3-ジヒドロキシ-2-メチルプロパン-2-イル基、1,3-ジヒドロキシ-2-エチルプロパン-2-イル基、1,3-ジヒドロキシ-2-ヒドロキシメチルプロパン-2-イル基、テトラヒドロキシブタン-2-イル基、1,3-ジヒドロキシ-2-メチルプロパン-2-イル基、1,3-ジヒドロキシ-2-エチルプロパン-2-イル基、1,3-ジヒドロキシ-2-ヒドロキシメチルプロパン-2-イル基、1,2-ジヒドロキシプロパン-3-イル基、1,1-ジヒドロキシブタン-2-イル基、1,1-ジヒドロキシペンタン-2-イル基、1,1-ジヒドロキシ-5-メチルヘキサン-2-イル基、1,1-ジヒドロキシプロパン-2-イル基、1,1-ジヒドロキシ-4-(-4-ヒドロキシフェニル)ブタン-2-イル基、ジ、トリ、テトラ、又はペンタヒドロキシペンタン-1-イル基、ジ、トリ、テトラ、ペンタ、又はヘキサヒドロキシヘキサン-1-イル基、ジ、トリ、テトラ、ペンタ、ヘキサ、又はヘプタヒドロキシヘプタン-1-イル基、ジ、トリ、テトラ、ペンタ、ヘキサ、ヘプタ、又はオクタヒドロキシオクタン-1-イル基等が挙げられる。 The group of the above formula is not particularly limited, but examples include 1,2-dihydroxypropan-1-yl group, 2,3-dihydroxypropan-1-yl group, 1,2-dihydroxypropan-2-yl group, 1,3-dihydroxypropan-2-yl group, trihydroxypropan-1-yl group, trihydroxypropan-2-yl group, trihydroxypropan-1-yl group, trihydroxypropan-2-yl group, 1, 2-dihydroxybutan-1-yl group, 1,3-dihydroxybutan-1-yl group, 1,4-dihydroxybutan-1-yl group, 2,3-dihydroxybutan-1-yl group, 2,4- Dihydroxybutan-1-yl group, 3,4-dihydroxybutan-1-yl group, 1,2,3-trihydroxybutan-1-yl group, 1,2,4-trihydroxybutan-1-yl group 1,3 ,4-trihydroxybutan-1-yl group, 2,3,4-trihydroxybutan-1-yl group, tetrahydroxybutan-1-yl group, 1,2-dihydroxy-2-methylpropan-1-yl group, 1,3-dihydroxy-2-methylpropan-1-yl group, 2,3-dihydroxy-2-methylpropan-1-yl group, trihydroxy-2-methylpropan-1-yl group, tetrahydroxy-2- methylpropan-1-yl group, 1,2-dihydroxybutan-2-yl group, 1,3-dihydroxybutan-2-yl group, 1,4-dihydroxybutan-2-yl group, 2,3-dihydroxybutane -2-yl group, 2,4-dihydroxybutan-2-yl group, 3,4-dihydroxybutan-2-yl group, tetrahydroxybutan-2-yl group, 1,3-dihydroxy-2-methylpropane- 2-yl group, 1,3-dihydroxy-2-ethylpropan-2-yl group, 1,3-dihydroxy-2-hydroxymethylpropan-2-yl group, tetrahydroxybutan-2-yl group, 1,3 -dihydroxy-2-methylpropan-2-yl group, 1,3-dihydroxy-2-ethylpropan-2-yl group, 1,3-dihydroxy-2-hydroxymethylpropan-2-yl group, 1,2- dihydroxypropan-3-yl group, 1,1-dihydroxybutan-2-yl group, 1,1-dihydroxypentan-2-yl group, 1,1-dihydroxy-5-methylhexan-2-yl group, 1, 1-dihydroxypropan-2-yl group, 1,1-dihydroxy-4-(-4-hydroxyphenyl ) butan-2-yl group, di, tri, tetra, or pentahydroxypentan-1-yl group, di, tri, tetra, penta, or hexahydroxyhexan-1-yl group, di, tri, tetra, penta, hexa or heptahydroxyheptan-1-yl group, di-, tri-, tetra-, penta-, hexa-, hepta- or octahydroxyoctan-1-yl group.
 以上のポリヒドロキシアルキル基の中でも、2,3-ジヒドロキシプロパン-1-イル基、1,3-ジヒドロキシプロパン-2-イル基、1,3-ジヒドロキシ-2-エチルプロパン-2-イル基、1,3-ジヒドロキシ-2-ヒドロキシメチルプロパン-2-イル基、ペンタヒドロキシヘキサン-1-イル基が好ましく、抗菌性の点から1,3-ジヒドロキシ-2-エチルプロパン-2-イル基、1,3-ジヒドロキシ-2-ヒドロキシメチルプロパン-2-イル基がより好ましい。 Among the above polyhydroxyalkyl groups, 2,3-dihydroxypropan-1-yl group, 1,3-dihydroxypropan-2-yl group, 1,3-dihydroxy-2-ethylpropan-2-yl group, 1 ,3-dihydroxy-2-hydroxymethylpropan-2-yl group and pentahydroxyhexan-1-yl group are preferable, and from the viewpoint of antibacterial properties, 1,3-dihydroxy-2-ethylpropan-2-yl group, 1, A 3-dihydroxy-2-hydroxymethylpropan-2-yl group is more preferred.
 安全性の観点において、成分(A)がモノヒドロキシアルキル基を有する場合、トリエタノールアミン、ジエタノールアミンが好ましく、特にトリエタノールアミンが好ましい。 From the viewpoint of safety, when component (A) has a monohydroxyalkyl group, triethanolamine and diethanolamine are preferred, and triethanolamine is particularly preferred.
 また、安全性、使用上の観点から、成分(A)は、医薬部外品原料規格(外原規)、医薬部外品添加物規格、日本薬局方(日局)、日本薬局方外医薬部外品規格(局外規)、医薬品添加物規格(薬添規)、食品添加物公定書(食添)に記載された化合物を原料(例えば、酸、塩基)に用いることが好ましく、特に限定されないが、モノエタノールアミン、ジエタノールアミン、トリエタノールアミン、2-アミノ-2-ヒドロキシメチル-1、3-プロパンジオール、2-アミノ-2-メチル-1-プロパノール、2-アミノ-2-メチル-1、3-プロパンジオール、モノイソプロパノールアミン、ジイソプロパノールアミン、トリイソプロパノールアミン、2-アセトアミドエタノールアミン、N-ラウリルジエタノールアミン、ジメチルオクタデシルアミンが好ましく、これらの中でも低臭気の観点から、トリエタノールアミン、2-アミノ-2-ヒドロキシメチル-1、3-プロパンジオールがより好ましい。 In addition, from the viewpoint of safety and use, component (A) is specified in the Standards for Quasi-drug Ingredients (Quasi-drugs Ingredients), Standards for Quasi-drug Additives, Japanese Pharmacopoeia (Japanese Pharmacopoeia), Japanese Pharmacopoeia Drugs It is preferable to use compounds listed in the Standards for Quasi-Drugs (Regulations), Pharmaceutical Additives Standards (Medicine Additives), and Food Additives Standards (Food Additives) as raw materials (e.g. acids, bases), especially limited monoethanolamine, diethanolamine, triethanolamine, 2-amino-2-hydroxymethyl-1, 3-propanediol, 2-amino-2-methyl-1-propanol, 2-amino-2-methyl-1 , 3-propanediol, monoisopropanolamine, diisopropanolamine, triisopropanolamine, 2-acetamidoethanolamine, N-lauryldiethanolamine, and dimethyloctadecylamine are preferred. Among them, triethanolamine, 2- Amino-2-hydroxymethyl-1,3-propanediol is more preferred.
 成分(A)は、成分(A)における官能基を導入可能な部位(窒素部位や、窒素と共に環を構成する炭素部位などの、基本骨格となる化学構造に含まれる原子)が、その1つ以上が水素結合性官能基を持たない有機基で置換されてもよい。そのような有機基としては、例えば、炭化水素基が挙げられる。炭化水素基としては、例えば、アルキル基が挙げられる。アルキル基は、炭素数1~18の直鎖状もしくは分岐状が好ましく、炭素数1~12の直鎖状もしくは分岐状がより好ましく、炭素数1~8の直鎖状もしくは分岐状が更に好ましく、炭素数1~4の直鎖状もしくは分岐状が更に好ましい。 In component (A), one of the moieties in component (A) into which a functional group can be introduced (atoms contained in the chemical structure serving as a basic skeleton, such as a nitrogen moiety and a carbon moiety forming a ring together with nitrogen) is The above may be substituted with an organic group that does not have a hydrogen-bonding functional group. Such organic groups include, for example, hydrocarbon groups. Hydrocarbon groups include, for example, alkyl groups. The alkyl group is preferably linear or branched with 1 to 18 carbon atoms, more preferably linear or branched with 1 to 12 carbon atoms, and even more preferably linear or branched with 1 to 8 carbon atoms. , a linear or branched chain having 1 to 4 carbon atoms is more preferable.
 成分(A)がアンモニウム化合物である場合、アニオンとしては、特に限定されるものではないが、例えば、水酸化物アニオン、ハロゲン系アニオン、硫黄系アニオン、リン系アニオン、シアン系アニオン、ホウ素系アニオン、フッ素系アニオン、窒素酸化物系アニオン、カルボン酸系アニオン等が挙げられ、これらの中でも水酸化物アニオンが好ましい。 When the component (A) is an ammonium compound, the anion is not particularly limited, but examples include hydroxide anions, halogen anions, sulfur anions, phosphorus anions, cyanide anions, and boron anions. , fluorine-based anions, nitrogen oxide-based anions, carboxylic acid-based anions, and the like, and among these, hydroxide anions are preferred.
 成分(A)のアミンもしくはアンモニウム化合物がアミン化合物である場合、前記成分(A)は、下記式(I)で表されるアミン化合物が好ましい。 When the amine or ammonium compound of component (A) is an amine compound, said component (A) is preferably an amine compound represented by the following formula (I).
Figure JPOXMLDOC01-appb-C000005
Figure JPOXMLDOC01-appb-C000005
(式中、R1はそれぞれ独立に、水酸基を1個以上有し、炭化水素部位が炭素数1~22の直鎖状もしくは分岐鎖状で、該炭化水素部位が酸素原子を含んでいてもよいヒドロキシ炭化水素基を示し、R2はそれぞれ独立に、水素原子又は炭素数1~22の有機基であり、mは0~3の整数を示す。) (In the formula, each R 1 independently has one or more hydroxyl groups, the hydrocarbon moiety is linear or branched with 1 to 22 carbon atoms, and the hydrocarbon moiety contains an oxygen atom. represents a good hydroxy hydrocarbon group, each R 2 is independently a hydrogen atom or an organic group having 1 to 22 carbon atoms, and m is an integer of 0 to 3.)
 前記式(I)において、mは1~3の整数であることが好ましい。 In the above formula (I), m is preferably an integer of 1-3.
 前記式(I)において、全てのR2が水素原子であることが好ましい。 In formula (I) above, all R 2 are preferably hydrogen atoms.
 前記式(I)において、ヒドロキシ炭化水素基は、前記酸素原子を含んでいてもよい炭化水素部位における炭化水素が飽和脂肪族炭化水素であることが好ましい。 In the above formula (I), in the hydroxy hydrocarbon group, the hydrocarbon in the hydrocarbon moiety that may contain an oxygen atom is preferably a saturated aliphatic hydrocarbon.
 前記式(I)において、R1のうち少なくとも1つが、水酸基を1個有し、前記酸素原子を含んでいてもよい炭化水素部位における炭化水素が飽和脂肪族炭化水素のヒドロキシ炭化水素基であることが好ましい。 In the formula (I), at least one of R 1 has one hydroxyl group, and the hydrocarbon in the hydrocarbon moiety optionally containing an oxygen atom is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group. is preferred.
 前記式(I)において、R1のうち少なくとも1つが、水酸基を2個以上有し、前記酸素原子を含んでいてもよい炭化水素部位の炭化水素が飽和脂肪族炭化水素のヒドロキシ炭化水素基であることが好ましい。 In the above formula (I), at least one of R 1 has two or more hydroxyl groups, and the hydrocarbon in the hydrocarbon moiety which may contain an oxygen atom is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group. Preferably.
 前記式(I)において、R1のうち少なくとも1つが、水酸基を1個以上有し、炭化水素部位が炭素数3~22の分岐鎖状で、前記酸素原子を含んでいてもよい炭化水素部位の炭化水素が飽和脂肪族炭化水素のヒドロキシ炭化水素基であることが好ましい。 In the formula (I), at least one of R 1 has one or more hydroxyl groups, the hydrocarbon moiety is a branched chain having 3 to 22 carbon atoms, and the hydrocarbon moiety may contain an oxygen atom. is preferably a hydroxy hydrocarbon group of a saturated aliphatic hydrocarbon.
 式(I)において示した上記の好ましいそれぞれの例は、それらの少なくともいずれかの組み合わせが、より好ましい態様となり得る。 A combination of at least one of the above preferred examples shown in formula (I) can be a more preferred embodiment.
 前記式(I)において、R1が水酸基を1個有し、炭化水素部位が炭素数1~6の直鎖状のヒドロキシ炭化水素基であり、R2が水素原子であり、mは1~3の整数であることが好ましい。
 前記式(I)において、R1が水酸基を2又は3個有し、炭化水素部位が分岐鎖状の炭素数2~6のヒドロキシ炭化水素基であり、R2が水素原子であり、mは1の整数であることが好ましい。
 前記式(I)において、R1が水酸基を2~6個有し、炭化水素部位が直鎖状の炭素数2~6のヒドロキシ炭化水素基であり、R2が水素原子であり、mは1の整数であることが好ましい。
In the above formula (I), R 1 has one hydroxyl group, the hydrocarbon moiety is a linear hydroxy hydrocarbon group having 1 to 6 carbon atoms, R 2 is a hydrogen atom, and m is 1 to An integer of three is preferred.
In the above formula (I), R 1 has 2 or 3 hydroxyl groups, the hydrocarbon moiety is a branched hydroxy hydrocarbon group having 2 to 6 carbon atoms, R 2 is a hydrogen atom, and m is An integer of 1 is preferred.
In the above formula (I), R 1 has 2 to 6 hydroxyl groups, the hydrocarbon moiety is a linear hydroxy hydrocarbon group having 2 to 6 carbon atoms, R 2 is a hydrogen atom, and m is An integer of 1 is preferred.
 成分(A)のアミンもしくはアンモニウム化合物がアンモニウム化合物である場合、前記成分(A)は、下記式(II)で表されるアンモニウム化合物であることが好ましい。 When the amine or ammonium compound of component (A) is an ammonium compound, said component (A) is preferably an ammonium compound represented by the following formula (II).
Figure JPOXMLDOC01-appb-C000006
Figure JPOXMLDOC01-appb-C000006
(式中、R3はそれぞれ独立に、水酸基を1個以上有し、炭化水素部位が炭素数1~22の直鎖状もしくは分岐鎖状で、該炭化水素部位が酸素原子を含んでいてもよいヒドロキシ炭化水素基を示し、R4はそれぞれ独立に、水素原子又は炭素数1~22の有機基であり、nは0~4の整数を示す。X-はアニオンを示す。) (In the formula, each R 3 independently has one or more hydroxyl groups, the hydrocarbon moiety is linear or branched with 1 to 22 carbon atoms, and the hydrocarbon moiety contains an oxygen atom. represents a good hydroxy hydrocarbon group, each R 4 is independently a hydrogen atom or an organic group having 1 to 22 carbon atoms, n represents an integer of 0 to 4, and X represents an anion.)
 前記式(II)において、X-で表されるアニオンは、水酸化物イオンが好ましい。 In formula (II) above, the anion represented by X is preferably a hydroxide ion.
 前記式(II)において、nは1~4の整数であることが好ましい。 In the above formula (II), n is preferably an integer of 1-4.
 前記式(II)において、全てのR4が水素原子であることが好ましい。 In formula (II), all R 4 are preferably hydrogen atoms.
 前記式(II)において、ヒドロキシ炭化水素基は、前記酸素原子を含んでいてもよい炭化水素部位における炭化水素が飽和脂肪族炭化水素であることが好ましい。 In the above formula (II), in the hydroxy hydrocarbon group, the hydrocarbon in the hydrocarbon moiety which may contain an oxygen atom is preferably a saturated aliphatic hydrocarbon.
 前記式(II)において、R3のうち少なくとも1つが、水酸基を1個有し、前記酸素原子を含んでいてもよい炭化水素部位における炭化水素が飽和脂肪族炭化水素のヒドロキシ炭化水素基が好ましい。 In the above formula (II), at least one of R 3 has one hydroxyl group, and the hydrocarbon in the hydrocarbon moiety optionally containing an oxygen atom is preferably a hydroxy hydrocarbon group in which the hydrocarbon is a saturated aliphatic hydrocarbon. .
 前記式(II)において、R3のうち少なくとも1つが、水酸基を2個以上有し、前記酸素原子を含んでいてもよい炭化水素部位の炭化水素が飽和脂肪族炭化水素のヒドロキシ炭化水素基であることが好ましい。 In the formula (II), at least one of R 3 has two or more hydroxyl groups, and the hydrocarbon in the hydrocarbon moiety which may contain an oxygen atom is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group. Preferably.
 前記式(II)において、R3のうち少なくとも1つが、水酸基を1個以上有し、炭化水素部位が炭素数3~22の分岐鎖状で、前記酸素原子を含んでいてもよい炭化水素部位の炭化水素が飽和脂肪族炭化水素のヒドロキシ炭化水素基であることが好ましい。 In the formula (II), at least one of R 3 has one or more hydroxyl groups, the hydrocarbon moiety is a branched chain having 3 to 22 carbon atoms, and the hydrocarbon moiety may contain an oxygen atom. is preferably a hydroxy hydrocarbon group of a saturated aliphatic hydrocarbon.
 式(II)において示した上記の好ましいそれぞれの例は、それらの少なくともいずれかの組み合わせが、より好ましい態様となり得る。 A combination of at least one of the above preferred examples shown in formula (II) can be a more preferred embodiment.
 前記式(II)において、R3が水酸基を1個有し、炭化水素部位が炭素数1~3のヒドロキシ炭化水素基であり、R4は炭素数1~3の炭化水素基であり、nは1の整数を示すことが好ましい。
 前記式(II)において、R4は炭素数1~4の炭化水素基であり、nは0の整数を示すことが好ましい。
In the above formula (II), R 3 has one hydroxyl group, the hydrocarbon moiety is a hydroxy hydrocarbon group having 1 to 3 carbon atoms, R 4 is a hydrocarbon group having 1 to 3 carbon atoms, and n preferably denotes an integer of 1.
In formula (II), R 4 is a hydrocarbon group having 1 to 4 carbon atoms, and n preferably represents an integer of 0.
 本発明の抗菌剤は、成分(A)と成分(B)が形成する有機アンモニウム塩も一つの好ましい態様である。 Another preferred embodiment of the antibacterial agent of the present invention is an organic ammonium salt formed by component (A) and component (B).
 好ましくは、前記成分(B)のカチオン性残基を有していてもよい前記成分(A)由来のカチオンと、前記成分(B)のアニオン性残基に由来するアニオンが形成する有機アンモニウム塩を含有する。
 前記カチオンは、アンモニウムカチオンが好ましい。
Preferably, an organic ammonium salt formed by a cation derived from the component (A), which may have a cationic residue of the component (B), and an anion derived from the anionic residue of the component (B). contains
The cation is preferably an ammonium cation.
 本発明において、成分(B)中の残基は電荷を有さない原子又は原子団(基)を指し、電荷を持ちカチオンとなるものをカチオン性残基、アニオンとなるものをアニオン性残基とする。 In the present invention, the residue in the component (B) refers to an uncharged atom or atomic group (group), a cationic residue having a charge that becomes a cation, and an anionic residue that becomes an anion. and
 本発明において、成分(B)のカルボン酸もしくはその塩は、カチオン性残基とアニオン性残基とを有する。カチオン性残基は、水素原子であるか又は、成分(A)の窒素原子と結合して水素結合性官能基や有機基となる基(原子団)である。好ましくは、成分(B)の酸は、プロトンとなる水素とアニオン性残基から構成される化合物である。 In the present invention, the carboxylic acid or its salt of component (B) has a cationic residue and an anionic residue. The cationic residue is a hydrogen atom or a group (atomic group) that combines with the nitrogen atom of component (A) to form a hydrogen-bonding functional group or an organic group. Preferably, the acid of component (B) is a compound composed of protonated hydrogen and an anionic residue.
 本発明において有機アンモニウム塩は、窒素原子をイオン中心とする有機カチオン又はNH4 +、及び有機アニオンを含む。特に、有機カチオン及び有機アニオンを含む。ここで「有機」の用語は元素として炭素及び水素を含むことを意味する。 In the present invention, the organic ammonium salt includes an organic cation or NH 4 + having a nitrogen atom as the ion center, and an organic anion. In particular it includes organic cations and organic anions. As used herein, the term "organic" is meant to include carbon and hydrogen as elements.
 前記成分(A)由来のカチオンとしては、アンモニウムカチオン(NH4 +、1級アンモニウムカチオン、2級アンモニウムカチオン、3級アンモニウムカチオン)、グアニジウムカチオン、例えば、特に限定されないが、イミダゾリウムカチオン、ピリジニウムカチオン、ピロリジニウムカチオン、ピペリジニウムカチオン、ピロリニウムカチン、ピラジニウムカチオン、トリアゾリウムカチオン、イソキノリニウムカチオン、オキサゾリニウムカチオン、チアゾリニウムカチオン、モルホリニウムカチオン、ピリミジニウムカチオン、ピペラジニウムカチオン、トリアジニウムカチオン、キノリニウムカチオン、インドリニウムカチオン、キノキサリニウムカチオン、イソオキサゾリウムカチオン等をはじめとする環状アミン由来のカチオン、カチオン性アミノ酸等が挙げられる。これらの中でもアンモニウムカチオン、イミダゾリウムカチオン、ピリジニウムカチオン、ピロリジニウムカチオン、ピペリジニウムカチオン、モルホリニウムカチオンが好ましく、アンモニウムカチオンがより好ましい。 Examples of cations derived from component (A) include ammonium cations (NH 4 + , primary ammonium cations, secondary ammonium cations, tertiary ammonium cations), guanidinium cations, and imidazolium cations, although not particularly limited. pyridinium cation, pyrrolidinium cation, piperidinium cation, pyrrolinium catine, pyrazinium cation, triazolium cation, isoquinolinium cation, oxazolinium cation, thiazolinium cation, morpholinium cation, pyrimidinium cation cations derived from cyclic amines such as nium cations, piperazinium cations, triazinium cations, quinolinium cations, indolinium cations, quinoxalinium cations, isoxazolium cations, and cationic amino acids. be done. Among these, ammonium cation, imidazolium cation, pyridinium cation, pyrrolidinium cation, piperidinium cation, and morpholinium cation are preferred, and ammonium cation is more preferred.
 前記成分(A)と成分(B)が形成する有機アンモニウム塩のカチオンは、下記式(III)で表されるカチオンが好ましい。また成分(A)がアンモニウム化合物である場合、そのカチオンも下記式(III)で表されるカチオンが好ましい。 The cation of the organic ammonium salt formed by the component (A) and the component (B) is preferably a cation represented by the following formula (III). Moreover, when the component (A) is an ammonium compound, its cation is also preferably a cation represented by the following formula (III).
Figure JPOXMLDOC01-appb-C000007
Figure JPOXMLDOC01-appb-C000007
(式中、R5はそれぞれ独立に、水酸基を1個以上有し、炭化水素部位が炭素数1~22の直鎖状もしくは分岐鎖状で、該炭化水素部位が酸素原子を含んでいてもよいヒドロキシ炭化水素基を示し、R6はそれぞれ独立に、水素原子又は炭素数1~22の有機基であり、oは0~4の整数を示す。) (In the formula, each R 5 independently has one or more hydroxyl groups, the hydrocarbon moiety is linear or branched with 1 to 22 carbon atoms, and the hydrocarbon moiety contains an oxygen atom. represents a good hydroxy hydrocarbon group, each R 6 is independently a hydrogen atom or an organic group having 1 to 22 carbon atoms, and o represents an integer of 0 to 4.)
 前記式(III)において、oは1~4の整数であることが好ましい。 In the above formula (III), o is preferably an integer of 1-4.
 前記式(III)において、全てのR6が水素原子であることが好ましい。 In formula (III), all R 6 are preferably hydrogen atoms.
 前記式(III)において、ヒドロキシ炭化水素基は、前記酸素原子を含んでいてもよい炭化水素部位における炭化水素が飽和脂肪族炭化水素であることが好ましい。 In the above formula (III), in the hydroxy hydrocarbon group, the hydrocarbon in the hydrocarbon moiety that may contain an oxygen atom is preferably a saturated aliphatic hydrocarbon.
 前記式(III)において、R5のうち少なくとも1つが、水酸基を1個有し、前記酸素原子を含んでいてもよい炭化水素部位における炭化水素が飽和脂肪族炭化水素のヒドロキシ炭化水素基であることが好ましい。 In formula (III), at least one of R 5 has one hydroxyl group, and the hydrocarbon in the hydrocarbon moiety optionally containing an oxygen atom is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group. is preferred.
 前記式(III)において、R5のうち少なくとも1つが、水酸基を2個以上有し、前記酸素原子を含んでいてもよい炭化水素部位の炭化水素が飽和脂肪族炭化水素のヒドロキシ炭化水素基であることが好ましい。 In the above formula (III), at least one of R 5 has two or more hydroxyl groups, and the hydrocarbon in the hydrocarbon moiety optionally containing an oxygen atom is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group. Preferably.
 前記式(III)において、R5のうち少なくとも1つが、水酸基を1個以上有し、炭化水素部位が炭素数3~22の分岐鎖状で、前記酸素原子を含んでいてもよい炭化水素部位の炭化水素が飽和脂肪族炭化水素のヒドロキシ炭化水素基であることが好ましい。 In the formula (III), at least one of R 5 has one or more hydroxyl groups, the hydrocarbon moiety is a branched chain having 3 to 22 carbon atoms, and the hydrocarbon moiety may contain an oxygen atom. is preferably a hydroxy hydrocarbon group of a saturated aliphatic hydrocarbon.
 前記式(III)で表されるカチオンのR6のうち少なくとも1つが水素原子の場合、その水素原子に対応するプロトンが前記成分(B)に由来することが好ましい。 When at least one of R 6 of the cation represented by the formula (III) is a hydrogen atom, the proton corresponding to the hydrogen atom is preferably derived from the component (B).
 式(III)において示した上記の好ましいそれぞれの例は、それらの少なくともいずれかの組み合わせが、より好ましい態様となり得る。 A combination of at least one of the above preferred examples shown in formula (III) can be a more preferred embodiment.
 本発明の抗菌剤において、成分(B)はカルボン酸もしくはその塩である。前記カルボン酸は、分子中に、少なくとも1個以上のカルボキシ基(-COOH)を持つ有機酸であり、酸素含有基、窒素含有基、硫黄含有基、リン含有基、炭化水素基等を有していてもよい。特に限定されないが、カルボン酸としては、例えば、飽和又は不飽和脂肪族炭化水素基、飽和又は不飽和脂環式炭化水素基、芳香族炭化水素基等、また、それらを組み合わせた炭化水素基とカルボキシ基を有するものが挙げられ、例えば、飽和脂肪族カルボン酸、不飽和脂肪族カルボン酸、飽和又は不飽和脂環式カルボン酸、芳香族カルボン酸、飽和脂肪族ヒドロキシカルボン酸、不飽和脂肪族ヒドロキシカルボン酸、飽和又は不飽和脂環式ヒドロキシカルボン酸、芳香族ヒドロキシカルボン酸、カルボニルカルボン酸、アルキルエーテルカルボン酸、ハロゲンカルボン酸等が挙げられる(以下に挙げるカルボン酸の炭素数は、カルボキシ基の炭素を含む。)。 In the antibacterial agent of the present invention, component (B) is a carboxylic acid or its salt. The carboxylic acid is an organic acid having at least one carboxy group (--COOH) in the molecule, and has an oxygen-containing group, a nitrogen-containing group, a sulfur-containing group, a phosphorus-containing group, a hydrocarbon group, and the like. may be Although not particularly limited, the carboxylic acid includes, for example, a saturated or unsaturated aliphatic hydrocarbon group, a saturated or unsaturated alicyclic hydrocarbon group, an aromatic hydrocarbon group, etc., and a hydrocarbon group combining them. those having a carboxy group, such as saturated aliphatic carboxylic acids, unsaturated aliphatic carboxylic acids, saturated or unsaturated alicyclic carboxylic acids, aromatic carboxylic acids, saturated aliphatic hydroxycarboxylic acids, unsaturated aliphatic hydroxycarboxylic acids, saturated or unsaturated alicyclic hydroxycarboxylic acids, aromatic hydroxycarboxylic acids, carbonylcarboxylic acids, alkyl ether carboxylic acids, halogen carboxylic acids, etc. (the number of carbon atoms in the carboxylic acids listed below is carboxy group of carbon.).
 前記飽和脂肪族カルボン酸は、直鎖状又は分岐鎖状の飽和脂肪族炭化水素基と1個以上のカルボキシ基からなり、炭素数1~22が好ましい。
 飽和脂肪族カルボン酸としては、カルボキシ基が1個の飽和脂肪族モノカルボン酸、カルボキシ基が2個の飽和脂肪族ジカルボン酸等が挙げられる。
 飽和脂肪族モノカルボン酸は、直鎖状又は分岐鎖状の飽和脂肪族炭化水素基と1個のカルボキシ基からなり、炭素数1~22が好ましい。具体的には、特に限定されないが、例えば、蟻酸、酢酸、プロピオン酸、酪酸、吉草酸、カプロン酸、エナント酸、カプリル酸、ペラルゴン酸、カプリン酸、ラウリン酸、ミリスチン酸、ペンタデシル酸、パルミチン酸、マルガリン酸、ステアリン酸、アラキジン酸、ヘンイコシル酸、ベヘン酸、イソ酪酸、2-メチル酪酸、イソ吉草酸、2-エチルヘキサン酸、イソノナン酸、イソパルミチン酸、イソステアリン酸等が挙げられる。
 飽和脂肪族ジカルボン酸は、直鎖状又は分岐鎖状の飽和脂肪族炭化水素基と2個のカルボキシ基からなり、炭素数2~22が好ましい。
 具体的には、特に限定されないが、例えば、シュウ酸、マロン酸、コハク酸、グルタル酸、アジピン酸、ピメリン酸、スベリン酸、アゼライン酸、セバシン酸等が挙げられる。
The saturated aliphatic carboxylic acid is composed of a linear or branched saturated aliphatic hydrocarbon group and one or more carboxy groups, and preferably has 1 to 22 carbon atoms.
Examples of saturated aliphatic carboxylic acids include saturated aliphatic monocarboxylic acids having one carboxy group and saturated aliphatic dicarboxylic acids having two carboxy groups.
The saturated aliphatic monocarboxylic acid is composed of a linear or branched saturated aliphatic hydrocarbon group and one carboxy group, and preferably has 1 to 22 carbon atoms. Specifically, but not limited to, formic acid, acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, enanthic acid, caprylic acid, pelargonic acid, capric acid, lauric acid, myristic acid, pentadecyl acid, palmitic acid , margaric acid, stearic acid, arachidic acid, henicosyl acid, behenic acid, isobutyric acid, 2-methylbutyric acid, isovaleric acid, 2-ethylhexanoic acid, isononanoic acid, isopalmitic acid, isostearic acid and the like.
The saturated aliphatic dicarboxylic acid is composed of a linear or branched saturated aliphatic hydrocarbon group and two carboxy groups, and preferably has 2 to 22 carbon atoms.
Specific examples include, but are not limited to, oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, and sebacic acid.
 前記不飽和脂肪族カルボン酸は、直鎖状又は分岐鎖状の不飽和脂肪族炭化水素基と1個以上のカルボキシ基からなり、炭素数3~22が好ましい。
 不飽和脂肪族カルボン酸としては、カルボキシ基が1個の不飽和脂肪族モノカルボン酸、カルボキシ基が2個の不飽和脂肪族ジカルボン酸等が挙げられる。
 不飽和脂肪族モノカルボン酸は、直鎖状又は分岐鎖状の不飽和脂肪族炭化水素基と1個のカルボキシ基からなり、炭素数1~22が好ましい。
 具体的には、特に限定されないが、例えば、アクリル酸、メタクリル酸、クロトン酸、オクテン酸、ノネン酸、デセン酸、ウンデセン酸、ウンデシレン酸、ドデセン酸、トリデセン酸、テトラデセン酸、ミリストレイン酸、ペンタデセン酸、ヘキサデセン酸、パルミトレイン酸、サピエン酸、ヘプタデセン酸、オクタデセン酸、オレイン酸、エライジン酸、バクセン酸、ノナデセン酸、イコセン酸、ガドレイン酸、ヘンイコセン酸、ドコセン酸、エルカ酸、オクタジエン酸、ノナジエン酸、デカジエン酸、ウンデカジエン酸、ドデカジエン酸、トリデカジエン酸、テトラデカジエン酸、ペンタデカジエン酸、ヘキサデカジエン酸、ヘプタデカジエン酸、オクタデカジエン酸、リノール酸、ノナデカジエン酸、イコサジエン酸、ヘンイコサジエン酸、ドコサジエン酸、オクタトリエン酸、ノナトリエン酸、デカトリエン酸、ウンデカトリエン酸、ドデカトリエン酸、トリデカトリエン酸、テトラデカトリエン酸、ペンタデカトリエン酸、ヘキサデカトリエン酸、ヘプタデカトリエン酸、オクタデカトリエン酸、リノレン酸、エレオステアリン酸、ノナデカトリエン酸、イコサトリエン酸、ミード酸、ジホモ-γ-リノレン酸、ヘンイコサトリエン酸、ドコサトリエン酸、デカテトラエン酸、ウンデカテトラエン酸、ドデカテトラエン酸、トリデカテトラエン酸、テトラデカテトラエン酸、ペンタデカテトラエン酸、ヘキサデカテトラエン酸、ヘキサデカテトラエン酸、ヘプタデカテトラエン酸、オクタデカテトラエン酸、ステアリドン酸、ノナデカテトラエン酸、イコサテトラエン酸、アラキドン酸、ヘンイコサテトラエン酸、ドコサテトラエン酸、アドレン酸、ウンデカペンタエン酸、ドデカペンタエン酸、トリデカペンタエン酸、テトラデカペンタエン酸、ペンタデカペンタエン酸、ヘキサデカペンタエン酸、ヘプタデカペンタエン酸、オクタデカペンタエン酸、ボセオペンタエン酸、ノナデカペンタエン酸、イコサペンタエン酸、ヘンイコサペンタエン酸、ドコサペンタエン酸、イワシ酸、トリデカヘキサエン酸、テトラデカヘキサエン酸、ペンタデカヘキサエン酸、ヘキサデカヘキサエン酸、ヘプタデカヘキサエン酸、オクタデカヘキサエン酸、ボセオヘキサエン酸、ノナデカヘキサエン酸、イコサヘキサエン酸、ヘンイコサヘキサエン酸、ドコサヘキサエン酸等が挙げられる。
 不飽和脂肪族ジカルボン酸は、直鎖状又は分岐鎖状の不飽和脂肪族炭化水素基と2個のカルボキシ基からなり、炭素数1~22が好ましい。
 具体的には、特に限定されないが、例えば、マレイン酸、フマル酸等が挙げられる。
The unsaturated aliphatic carboxylic acid is composed of a linear or branched unsaturated aliphatic hydrocarbon group and one or more carboxy groups, and preferably has 3 to 22 carbon atoms.
Examples of unsaturated aliphatic carboxylic acids include unsaturated aliphatic monocarboxylic acids having one carboxy group and unsaturated aliphatic dicarboxylic acids having two carboxy groups.
The unsaturated aliphatic monocarboxylic acid is composed of a linear or branched unsaturated aliphatic hydrocarbon group and one carboxy group, and preferably has 1 to 22 carbon atoms.
Specifically, but not particularly limited, for example, acrylic acid, methacrylic acid, crotonic acid, octenoic acid, nonenoic acid, decenoic acid, undecenoic acid, undecylenic acid, dodecenoic acid, tridecenoic acid, tetradecenoic acid, myristoleic acid, pentadecene acid, hexadecenoic acid, palmitoleic acid, sapienic acid, heptadecenoic acid, octadecenoic acid, oleic acid, elaidic acid, vaccenic acid, nonadecenic acid, icosenoic acid, gadoleic acid, henicosenoic acid, docosenoic acid, erucic acid, octadienoic acid, nonadienoic acid, Decadienoic acid, undecadienoic acid, dodecadienoic acid, tridecadienoic acid, tetradecadienoic acid, pentadecadienoic acid, hexadecadienoic acid, heptadecadienoic acid, octadecadienoic acid, linoleic acid, nonadecadienoic acid, icosadienoic acid, henicosadienoic acid, docosadienoic acid, Octatrienoic acid, nonatrienoic acid, decatrienoic acid, undecatrienoic acid, dodecatrienoic acid, tridecatrienoic acid, tetradecatrienoic acid, pentadecatrienoic acid, hexadecatrienoic acid, heptadecatrienoic acid, octadecatrienoic acid, linolenic acid acid, eleostearic acid, nonadecatrienoic acid, icosatrienoic acid, mead acid, dihomo-γ-linolenic acid, henicosatrienoic acid, docosatrienoic acid, decatetraenoic acid, undecatetraenoic acid, dodecatetraenoic acid, tridecatetraene acid, tetradecatetraenoic acid, pentadecatetraenoic acid, hexadecatetraenoic acid, hexadecatetraenoic acid, heptadecatetraenoic acid, octadecatetraenoic acid, stearidonic acid, nonadecatetraenoic acid, icosatetraenoic acid, Arachidonic acid, henicosatetraenoic acid, docosatetraenoic acid, adrenic acid, undecapentaenoic acid, dodecapentaenoic acid, tridecapentaenoic acid, tetradecapentaenoic acid, pentadecapentaenoic acid, hexadecapentaenoic acid Enoic acid, heptadecapentaenoic acid, octadecapentaenoic acid, boseopentaenoic acid, nonadecapentaenoic acid, icosapentaenoic acid, henicosapentaenoic acid, docosapentaenoic acid, sardine acid, tridecahexaenoic acid, tetradecahexaenoic acid , pentadecahexaenoic acid, hexadecahexaenoic acid, heptadecahexaenoic acid, octadecahexaenoic acid, boseohexaenoic acid, nonadecahexaenoic acid, icosahexaenoic acid, henicosahexaenoic acid, docosahexaenoic acid, and the like. .
The unsaturated aliphatic dicarboxylic acid is composed of a linear or branched unsaturated aliphatic hydrocarbon group and two carboxy groups, preferably having 1 to 22 carbon atoms.
Specific examples include, but are not particularly limited to, maleic acid and fumaric acid.
 前記飽和又は不飽和脂環式カルボン酸は、芳香族性を持たない飽和もしくは不飽和の炭素環と1個以上のカルボキシ基からなり、炭素数6~20が好ましい。中でも、シクロヘキサン環骨格を有する飽和脂環式カルボン酸が好ましい。
 飽和又は不飽和脂環式カルボン酸としては、カルボキシ基が1個の飽和又は不飽和脂環式モノカルボン酸、カルボキシ基が2個の飽和又は不飽和脂環式ジカルボン酸等が挙げられる。
 飽和又は不飽和脂環式モノカルボン酸としては、特に限定されないが、例えば、シクロヘキサンカルボン酸等が挙げられる。
 飽和又は不飽和脂環式ジカルボン酸としては、特に限定されないが、例えば、シクロヘキサンジカルボン酸、テトラヒドロフタル酸等が挙げられる。
The saturated or unsaturated alicyclic carboxylic acid is composed of a saturated or unsaturated carbocyclic ring having no aromaticity and one or more carboxy groups, and preferably has 6 to 20 carbon atoms. Among them, a saturated alicyclic carboxylic acid having a cyclohexane ring skeleton is preferred.
Saturated or unsaturated alicyclic carboxylic acids include saturated or unsaturated alicyclic monocarboxylic acids having one carboxy group and saturated or unsaturated alicyclic dicarboxylic acids having two carboxy groups.
Examples of the saturated or unsaturated alicyclic monocarboxylic acid include, but are not particularly limited to, cyclohexanecarboxylic acid.
Examples of the saturated or unsaturated alicyclic dicarboxylic acid include, but are not particularly limited to, cyclohexanedicarboxylic acid, tetrahydrophthalic acid, and the like.
 前記芳香族カルボン酸は、芳香族性を持つ単環又は複数の環と1個以上のカルボン酸からなり、炭素数6~20が好ましい。中でも、ベンゼン環骨格を有する芳香族カルボン酸が好ましい。
 芳香族カルボン酸としては、カルボキシ基が1個の芳香族モノカルボン酸、カルボキシ基が2個の芳香族ジカルボン酸、カルボキシ基が3個の芳香族トリカルボン酸等が挙げられる。
 芳香族モノカルボン酸としては、特に限定されないが、例えば、安息香酸、ケイ皮酸、トルイル酸、キシリル酸、ヘメリト酸、メシチレン酸、プレニチル酸、メシト酸、クミン酸、アニス酸、ベラトルム酸等が挙げられる。
 芳香族ジカルボン酸としては、特に限定されないが、例えば、フタル酸、イソフタル酸、テレフタル酸等が挙げられる。
 芳香族トリカルボン酸としては、特に限定されないが、例えば、トリメシン酸、ヘミメリト酸、トリメリト酸等が挙げられる。
The aromatic carboxylic acid is composed of a single ring or a plurality of aromatic rings and one or more carboxylic acids, and preferably has 6 to 20 carbon atoms. Among them, aromatic carboxylic acids having a benzene ring skeleton are preferred.
Examples of aromatic carboxylic acids include aromatic monocarboxylic acids having one carboxy group, aromatic dicarboxylic acids having two carboxy groups, and aromatic tricarboxylic acids having three carboxy groups.
Examples of aromatic monocarboxylic acids include, but are not limited to, benzoic acid, cinnamic acid, toluic acid, xyllic acid, hemellitic acid, mesitylene acid, prenityl acid, mesitic acid, cumic acid, anisic acid, and veratrum acid. mentioned.
Examples of the aromatic dicarboxylic acid include, but are not limited to, phthalic acid, isophthalic acid, terephthalic acid, and the like.
Examples of the aromatic tricarboxylic acid include, but are not limited to, trimesic acid, hemimellitic acid, and trimellitic acid.
 前記飽和脂肪族ヒドロキシカルボン酸は、直鎖状又は分岐鎖状の飽和脂肪族炭化水素基、1個以上のカルボキシ基及び1個以上の水酸基からなり、炭素数2~24が好ましい。中でも、1~5個の水酸基を有する炭素数2~7の飽和脂肪族ヒドロキシカルボン酸が好ましい。
 飽和脂肪族ヒドロキシカルボン酸としては、カルボキシ基が1個の飽和脂肪族ヒドロキシモノカルボン酸、カルボキシ基が2個又は3個の飽和脂肪族ヒドロキシジ又はトリカルボン酸等が挙げられる。
 飽和脂肪族ヒドロキシモノカルボン酸は、炭素数2~20が好ましく、炭素数2~7がより好ましい。水酸基の個数は1~5が好ましい。具体的には、特に限定されないが、例えば、グリコール酸、乳酸、グリセリン酸、ヒドロキシ酢酸、ヒドロキシ酪酸、2-ヒドロキシデカン酸、3-ヒドロキシデカン酸、12-ヒドロキシステアリン酸、ジヒドロキシステアリン酸、セレブロン酸、ロイシン酸、メバロン酸、パントイン酸、グルコン酸、ガラクトン酸、マンノン酸、アラビノン酸、フルクツロン酸、タガツロン酸、アルドン酸等が挙げられる。
 前記飽和脂肪族ヒドロキシジカルボン酸は、直鎖状又は分岐鎖状の飽和脂肪族炭化水素基、2個のカルボキシ基及び1個以上の水酸基からなり、炭素数4~24が好ましい。中でも、1~4個の水酸基を有する炭素数2~7の飽和脂肪族ヒドロキシカルボン酸が好ましい。具体的には、特に限定されないが、例えば、タルトロン酸、リンゴ酸、酒石酸、シトラマル酸等が挙げられる。
 前記飽和脂肪族ヒドロキシトリカルボン酸は、直鎖状又は分岐鎖状の飽和脂肪族炭化水素基、3個のカルボキシ基及び1個以上の水酸基からなり、炭素数4~24が好ましい。中でも、1~4個の水酸基を有する炭素数2~7の飽和脂肪族ヒドロキシカルボン酸が好ましい。具体的には、特に限定されないが、例えば、クエン酸、イソクエン酸等が挙げられる。
The saturated aliphatic hydroxycarboxylic acid is composed of a linear or branched saturated aliphatic hydrocarbon group, one or more carboxyl groups and one or more hydroxyl groups, and preferably has 2 to 24 carbon atoms. Among them, saturated aliphatic hydroxycarboxylic acids having 2 to 7 carbon atoms and having 1 to 5 hydroxyl groups are preferred.
Examples of saturated aliphatic hydroxycarboxylic acids include saturated aliphatic hydroxymonocarboxylic acids having one carboxy group and saturated aliphatic hydroxydi- or tricarboxylic acids having two or three carboxy groups.
The saturated aliphatic hydroxymonocarboxylic acid preferably has 2 to 20 carbon atoms, more preferably 2 to 7 carbon atoms. The number of hydroxyl groups is preferably 1-5. Specifically, but not limited to, for example, glycolic acid, lactic acid, glyceric acid, hydroxyacetic acid, hydroxybutyric acid, 2-hydroxydecanoic acid, 3-hydroxydecanoic acid, 12-hydroxystearic acid, dihydroxystearic acid, cerebronic acid , leucic acid, mevalonic acid, pantoic acid, gluconic acid, galactonic acid, mannonic acid, arabinonic acid, fructuronic acid, tagaturonic acid, aldonic acid and the like.
The saturated aliphatic hydroxydicarboxylic acid is composed of a linear or branched saturated aliphatic hydrocarbon group, two carboxy groups and one or more hydroxyl groups, and preferably has 4 to 24 carbon atoms. Among them, saturated aliphatic hydroxycarboxylic acids having 2 to 7 carbon atoms and having 1 to 4 hydroxyl groups are preferred. Specific examples include, but are not particularly limited to, tartronic acid, malic acid, tartaric acid, citramalic acid, and the like.
The saturated aliphatic hydroxytricarboxylic acid is composed of a linear or branched saturated aliphatic hydrocarbon group, three carboxy groups and one or more hydroxyl groups, and preferably has 4 to 24 carbon atoms. Among them, saturated aliphatic hydroxycarboxylic acids having 2 to 7 carbon atoms and having 1 to 4 hydroxyl groups are preferred. Specific examples include, but are not particularly limited to, citric acid, isocitric acid, and the like.
 前記不飽和脂肪族ヒドロキシカルボン酸は、直鎖状又は分岐鎖状の飽和脂肪族和炭化水素基、1個以上のカルボキシ基及び1個以上の水酸基からなり、炭素数3~22が好ましい。具体的には、特に限定されないが、例えば、リシノール酸、リシノレイン酸、リシネライジン酸等が挙げられる。 The unsaturated aliphatic hydroxycarboxylic acid is composed of a linear or branched saturated aliphatic hydrocarbon group, one or more carboxyl groups and one or more hydroxyl groups, and preferably has 3 to 22 carbon atoms. Specific examples include, but are not particularly limited to, ricinoleic acid, ricinoleic acid, ricineraidic acid, and the like.
 前記飽和又は不飽和の脂環式ヒドロキシカルボン酸は、芳香族性を持たない飽和もしくは不飽和の炭素環、1個以上のカルボキシ基及び1個以上の水酸基からなり、炭素数4~20が好ましい。中でも、1~4個の水酸基を有する6員環骨格の飽和脂環式ヒドロキシカルボン酸が好ましく、具体的には、特に限定されないが、例えば、ヒドロキシシクロヘキサンカルボン酸、ジヒドロキシシクロヘキサンカルボン酸、キナ酸(1,3,4,5-テトラヒドロキシシクロヘキサンカルボン酸)、シキミ酸、グルクロン酸、ガラクツロン酸、マンヌロン酸、イズロン酸、グルロン酸等が挙げられる。また、水酸基を有する環状ラクトンも好ましく使用でき、具体的には、特に限定されないが、例えば、アスコルビン酸、エリソルビン酸等が挙げられる。 The saturated or unsaturated alicyclic hydroxycarboxylic acid comprises a saturated or unsaturated carbocyclic ring having no aromaticity, one or more carboxyl groups and one or more hydroxyl groups, and preferably has 4 to 20 carbon atoms. . Among them, saturated alicyclic hydroxycarboxylic acids having a 6-membered ring skeleton having 1 to 4 hydroxyl groups are preferable, and specifically, although not particularly limited, examples include hydroxycyclohexanecarboxylic acid, dihydroxycyclohexanecarboxylic acid, quinic acid ( 1,3,4,5-tetrahydroxycyclohexanecarboxylic acid), shikimic acid, glucuronic acid, galacturonic acid, mannuronic acid, iduronic acid, guluronic acid and the like. A cyclic lactone having a hydroxyl group can also be preferably used, and specific examples thereof include, but are not limited to, ascorbic acid and erythorbic acid.
 前記芳香族ヒドロキシカルボン酸は、芳香族性を持つ単環あるいは複数の環、1個以上のカルボキシ基及び1個以上の水酸基からなり、炭素数6~20が好ましい。中でも、1~5個の水酸基を有するベンゼン環骨格の芳香族カルボン酸が好ましく、具体的には、特に限定されないが、例えば、サリチル酸、ヒドロキシ安息香酸、ジヒドロキシ安息香酸、トリヒドロキシ安息香酸、ヒドロキシメチル安息香酸、バニリン酸、シリング酸、プロトカテク酸、ゲンチジン酸、オルセリン酸、マンデル酸、ベンジル酸、アトロラクチン酸、フロレト酸、クマル酸、ウンベル酸、コーヒー酸、フェルラ酸、シナピン酸、クレソチン酸、クロロゲン酸、ロズマリン酸等が挙げられる。 The aromatic hydroxycarboxylic acid is composed of an aromatic single ring or multiple rings, one or more carboxyl groups and one or more hydroxyl groups, and preferably has 6 to 20 carbon atoms. Among them, aromatic carboxylic acids having a benzene ring skeleton having 1 to 5 hydroxyl groups are preferred, and specific examples include, but are not limited to, salicylic acid, hydroxybenzoic acid, dihydroxybenzoic acid, trihydroxybenzoic acid, and hydroxymethyl. Benzoic acid, vanillic acid, syringic acid, protocatechuic acid, gentisic acid, orceric acid, mandelic acid, benzilic acid, atrolactic acid, phloretic acid, coumaric acid, umberic acid, caffeic acid, ferulic acid, sinapic acid, cresotic acid, chlorogen acid, rosmarinic acid and the like.
 前記カルボニルカルボン酸は、分子内にカルボニル基を有する炭素数3~22のカルボン酸であり、1~2個のカルボニル基を有する炭素数3~7のカルボニルカルボン酸が好ましい。具体的には、特に限定されないが、例えば、ピルビン酸、ケト酪酸等が挙げられる。 The carbonylcarboxylic acid is a carboxylic acid having 3 to 22 carbon atoms and having a carbonyl group in the molecule, preferably a carbonylcarboxylic acid having 3 to 7 carbon atoms and having 1 to 2 carbonyl groups. Specific examples include, but are not particularly limited to, pyruvic acid, ketobutyric acid, and the like.
 前記アルキルエーテルカルボン酸は、ポリオキシアルキレンアルキルエーテルカルボン酸を含む、分子内にエーテル基を有する炭素数2~22のカルボン酸であり、1~2個のエーテル基を有する炭素数2~12のアルキルカルボン酸が好ましい。具体的には、特に限定されないが、例えば、メトキシ酢酸、エトキシ酢酸、メトキシ酪酸、エトキシ酪酸等が挙げられる。 The alkyl ether carboxylic acid is a carboxylic acid having 2 to 22 carbon atoms and having an ether group in the molecule, including a polyoxyalkylene alkyl ether carboxylic acid, and a carboxylic acid having 2 to 12 carbon atoms and having 1 to 2 ether groups. Alkyl carboxylic acids are preferred. Specific examples include, but are not particularly limited to, methoxyacetic acid, ethoxyacetic acid, methoxybutyric acid, ethoxybutyric acid, and the like.
 前記ハロゲンカルボン酸としては、炭素数2~22のハロゲンカルボン酸が好ましい。具体的には、特に限定されないが、例えば、トリフルオロ酢酸、トリクロロ酢酸、トリブロモ酢酸、ペンタフルオロプロピオン酸、ペンタクロロプロピオン酸、ペンタブロモプロピオン酸、パーフルオロノナン酸、パークロロノナン酸、パーブロモノナン酸等のハロゲン置換のハロゲンカルボン酸等が挙げられる。 As the halogen carboxylic acid, a halogen carboxylic acid having 2 to 22 carbon atoms is preferable. Specifically, but not particularly limited, for example, trifluoroacetic acid, trichloroacetic acid, tribromoacetic acid, pentafluoropropionic acid, pentachloropropionic acid, pentabromopropionic acid, perfluorononanoic acid, perchlorononanoic acid, perbromonanoic acid, etc. and halogen-substituted halogen carboxylic acids.
 成分(B)におけるカルボン酸の塩としては、上記カルボン酸のアニオンとカチオン(アルカリ金属カチオン、アルカリ土類金属カチオン又はアンモニウムカチオン等)との塩が挙げられる。 Examples of the carboxylic acid salt in component (B) include salts of the above carboxylic acid anions and cations (alkali metal cations, alkaline earth metal cations, ammonium cations, etc.).
 上記成分(B)のカルボン酸のもしくはその塩の中でも、カルボン酸が好ましく、抗菌性の点では、カルボキシ基及び水酸基を有するカルボン酸がより好ましく、カルボキシ基を2個以上及び水酸基を有するものが更に好ましい。有機材料、無機材料との親和性の点から水酸基を有するカルボン酸は好ましい態様の一つである。 Among the carboxylic acids or salts thereof of component (B), carboxylic acids are preferred, and carboxylic acids having a carboxy group and a hydroxyl group are more preferred from the viewpoint of antibacterial properties, and those having two or more carboxy groups and a hydroxyl group are preferred. More preferred. A carboxylic acid having a hydroxyl group is one of the preferred embodiments in terms of affinity with organic materials and inorganic materials.
 また、安全性、使用上の観点から、成分(B)は、医薬部外品原料規格(外原規)、医薬部外品添加物規格、日本薬局方(日局)、日本薬局方外医薬部外品規格(局外規)、医薬品添加物規格(薬添規)、食品添加物公定書(食添)に記載された化合物を原料に用いることが好ましく、特に限定されないが、例えば、酢酸、カプリル酸、カプリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、リノール酸、乳酸、グリコール酸、コハク酸、クエン酸、塩酸、フマル酸、リン酸、アスコルビン酸、リンゴ酸、酒石酸等やそれらの塩が挙げられる。 In addition, from the viewpoint of safety and use, component (B) is specified in the Standards for Quasi-drug Ingredients (Quasi-drugs Ingredients), Standards for Quasi-drugs Additives, Japanese Pharmacopoeia (Japanese Pharmacopoeia), Japanese Pharmacopoeia It is preferable to use compounds listed in the Standards for Quasi-Drugs (Regulations), Standards for Pharmaceutical Additives (Medicine Additives), and Food Additives Standards (Food Additives) as raw materials. Caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, lactic acid, glycolic acid, succinic acid, citric acid, hydrochloric acid, fumaric acid, phosphoric acid, ascorbic acid, malic acid, tartaric acid etc. and salts thereof.
 本発明の抗菌剤は、成分(A)及び(B)のみを配合したものであってもよく、成分(A)と(B)を含む組成物であってもよい。 The antibacterial agent of the present invention may contain only components (A) and (B), or may be a composition containing components (A) and (B).
 本発明の抗菌剤において、成分(A)と成分(B)の配合モル比は、特に限定されず、1:99~99:1とすることができ、好ましくは、1:9~9:1であり、より好ましくは1:5~5:1であり、更に好ましくは1:3~3:1、特に好ましくは1:2~2:1、最も好ましくは1:1である。 In the antibacterial agent of the present invention, the blending molar ratio of component (A) and component (B) is not particularly limited, and can be 1:99 to 99:1, preferably 1:9 to 9:1. , more preferably 1:5 to 5:1, still more preferably 1:3 to 3:1, particularly preferably 1:2 to 2:1, most preferably 1:1.
 特に、成分(B)が多塩基酸の場合には、成分(A)と成分(B)の配合は、成分(B)の価数に対して成分(A)の価数が等価もしくは等価未満の配合であってよく(成分(B)が多塩基酸の場合には、部分中和塩又は完全中和塩でもよい。)、抗菌性能の点から等価未満が好ましい。 In particular, when the component (B) is a polybasic acid, the blending of the component (A) and the component (B) is such that the valence of the component (A) is equal to or less than the valence of the component (B). (When the component (B) is a polybasic acid, it may be a partially neutralized salt or a completely neutralized salt.), preferably less than equivalent in terms of antibacterial performance.
 例えば、成分(B)が2塩基酸、成分(A)の価数が1の場合、成分(A)と成分(B)の配合モル比は1:1モル~2:1モルとすることができる。また、成分(A)は2種以上を使用してもよい。抗菌性能の点においては、未中和のカルボキシ基を有する配合が好ましく、成分(A)と成分(B)の配合モル比は1:1モルが好ましい。 For example, when component (B) is a dibasic acid and component (A) has a valence of 1, the blending molar ratio of component (A) and component (B) can be 1:1 mol to 2:1 mol. can. Two or more kinds of components (A) may be used. From the point of view of antibacterial performance, it is preferable to use an unneutralized carboxyl group, and the molar ratio of component (A) to component (B) is preferably 1:1.
 一方で、抗菌性能の点において、成分(A)及び成分(B)が有するアミノ基の合計数とカルボキシ基の合計数の比(アミノ基の合計数/カルボキシ基の合計数)は、1未満であることが好ましい。 On the other hand, in terms of antibacterial performance, the ratio of the total number of amino groups to the total number of carboxy groups (total number of amino groups / total number of carboxy groups) of components (A) and (B) is less than 1. is preferably
 成分(A)と成分(B)が有機アンモニウム塩を形成する場合、成分(A)又は成分(B)のカルボキシ基から水素イオンが解離して生じるカルボキシレート基の他に、塩の形成に関与しないカルボキシ基を成分(A)又は成分(B)に1個以上有することが好ましく、成分(B)に塩の形成に関与しないカルボキシ基を1個以上有することがより好ましい。 When component (A) and component (B) form an organic ammonium salt, in addition to the carboxylate group generated by the dissociation of hydrogen ions from the carboxy group of component (A) or component (B), it participates in the formation of the salt. Component (A) or component (B) preferably has one or more carboxy groups that do not participate in salt formation, and more preferably component (B) has one or more carboxy groups that do not participate in salt formation.
 本発明の抗菌剤は、成分(A)と成分(B)の混合物又は成分(A)と成分(B)との塩が、無水状態(無水物)であってもよく、空気中の水分を吸収した水和物であってもよい。水和物とは、化合物を空気中25℃で放置した時、吸水し、その水分率が飽和状態となった化合物をいう。空気中25℃で放置した時、吸水しない化合物は、水和物が無く、無水物である。 In the antibacterial agent of the present invention, a mixture of component (A) and component (B) or a salt of component (A) and component (B) may be in an anhydrous state (anhydrous), and can absorb moisture in the air. It may be an absorbed hydrate. A hydrate refers to a compound that, when left in the air at 25°C, absorbs water and has a saturated moisture content. Compounds that do not absorb water when left in air at 25° C. are non-hydrated and anhydrous.
 本発明の抗菌剤は、成分(A)と(B)との混合物又は(A)と(B)との塩は、無水物及び水和物が25℃で液体、固体のいずれであってもよいが、例えば、25℃で液体であると、使用部分に本発明の抗菌剤を含む液体をスプレー、塗布した後に溶剤が蒸発した際に液体として残り、広範囲で効果を発現し、結晶が析出したり、凝集して固化したりする等の使用上の問題が生じない。また、25℃で液体であると、他の添加剤と使用する場合、抗菌性を有する溶媒、基剤として使用可能である。これらの点で、無水物及び/又は水和物が25℃で液体であることが好ましい。 The antibacterial agent of the present invention is a mixture of components (A) and (B) or a salt of (A) and (B), anhydrides and hydrates at 25 ° C. Whether liquid or solid However, for example, if it is liquid at 25 ° C., it will remain as a liquid when the solvent evaporates after spraying or applying the liquid containing the antibacterial agent of the present invention to the part to be used, and the effect will be exhibited in a wide range, and crystals will precipitate. There are no problems in use such as coagulation or agglomeration and solidification. Moreover, when it is liquid at 25° C., it can be used as a solvent or base having antibacterial properties when used with other additives. From these points of view, the anhydride and/or hydrate are preferably liquid at 25°C.
 本発明の抗菌剤を使用する対象物の表面に、例えば酸素含有基、窒素含有基等、硫黄含有基、リン含有基、金属等の水素結合性官能基と相互作用、結合する官能基を有する場合、成分(A)及び/又は成分(B)の水素結合性官能基と相互作用、結合し、本発明の抗菌剤は対象物に良好に長時間付着し、効果を発揮することが可能である。 The surface of the object on which the antibacterial agent of the present invention is used has functional groups that interact and bond with hydrogen-bonding functional groups such as oxygen-containing groups, nitrogen-containing groups, sulfur-containing groups, phosphorus-containing groups, and metals. In this case, it interacts and bonds with the hydrogen-bonding functional groups of component (A) and/or component (B), and the antibacterial agent of the present invention adheres well to the object for a long time and can exhibit its effect. be.
 成分(A)と成分(B)の組合せの好ましい態様としては、抗菌性、安全性の点から、成分(A)は、好ましくは直鎖又は分岐鎖のヒドロキシ基を1個以上有する飽和脂肪族炭化水素基を有し、より好ましくは炭素数1~6のモノヒドロキシアルキル基又はポリヒドロキシアルキル基を有するアミン化合物であり、更に好ましくはトリエタノールアミン、2-アミノ-2-ヒドロキシメチル-1、3-プロパンジオール、2-アミノ-2-エチル-1、3-プロパンジオールであり、成分(B)は、好ましくは、飽和脂肪族ヒドロキシカルボン酸(乳酸、リンゴ酸、クエン酸、酒石酸等)であり、より好ましくは飽和脂肪族ヒドロキシジ又はトリカルボン酸(リンゴ酸、クエン酸、酒石酸等)である。
 成分(A)と成分(B)の組合せの好ましい態様としては、抗菌性、安全性の点から、成分(A)は、直鎖又は分岐鎖のヒドロキシ基を1個以上有する飽和脂肪族炭化水素基を有するアミン化合物であり、成分(B)は、飽和脂肪族ヒドロキシカルボン酸(乳酸、リンゴ酸、クエン酸、酒石酸等)である。
 成分(A)と成分(B)の組合せの好ましい態様としては、抗菌性、安全性の点から、成分(A)は、炭素数1~6のモノヒドロキシアルキル基又はポリヒドロキシアルキル基を有するアミン化合物であり、成分(B)は、飽和脂肪族ヒドロキシジ又はトリカルボン酸(リンゴ酸、クエン酸、酒石酸等)である。
 成分(A)と成分(B)の組合せの好ましい態様としては、抗菌性、安全性の点から、成分(A)は、トリエタノールアミン、2-アミノ-2-ヒドロキシメチル-1、3-プロパンジオール又は2-アミノ-2-エチル-1、3-プロパンジオールであり、成分(B)は、リンゴ酸、クエン酸又は酒石酸である。
As a preferred embodiment of the combination of component (A) and component (B), from the viewpoint of antibacterial properties and safety, component (A) is preferably a saturated aliphatic compound having one or more linear or branched hydroxy groups. An amine compound having a hydrocarbon group, more preferably a monohydroxyalkyl group or a polyhydroxyalkyl group having 1 to 6 carbon atoms, more preferably triethanolamine, 2-amino-2-hydroxymethyl-1, 3-propanediol, 2-amino-2-ethyl-1,3-propanediol, and component (B) is preferably a saturated aliphatic hydroxycarboxylic acid (lactic acid, malic acid, citric acid, tartaric acid, etc.) and more preferably saturated aliphatic hydroxy di- or tricarboxylic acids (malic acid, citric acid, tartaric acid, etc.).
As a preferred embodiment of the combination of component (A) and component (B), component (A) is a saturated aliphatic hydrocarbon having one or more linear or branched hydroxy groups from the viewpoint of antibacterial properties and safety. It is an amine compound having a group, and component (B) is a saturated aliphatic hydroxycarboxylic acid (lactic acid, malic acid, citric acid, tartaric acid, etc.).
As a preferred embodiment of the combination of component (A) and component (B), component (A) is an amine having a monohydroxyalkyl group or a polyhydroxyalkyl group having 1 to 6 carbon atoms from the viewpoint of antibacterial properties and safety. compound, component (B) is a saturated aliphatic hydroxy di- or tricarboxylic acid (malic acid, citric acid, tartaric acid, etc.).
In a preferred embodiment of the combination of component (A) and component (B), component (A) is triethanolamine, 2-amino-2-hydroxymethyl-1,3-propane from the viewpoint of antibacterial properties and safety. diol or 2-amino-2-ethyl-1,3-propanediol and component (B) is malic acid, citric acid or tartaric acid.
 本発明の抗菌剤は、成分(A)と(B)との塩であると、低湿度環境下においても揮発せず、残存して抗菌効果を長期に保持する観点から好ましい。 When the antibacterial agent of the present invention is a salt of components (A) and (B), it is preferable from the viewpoint of maintaining the antibacterial effect over a long period of time without volatilizing even in a low-humidity environment.
 抗菌剤の形態としては、特に限定されないが、例えば、液状、固体状、ゲル状、クリーム状等とすることができる。 The form of the antibacterial agent is not particularly limited, but can be, for example, liquid, solid, gel, or cream.
 本発明の抗菌剤は、成分(A)及び(B)の他に溶媒、その他成分を配合したものであってよい。溶媒としては、特に限定されないが、例えば、水、メタノール、エタノール、プロパノール、イソプロパノール、ブタノール、エチレングリコール、プロピレングリコール、1,3-ブチレングリコール、ジエチレングリコール、ジプロピレングリコール、イソプレングリコール、へキシレングリコール、グリセリン、ベンジルアルコール、オレイルアルコール、酢酸メチル、酢酸エチル、酢酸イソプロピル、酢酸ブチル、エチルエーテル、アセトン、トルエン、ヘキサン、ヘプタン、パラフィン、アセトニトリル等が挙げられ、これらは1種単独で使用してもよく、2種以上を組み合わせて使用してもよい。 The antibacterial agent of the present invention may contain a solvent and other components in addition to components (A) and (B). Examples of solvents include, but are not limited to, water, methanol, ethanol, propanol, isopropanol, butanol, ethylene glycol, propylene glycol, 1,3-butylene glycol, diethylene glycol, dipropylene glycol, isoprene glycol, hexylene glycol, glycerin. , benzyl alcohol, oleyl alcohol, methyl acetate, ethyl acetate, isopropyl acetate, butyl acetate, ethyl ether, acetone, toluene, hexane, heptane, paraffin, acetonitrile, etc. These may be used alone, You may use it in combination of 2 or more types.
(抗菌性組成物、抗ウイルス性組成物)
 本発明の抗菌性組成物又は抗ウイルス性組成物は、以上に説明した本発明の抗菌剤を添加したものである。
(Antibacterial composition, antiviral composition)
The antibacterial composition or antiviral composition of the present invention is obtained by adding the antibacterial agent of the present invention explained above.
 本発明の抗菌性組成物又は抗ウイルス性組成物は、製造する際に、予め成分(A)及び(B)を配合した本発明の抗菌剤を、溶媒、その他の成分等と混合することの他に、抗菌性組成物を製造するまでに成分(A)及び(B)を配合することを包含する。 The antibacterial composition or antiviral composition of the present invention can be produced by mixing the antibacterial agent of the present invention, in which the components (A) and (B) have been blended in advance, with a solvent, other ingredients, etc. Others include blending components (A) and (B) prior to making the antimicrobial composition.
 本発明の抗菌性組成物の性状は、特に限定されないが、例えば、液状、固体状、ゲル状等であってよく、流動性があるものでもないものでもよく、用途、目的に応じて適宜選択することができる。また、抗菌性組成物の形態としては、特に限定されないが、例えば、成分(A)及び(B)を溶媒に希釈した溶液、その他の成分との混合物等が挙げられる。これらの製造時に添加する添加剤等や既存の抗菌剤、抗ウイルス剤、消毒剤等の溶媒等が挙げられる。 The properties of the antibacterial composition of the present invention are not particularly limited, but may be, for example, liquid, solid, gel, or the like. can do. The form of the antibacterial composition is not particularly limited, but examples thereof include a solution obtained by diluting the components (A) and (B) in a solvent, a mixture with other components, and the like. Additives and the like added at the time of production of these, and solvents such as existing antibacterial agents, antiviral agents, disinfectants, and the like can be mentioned.
 本発明の抗菌性組成物又は抗ウイルス性組成物は、本発明の抗菌剤を必須成分とし、本発明の効果を損なわない範囲内において、その他の成分を添加してもよい。
 その他の成分としては、特に限定されないが、例えば、上記の溶媒、本発明の抗菌剤以外の既存の抗菌剤、抗ウイルス剤、消毒剤等の菌、ウイルスに対する効果を有する薬剤、界面活性剤(アニオン性界面活性剤、カチオン性界面活性剤、非イオン性界面活性剤、両性界面活性剤等)、樹脂、紫外線吸収剤(有機系、無機系を含む)、香料、保湿剤、金属酸化物類、中和剤、pH調整剤、着色剤、抗酸化剤、腐食防止剤、防錆剤、金属不活性化剤、消泡剤等が挙げられる。これらは1種単独で使用してもよく、2種以上を組み合わせて使用してもよい。
The antibacterial composition or antiviral composition of the present invention contains the antibacterial agent of the present invention as an essential ingredient, and other ingredients may be added to the extent that the effects of the present invention are not impaired.
Other ingredients are not particularly limited, but for example, the above solvents, existing antibacterial agents other than the antibacterial agent of the present invention, antiviral agents, bacteria such as disinfectants, agents having an effect on viruses, surfactants ( anionic surfactants, cationic surfactants, nonionic surfactants, amphoteric surfactants, etc.), resins, UV absorbers (including organic and inorganic), fragrances, moisturizers, metal oxides , neutralizers, pH adjusters, coloring agents, antioxidants, corrosion inhibitors, rust inhibitors, metal deactivators, antifoaming agents and the like. These may be used individually by 1 type, and may be used in combination of 2 or more type.
 本発明の抗菌性組成物又は抗ウイルス性組成物における成分(A)及び(B)の含有量は、特に限定されないが、例えば、組成物全量に対して、例えば、1~100質量%、あるいは10~90質量%である。 The content of components (A) and (B) in the antibacterial composition or antiviral composition of the present invention is not particularly limited, but is, for example, 1 to 100% by mass relative to the total amount of the composition, or 10 to 90% by mass.
 これらの有機アンモニウム塩は不揮発性であり、中でも液体の化合物は揮発成分が蒸発後、高濃度の状態かつ均一にコートできることから、効果的かつ持続的な抗菌性が得られる。また、既存の抗菌剤、抗ウイルス剤、消毒剤等の菌、ウイルスに対する効果を有する薬剤の溶媒としての効果も発揮する。このことから、既存の抗菌剤、抗ウイルス剤、消毒剤等をより高濃度配合できる。そのほか、固体状の薬剤であっても、持続的に溶解状態を維持できかつ均一に対象物表面をコートできる。そのため、本発明の抗菌剤の抗菌性に加え、既存の抗菌剤、抗ウイルス剤、消毒剤等の効果を十分に発揮することが可能である。更に、本発明の配合物と既存の抗菌剤、抗ウイルス剤、消毒剤との相乗効果も期待でき、より低濃度で抗菌性、抗ウイルス性が得られる。 These organic ammonium salts are non-volatile, and liquid compounds in particular can be uniformly coated in a high-concentration state after the volatile components evaporate, providing effective and long-lasting antibacterial properties. In addition, it also exerts an effect as a solvent for drugs that are effective against bacteria and viruses, such as existing antibacterial agents, antiviral agents, and disinfectants. As a result, existing antibacterial agents, antiviral agents, disinfectants, etc. can be blended at higher concentrations. In addition, even a solid drug can be maintained in a dissolved state and uniformly coat the surface of the object. Therefore, in addition to the antibacterial properties of the antibacterial agent of the present invention, it is possible to sufficiently exhibit the effects of existing antibacterial agents, antiviral agents, disinfectants, and the like. Furthermore, a synergistic effect can be expected between the formulation of the present invention and existing antibacterial agents, antiviral agents, and disinfectants, and antibacterial and antiviral properties can be obtained at lower concentrations.
 前記既存の抗菌剤としては、特に限定されないが、例えば、メチルパラベン等のパラオキシ安息香酸エステル及びそのナトリウム塩、安息香酸及びその塩、サリチル酸及びその塩、ソルビン酸及びその塩、デヒドロ酢酸及びその塩、クロルクレゾール、レゾルシン、安息香酸パントテニルエチルエーテル、イソプロピルメチルフェノール(シメン-5-オール)、塩化セチルピリジニウム、感光素、フェノール、ラウリルジアミノエチルグリシンナトリウム、塩化ベンザルコニウム、塩化ベンゼトニウム、クロルヘキシジン及びその塩、オルトフェニルフェノール及びその塩、クロロキシレノール、クロルフェネシン、臭化アルキルイソキノリニウム、チアントール、チモール、トリクロロカルバニリド、パラクロルフェノール、ハロカルバン、ヒノキチオール、ピリチオン亜鉛、ピロクトンオラミン、ブチルカルバミン酸ヨウ化プロピニルポリアミノプロピルビグアナイド、メチルイソチアゾリノン、ヨウ化パラジメチルアミノスチリルヘプチルメチルチアゾリウム、βラクタム系抗生物質(ペニシリン系、セフェム系、カルバペネム系、モノバクタム系、ペネム系)、アミノグリコシド系抗生物質、リンコマイシン系抗生物質、ホスホマイシン系抗生物質、テトラサイクリン系抗生物質、クロラムフェニコール系抗生物質、マクロライド系抗生物質、ケトライド系抗生物質、ポリペプチド系構成物質、グリコペプチド系抗生物質、ストレプトグラミン系抗生物質、キノロン系抗生物質、サルファ剤、オキサゾリジノン系抗菌薬等が挙げられる。前記ウイルスに効果を有する薬剤としては、特に限定されないが、例えば、直鎖アルキルベンゼンスルホン酸ナトリウム、アルキルグリコシド、アルキルアミンオキシド、塩化ベンザルコニウム、塩化ベンゼトニウム、塩化ジアルキルジメチルアンモニウム、ポリオキシエチレンアルキルエーテル、脂肪酸カリウム、脂肪酸ナトリウム、クロルヘキシジングルコン酸、ポリヘキサメチレンビグアナイド、o-フタルアルデヒド(フタラール)、グルタルアルデヒド(グルタラール)、ポビドンヨード、次亜塩素酸ナトリウム、過酢酸等が挙げられる。 Examples of the existing antibacterial agents include, but are not limited to, paraoxybenzoic acid esters such as methylparaben and sodium salts thereof, benzoic acid and salts thereof, salicylic acid and salts thereof, sorbic acid and salts thereof, dehydroacetic acid and salts thereof, Chlorcresol, resorcinol, pantothenyl ethyl benzoate, isopropylmethylphenol (cymen-5-ol), cetylpyridinium chloride, photosensitizer, phenol, sodium lauryldiaminoethylglycinate, benzalkonium chloride, benzethonium chloride, chlorhexidine and its salts , orthophenylphenol and its salts, chloroxylenol, chlorphenesin, alkylisoquinolinium bromide, thianthol, thymol, trichlorocarbanilide, parachlorophenol, halocarbane, hinokitiol, zinc pyrithione, piroctone olamine, butyl Carbamate propynyl iodide polyaminopropyl biguanide, methylisothiazolinone, paradimethylaminostyrylheptylmethylthiazolium iodide, β-lactam antibiotics (penicillins, cephems, carbapenems, monobactams, penems), aminoglycosides antibiotics, lincomycin antibiotics, fosfomycin antibiotics, tetracycline antibiotics, chloramphenicol antibiotics, macrolide antibiotics, ketolide antibiotics, polypeptide constituents, glycopeptide antibiotics, Examples include streptogramin antibiotics, quinolone antibiotics, sulfa drugs, oxazolidinone antibiotics, and the like. The drug effective against viruses is not particularly limited, but examples include sodium linear alkylbenzene sulfonate, alkyl glycoside, alkylamine oxide, benzalkonium chloride, benzethonium chloride, dialkyldimethylammonium chloride, polyoxyethylene alkyl ether, Fatty acid potassium, fatty acid sodium, chlorhexidine gluconic acid, polyhexamethylene biguanide, o-phthalaldehyde (phthalal), glutaraldehyde (glutaral), povidone iodine, sodium hypochlorite, peracetic acid and the like.
 上記の既存の抗菌剤、抗ウイルス剤、消毒剤等の菌、ウイルスに対する効果を有する薬剤の配合量は、本発明の抗菌剤との相溶性、溶媒への溶解度にもよるが、特に限定されず、抗菌性組成物の0.01質量%~10質量%とすることができ、本発明の抗菌剤との質量比は、1:99~99:1とすることができる。 The amount of the above-mentioned existing antibacterial agents, antiviral agents, antiseptics, and other agents that are effective against bacteria and viruses is not particularly limited, although it depends on the compatibility with the antibacterial agent of the present invention and the solubility in the solvent. However, it can be 0.01% to 10% by weight of the antibacterial composition, and the weight ratio with the antibacterial agent of the present invention can be 1:99 to 99:1.
 本発明の抗菌剤に配合される成分(A)と(B)との混合物又は(A)と(B)との塩は不揮発性である。そのため、抗菌性組成物を使用した際に、抗菌性組成物に含まれる水、アルコール等の揮発成分が蒸発して、既存の抗菌剤、抗ウイルス剤、消毒剤等の菌、ウイルスに対する効果を有する薬剤の濃度が高くなる。このことから、抗菌性組成物は低濃度であっても使用時にはそれらの効果を発現することができる。 The mixture of components (A) and (B) or the salt of (A) and (B) to be incorporated into the antibacterial agent of the present invention is non-volatile. Therefore, when the antibacterial composition is used, the volatile components such as water and alcohol contained in the antibacterial composition evaporate, and the existing antibacterial agents, antiviral agents, disinfectants, etc. are effective against bacteria and viruses. higher drug concentration Therefore, the antibacterial composition can exert its effect even at a low concentration when used.
 以上に本発明の実施形態について説明したが、本発明はこれらの実施形態に限定されるものではなく、その要旨を逸脱しない範囲内において各種の変更が可能である。また、式(I)において示した上記の好ましいそれぞれの例、式(II)において示した上記の好ましいそれぞれの例、式(III)において示した上記の好ましいそれぞれの例は、それらのうち少なくともいずれかの組み合わせが、実施例の結果に基づきより好ましい態様となり得る。式(I)~式(III)において示した上記の好ましいそれぞれの例は、それら全てのうち少なくともいずれかの組み合わせが、実施例の結果に基づきより好ましい態様となり得る。また、それらとアニオンにおいて示した上記の好ましいそれぞれの例との組み合わせや、更にはそれらと成分(A)と(B)との混合物又は(A)と(B)との塩の特性との組み合わせや、更にはそれらと高分子化合物の好ましいそれぞれの例との組み合わせが、実施例の結果に基づきより好ましい態様となり得る。 Although the embodiments of the present invention have been described above, the present invention is not limited to these embodiments, and various modifications are possible without departing from the scope of the invention. In addition, each of the above preferred examples shown in formula (I), each of the above preferred examples shown in formula (II), and each of the above preferred examples shown in formula (III) are at least any of them. Any combination can be a more preferable embodiment based on the results of the examples. At least one combination of all of the above preferred examples shown in formulas (I) to (III) can be a more preferred embodiment based on the results of the examples. Also, combinations of them with the respective preferred examples shown above for anions, and further combinations thereof with the properties of mixtures of components (A) and (B) or salts of (A) and (B) Or, furthermore, a combination of each of them and preferable examples of the polymer compound can be a more preferable embodiment based on the results of the examples.
 以下に、実施例により本発明を更に詳しく説明するが、本発明はこれらの実施例に限定されるものではない。 The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these examples.
最小発育阻止濃度(MIC)測定、ハロー試験に以下の試薬等を使用した。
黄色ブドウ球菌 NBRC15035株:NITE
乳酸カリウム:富士フィルム和光純薬製
培地 Muller-Hinton broth:Becton, Dickinson and Company製
培地 L-乾燥品復元用培地「ダイゴ」:富士フィルム和光純薬製
塩化カルシウム:富士フィルム和光純薬製
塩化マグネシウム:富士フィルム和光純薬製
塩化ナトリウム:富士フィルム和光純薬製
スキムミルク:雪印メグミルク製
肉エキス:Solabia Biokar Diagnostics製
ペプトン:Solabia Biokar Diagnostics製
塩化ナトリウム:富士フィルム和光純薬製
寒天:富士フィルム和光純薬製
The following reagents and the like were used for minimum inhibitory concentration (MIC) measurement and halo test.
Staphylococcus aureus strain NBRC15035: NITE
Potassium lactate: Medium manufactured by Fujifilm Wako Pure Chemicals Muller-Hinton broth: Medium manufactured by Becton, Dickinson and Company L-Dried product restoration medium "Daigo": Calcium chloride manufactured by Fujifilm Wako Purechemicals: Magnesium chloride manufactured by Fujifilm Wako Pure Chemicals : Fuji Film Wako Pure Chemical Sodium Chloride : Fuji Film Wako Pure Chemical Skim Milk : Snow Brand Megmilk Meat Extract : Solabia Biokar Diagnostics Peptone : Solabia Biokar Diagnostics Sodium Chloride : Fuji Film Wako Pure Chemical Agar : Fuji Film Wako Pure Chemical Made
1.配合物(塩)の調製
 実施例1~8、21~43の配合物(塩)を特開2019-023185に記載の方法で調製し、25℃での状態を確認した(表1A~1D)。
1. Preparation of formulations (salts) The formulations (salts) of Examples 1 to 8 and 21 to 43 were prepared by the method described in JP 2019-023185, and the state at 25 ° C. was confirmed (Tables 1A to 1D). .
2.配合物(塩)の抗菌性評価1(最小発育阻止濃度)
 表1A~1D、2A、2Bに示す実施例1~8、21~43、比較例1、8、9の黄色ブドウ球菌に対する最小発育阻止濃度(MIC)を微量液体希釈法(日本化学療法学会標準法記載)にて測定し、各種配合物(塩)の抗菌活性を確認した。配合物(塩)濃度250、200、150、100、50、25、12.5、8、4、2、0.8、0.4、0.2、0.1、0.05mg/mLを評価し、表1A~1DにMICを示した。MICの値が低いほど、抗菌活性に優れることを示す。
2. Antibacterial evaluation 1 (minimum inhibitory concentration) of formulation (salt)
Examples 1 to 8, 21 to 43, Comparative Examples 1, 8, and 9 shown in Tables 1A to 1D, 2A, and 2B for Staphylococcus aureus minimal inhibitory concentrations (MIC) were measured by the microdilution method (Japanese Society of Chemotherapy standard (described in the law) to confirm the antibacterial activity of various compounds (salts). Formulation (salt) concentrations of 250, 200, 150, 100, 50, 25, 12.5, 8, 4, 2, 0.8, 0.4, 0.2, 0.1, 0.05 mg/mL were evaluated and the MICs are shown in Tables 1A-1D. A lower MIC value indicates better antibacterial activity.
 表1A~1Dの結果より実施例1~8、21~43は比較例1、8、9より高い抗菌性を示し、MICは、4mg/mL~100mg/mLであった。比較例8、9の乳酸ナトリウム、リンゴ酸二ナトリウムでは、濃度250mg/mLの試験においても菌の発育を阻止できなかった。実施例1、2、6と比較例1、8の同成分(B)の配合物を比較した場合、水素結合性官能基(水酸基)が成分(A)に有る実施例1、2、6が高い抗菌性を有することを確認した。また、同成分(A)の実施例1と実施例21、22、実施例2と実施例3~5、実施例6と実施例7、8を比較した場合、成分(B)にカルボキシレート基が2個以上有する配合物(塩)が、更に、同成分(B)の実施例3と7を比較した場合、上記式のR7がアルキル基の成分(A)の配合物(塩)は抗菌性が高い傾向であった。 From the results in Tables 1A to 1D, Examples 1 to 8 and 21 to 43 exhibited higher antibacterial properties than Comparative Examples 1, 8 and 9, with MICs of 4 mg/mL to 100 mg/mL. Sodium lactate and disodium malate in Comparative Examples 8 and 9 could not inhibit bacterial growth even in the test at a concentration of 250 mg/mL. When comparing the formulations of the same component (B) of Examples 1, 2, 6 and Comparative Examples 1, 8, Examples 1, 2, 6 having a hydrogen-bonding functional group (hydroxyl group) in Component (A) It was confirmed to have high antibacterial properties. Further, when comparing Example 1 with Examples 21 and 22, Example 2 with Examples 3 and 5, and Example 6 with Examples 7 and 8 of the same component (A), the carboxylate group in component (B) When comparing Examples 3 and 7 of the same component (B), the compound (salt) of component (A) in which R 7 in the above formula is an alkyl group is It tended to be highly antibacterial.
3.配合物(塩)の抗菌性評価2(ハロー試験1)
 JISL1902を参考に黄色ブドウ球菌を用いて、ハロー試験を行った。試験片として21φm/mの桐山ロート用ろ紙(桐山製作所製)を用い、菌体を含んだ培地上にろ紙を置き、そこに表2A、Bに記載した濃度の配合物(塩)水溶液(実施例9~11、比較例2~4)を100μL滴下した。その後培養を行い、ハローの有無を目視で確認し、表2A、2Bにハローの有無を示した。
3. Antibacterial evaluation 2 of compound (salt) (halo test 1)
A halo test was performed using Staphylococcus aureus with reference to JISL1902. Filter paper for Kiriyama funnel (manufactured by Kiriyama Seisakusho) of 21 φm / m was used as a test piece, and the filter paper was placed on the medium containing the bacterial cells, and the formulation (salt) aqueous solution (execution Examples 9 to 11 and Comparative Examples 2 to 4) were added dropwise at 100 μL. After that, culture was performed, and the presence or absence of halos was visually confirmed, and the presence or absence of halos is shown in Tables 2A and 2B.
4.配合物(塩)の付着性評価及び抗菌性評価3(ハロー試験2)
4-1.付着性評価
 21φm/mの桐山ロート用ろ紙に表2A、2Bに記載した濃度の配合物(塩)水溶液(実施例9~11)を100μL滴下し、60℃で8時間真空乾燥した。ろ紙の重量変化よりサンプルの付着率を算出した(表2A、2B)。なお、空試験として、ろ紙に水100μLを滴下し真空乾燥させた際の操作前後の重量変化を測定し、補正値として用いた。
A:付着したサンプルの重量=乾燥後のろ紙の重量(mg)-試験前のろ紙の重量(mg)+補正値(1.15mg)
B:塗布したサンプルの重量=100μLの水溶液の重量(mg)×濃度(質量%)/100
付着率(%)=100×A/B
4. Adhesion evaluation and antibacterial evaluation 3 (halo test 2) of formulation (salt)
4-1. Adhesion Evaluation 100 μL of the compound (salt) aqueous solution (Examples 9 to 11) having the concentration shown in Tables 2A and 2B was dropped onto a 21φm/m filter paper for Kiriyama funnel, and vacuum-dried at 60° C. for 8 hours. The adhesion rate of the sample was calculated from the weight change of the filter paper (Tables 2A and 2B). As a blank test, 100 μL of water was dropped onto the filter paper and the filter paper was dried in a vacuum.
A: Weight of attached sample = weight of filter paper after drying (mg) - weight of filter paper before test (mg) + correction value (1.15 mg)
B: weight of applied sample = weight of 100 µL aqueous solution (mg) x concentration (% by mass)/100
Adhesion rate (%) = 100 x A/B
4-2.ハロー試験2
 JISL1902を参考に黄色ブドウ球菌を用いて、事前に滅菌し上記4-1.の配合物水溶液を滴下した後に60℃で8時間真空乾燥処理したろ紙を試験片として使用し、ハロー試験を行った。試験後、ハローの有無を目視で確認し、表2A、Bにハローの有無を示した。
4-2. Hello test 2
Using Staphylococcus aureus with reference to JISL1902, sterilize in advance and 4-1. A halo test was performed using a filter paper as a test piece, which was vacuum-dried at 60.degree. After the test, the presence or absence of halos was visually confirmed, and the presence or absence of halos is shown in Tables 2A and 2B.
 ハロー試験1の結果より広く殺菌、抗菌効果が知られているエタノールは培養中に揮発することで抗菌効果を示すことができず、ハローが観測されなかった。一方、実施例の配合物は、ハローが観測された。本発明の配合物は、不揮発性であるためにろ紙に付着したまま揮発せず抗菌効果を長期間発現することができることが示唆された。  From the results of the halo test 1, ethanol, which is widely known for its bactericidal and antibacterial effects, volatilized during culture and could not demonstrate any antibacterial effects, and no halo was observed. On the other hand, halos were observed in the formulations of the examples. It was suggested that the compound of the present invention is non-volatile, so that it does not volatilize while adhering to the filter paper and can exhibit antibacterial effects for a long period of time.
 ハロー試験2でもエタノールは揮発し、ろ紙へ付着しなかったのに対して実施例の配合物は水素結合性官能基を有するため、水素結合性官能基を有するろ紙に良好に付着し、加熱真空乾燥した後も、不揮発性のため長期期間、抗菌性が持続することを確認した。 In the halo test 2, ethanol volatilized and did not adhere to the filter paper. Even after drying, it was confirmed that antibacterial properties persist for a long period of time due to non-volatility.
5.配合物の難溶性物質に対する溶解性、安定性評価
 表3A、Bに示す配合物(塩)の50質量%水溶液(実施例12~18、比較例5は乳酸カリウム50質量%水溶液、比較例6は水のみ)に、難水溶性の抗菌剤である4-メチルパラベン(東京化成製、以下、パラベン)を1.0、0.5、0.25質量%80℃で溶解し、抗菌性組成物を調製した。その後、密閉した条件下、25℃で24時間静置し、各抗菌性組成物の外観を目視で確認し、下記の基準で溶解性を評価した(表3A、B)。
◎:1.0質量%以上 結晶析出無し、透明溶解
〇:0.5質量%以上1.0質量%未満 結晶析出無し、透明溶解
△:0.25質量%以上0.5質量%未満 結晶析出無し、透明溶解
×:0.25質量%未満 結晶析出もしくは白濁
5. 50% by mass aqueous solution of the formulation (salt) shown in Tables 3A and B (Examples 12 to 18, Comparative Example 5 is a 50% by mass aqueous solution of potassium lactate, Comparative Example 6 is water only), 4-methylparaben (manufactured by Tokyo Kasei, hereinafter referred to as paraben), which is a poorly water-soluble antibacterial agent, is dissolved at 1.0, 0.5, 0.25% by mass at 80 ° C., and an antibacterial composition was prepared. After that, it was allowed to stand at 25° C. for 24 hours under closed conditions, and the appearance of each antibacterial composition was visually confirmed, and the solubility was evaluated according to the following criteria (Table 3A, B).
◎: 1.0% by mass or more, no crystal precipitation, transparent dissolution ○: 0.5% by mass or more and less than 1.0% by mass, no crystal precipitation, transparent dissolution △: 0.25% by mass or more, less than 0.5% by mass, crystal precipitation None, transparent dissolution ×: Less than 0.25% by mass Crystal precipitation or cloudiness
 ウイルスに対する有効性が認められている抗ウイルス性物質であるポリオキシエチレンアルキルエーテル(ミヨシ油脂製:ペレテックス2465)、アルキルグリコシド(東京化成工業製:n-オクチルβ-D-グルコピラノシド)、塩化ベンザルコニウム(ナカライテスク製:塩化ベンザルコニウム)、塩化ベンゼトニウム(東京化成工業製:ベンゼトニウムクロリド)、o-フタルアルデヒド(富士フィルム和光純薬製:フタルアルデヒド)についても同様の操作を行い、上記の基準で溶解性を評価した(表3A、B)。 Polyoxyethylene alkyl ether (manufactured by Miyoshi Oil & Fat Co., Ltd.: Peletex 2465), alkyl glycoside (manufactured by Tokyo Chemical Industry Co., Ltd.: n-octyl β-D-glucopyranoside), benzalco chloride, which is an antiviral substance that is recognized to be effective against viruses (manufactured by Nacalai Tesque: benzalkonium chloride), benzethonium chloride (manufactured by Tokyo Chemical Industry: benzethonium chloride), and o-phthalaldehyde (manufactured by Fuji Film Wako Pure Chemical: phthalaldehyde). was evaluated for solubility (Table 3A, B).
 本発明の配合物(塩)は難水溶性の抗菌剤や他の抗ウイルス性物質を良好に溶解し、抗菌性組成物が得られた。同成分(B)の実施例13~14と実施例16~18を比較した場合、上記式のR7がアルキル基の成分(A)の配合物(塩)パラベンに対する溶解性が高い傾向を確認した。 The formulation (salt) of the present invention dissolves sparingly water-soluble antibacterial agents and other antiviral substances well, resulting in an antibacterial composition. When comparing Examples 13 to 14 and Examples 16 to 18 of the same component (B), it was confirmed that the compound (salt) of component (A) in which R 7 in the above formula is an alkyl group tends to have a higher solubility in parabens. did.
6.抗菌性組成物の抗菌性評価(最小発育阻止濃度)
 表4A、Bに示す成分(A)、(B)の配合物及びパラベンをそれぞれ同量含むように調製した実施例19、20とパラベンのみを含む比較例8を上記2.と同様の試験方法で、パラベンの濃度1.0mg/mL(実施例19、20の抗菌性組成物は抗菌剤合計2.0mg/mL)を評価し、菌体の発育の有無より抗菌性の有無を評価した。
6. Antibacterial evaluation of antibacterial composition (minimum inhibitory concentration)
Examples 19 and 20 prepared so as to contain the same amounts of the formulations of components (A) and (B) shown in Tables 4A and B and paraben, respectively, and Comparative Example 8 containing only paraben were prepared in 2. above. In the same test method as above, the paraben concentration of 1.0 mg / mL (the antibacterial composition of Examples 19 and 20 is a total of 2.0 mg / mL of antibacterial agents) was evaluated, and the presence or absence of bacterial growth The presence or absence was evaluated.
 1mg/mLの比較例1、参考例1,2のパラベンもしくは配合物(塩)のみでは抗菌性を示さないが、パラベンと配合物(塩)を、それぞれ1mg/mL混合し合計で2mg/mLの抗菌性組成物とした実施例19、20は、配合物(塩)の抗菌効果にパラベンの抗菌効果が付与され、組成物として抗菌性を示した。 1 mg/mL of the parabens or the formulations (salts) of Comparative Example 1 and Reference Examples 1 and 2 alone do not exhibit antibacterial properties, but the parabens and the formulations (salts) are mixed at 1 mg/mL each to give a total of 2 mg/mL. Examples 19 and 20, which were antibacterial compositions, showed antibacterial properties as a composition because the antibacterial effect of paraben was added to the antibacterial effect of the formulation (salt).
 つまり、本発明の配合物(塩)に他の添加剤を添加することで、その添加剤の効果を本発明の配合物(塩)を含む組成物に付与することができ、例えば、5.の抗ウイルス性物質を添加(溶解)して得られる組成物は抗菌性に加えて抗ウイルス性も付与される。 In other words, by adding another additive to the formulation (salt) of the present invention, the effect of the additive can be imparted to the composition containing the formulation (salt) of the present invention. The composition obtained by adding (dissolving) the antiviral substance in (1) is endowed with antiviral properties in addition to antibacterial properties.
 7.抗菌性組成物の安定性評価
 配合物4又は8の50質量%水溶液及び水に0.25質量%溶液となるようにパラベン(添加剤)を溶解させ、上部が解放されたサンプル瓶中に入れて50℃で48時間静置した。試験後各抗菌性組成物の外観を目視で確認した。
7. Stability Evaluation of Antibacterial Composition Dissolve paraben (additive) in 50% by weight aqueous solution of Formulation 4 or 8 and water to give a 0.25% by weight solution and place in a sample bottle with an open top. and allowed to stand at 50° C. for 48 hours. After the test, the appearance of each antibacterial composition was visually confirmed.
 水のみの場合は水分が蒸発し、パラベンの結晶が析出した。一方配合物4又は8の50質量%水溶液では完全に液体が蒸発することはなく、結晶の析出も観測されず、本発明の組成物は、本発明の配合物(塩)の不揮発性より添加剤の溶解性を保持し安定性が良好で、配合物(塩)、添加剤の効果を長期間効率的に発揮することができる。 When only water was used, the water evaporated and paraben crystals precipitated. On the other hand, in the 50% by mass aqueous solution of Formulation 4 or 8, the liquid did not completely evaporate, and no crystal precipitation was observed. It maintains the solubility of the agent and has good stability, and the effects of the compound (salt) and additives can be efficiently exhibited for a long period of time.
8.抗菌組成物の持続性評価
 滅菌していない21φm/mの桐山ロート用ろ紙に各配合物(塩)を300μL塗布し、上部を解放したシャーレ内に置き、1週間人の出入りの活発な室内に静置した。塗布面を寒天培地に接するように3.で使用したものと同等の組成の寒天培地上に置き、37℃で一日培養した。その後ろ紙を取り除き、37℃で一日培養を行い、目視により菌の増殖を確認した。
 実施例44:50質量%トロメタミン/クエン酸(配合物No.4)水溶液
 比較例10:水
 比較例11:70質量%エタノール(配合物No.10)水溶液
8. Sustainability evaluation of antibacterial composition 300 μL of each compound (salt) was applied to an unsterilized 21 φm / m filter paper for Kiriyama funnel, placed in a petri dish with the upper part open, and placed in a room with active people coming and going for 1 week. left undisturbed. 3. Place the coated surface in contact with the agar medium. was placed on an agar medium having the same composition as that used in 1. and cultured at 37° C. for one day. The backing paper was removed, culture was carried out at 37° C. for one day, and growth of the bacteria was confirmed visually.
Example 44: 50 wt% tromethamine/citric acid (Formulation No. 4) aqueous solution Comparative Example 10: Water Comparative Example 11: 70 wt% ethanol (Formulation No. 10) aqueous solution
 実施例44と比較例10、11を比較すると、実施例44では菌の増殖がみられなかったが、比較10、11では菌の増殖が確認された。また比較例10、11を比較すると比較例10の方がより多量の菌体の増殖が確認された。
 比較例10ではもともとろ紙に付着していた菌および静置中に付着した菌体の増殖が確認され、比較例11ではろ紙に付着していた菌体はエタノールの殺菌作用により不活化されたが、エタノールの揮発後に付着した菌体が確認されたと考えられる。一方実施例44では本発明の配合物が不揮発性であったため、水分蒸発後ろ紙に配合物が高濃度の状態で付着し、抗菌効果を維持し続けたために菌体の増殖が確認されなかったと考えられる。
 ゆえに、本発明の配合物は、不揮発性であるためにろ紙に付着したまま揮発せず抗菌効果を長期間発現することができることが示唆された。
Comparing Example 44 with Comparative Examples 10 and 11, growth of bacteria was not observed in Example 44, but growth of bacteria was confirmed in Comparative Examples 10 and 11. Further, when comparing Comparative Examples 10 and 11, it was confirmed that Comparative Example 10 proliferated a larger amount of cells.
In Comparative Example 10, it was confirmed that the bacteria that had originally adhered to the filter paper and the bacteria that had adhered to the filter paper during the standing period proliferated, and in Comparative Example 11, the bacteria that had adhered to the filter paper were inactivated by the bactericidal action of ethanol. , it is considered that the adhered bacterial cells were confirmed after ethanol volatilization. On the other hand, in Example 44, since the composition of the present invention was non-volatile, the composition adhered to the paper after water evaporation in a high-concentration state, and the antibacterial effect was maintained. Conceivable.
Therefore, it was suggested that the composition of the present invention is non-volatile, so that it does not volatilize while adhering to the filter paper and can exhibit antibacterial effects for a long period of time.
Figure JPOXMLDOC01-appb-T000008
Figure JPOXMLDOC01-appb-T000008
Figure JPOXMLDOC01-appb-T000009
Figure JPOXMLDOC01-appb-T000009
Figure JPOXMLDOC01-appb-T000010
Figure JPOXMLDOC01-appb-T000010
Figure JPOXMLDOC01-appb-T000011
Figure JPOXMLDOC01-appb-T000011
Figure JPOXMLDOC01-appb-T000012
Figure JPOXMLDOC01-appb-T000012
Figure JPOXMLDOC01-appb-T000013
Figure JPOXMLDOC01-appb-T000013
Figure JPOXMLDOC01-appb-T000014
Figure JPOXMLDOC01-appb-T000014
Figure JPOXMLDOC01-appb-T000015
Figure JPOXMLDOC01-appb-T000015
Figure JPOXMLDOC01-appb-T000016
Figure JPOXMLDOC01-appb-T000016
Figure JPOXMLDOC01-appb-T000017
Figure JPOXMLDOC01-appb-T000017

Claims (25)

  1.  次の成分(A)及び(B)の配合物である抗菌剤。
    (A)水素結合性官能基を有するアミンもしくはアンモニウム化合物(但し、アミノ酸を除く。)
    (B)カルボン酸もしくはその塩
    An antimicrobial agent which is a blend of components (A) and (B) below.
    (A) an amine or ammonium compound having a hydrogen-bonding functional group (excluding amino acids);
    (B) carboxylic acid or salt thereof
  2.  前記成分(A)は、水酸基を1個以上有し、炭化水素部位が直鎖状もしくは分岐鎖状で、該炭化水素部位が酸素原子を含んでいてもよいヒドロキシ炭化水素基を有する請求項1に記載の抗菌剤。 2. The component (A) has one or more hydroxyl groups, the hydrocarbon moiety is linear or branched, and the hydrocarbon moiety has a hydroxyhydrocarbon group which may contain an oxygen atom. Antibacterial agent according to.
  3.  前記成分(A)は、下記式(I)又は(II):
    Figure JPOXMLDOC01-appb-C000001
    (式中、R1はそれぞれ独立に、水酸基を1個以上有し、炭化水素部位が炭素数1~22の直鎖状もしくは分岐鎖状で、該炭化水素部位が酸素原子を含んでいてもよいヒドロキシ炭化水素基を示し、R2はそれぞれ独立に、水素原子又は炭素数1~22の有機基を示し、mは0~3の整数を示す。)
    Figure JPOXMLDOC01-appb-C000002
    (式中、R3はそれぞれ独立に、水酸基を1個以上有し、炭化水素部位が炭素数1~22の直鎖状もしくは分岐鎖状で、該炭化水素部位が酸素原子を含んでいてもよいヒドロキシ炭化水素基を示し、R4はそれぞれ独立に、水素原子又は炭素数1~22の有機基を示し、nは0~4の整数を示す。X-はアニオンを示す。)
    で表される請求項1又は2に記載の抗菌剤。
    The component (A) has the following formula (I) or (II):
    Figure JPOXMLDOC01-appb-C000001
    (In the formula, each R 1 independently has one or more hydroxyl groups, the hydrocarbon moiety is linear or branched with 1 to 22 carbon atoms, and the hydrocarbon moiety contains an oxygen atom. represents a good hydroxy hydrocarbon group, each R 2 independently represents a hydrogen atom or an organic group having 1 to 22 carbon atoms, and m represents an integer of 0 to 3.)
    Figure JPOXMLDOC01-appb-C000002
    (In the formula, each R 3 independently has one or more hydroxyl groups, the hydrocarbon moiety is linear or branched with 1 to 22 carbon atoms, and the hydrocarbon moiety contains an oxygen atom. represents a good hydroxy hydrocarbon group, each R 4 independently represents a hydrogen atom or an organic group having 1 to 22 carbon atoms, n represents an integer of 0 to 4, and X represents an anion.)
    The antibacterial agent according to claim 1 or 2, represented by.
  4.  前記式(I)において、mは1~3の整数であり、前記式(II)において、nは1~4の整数である請求項3に記載の抗菌剤。 The antibacterial agent according to claim 3, wherein m is an integer of 1 to 3 in the formula (I), and n is an integer of 1 to 4 in the formula (II).
  5.  前記式(I)において、全てのR2が水素原子であり、前記式(II)において、全てのR4が水素原子である請求項3又は4に記載の抗菌剤。 5. The antibacterial agent according to claim 3 or 4, wherein in formula (I), all R2 are hydrogen atoms, and in formula (II), all R4 are hydrogen atoms.
  6.  前記式(I)において、R1のうち少なくとも1つが、水酸基を1個有し、前記酸素原子を含んでいてもよい炭化水素部位における炭化水素が飽和脂肪族炭化水素のヒドロキシ炭化水素基であり、
     前記式(II)において、R3のうち少なくとも1つが、水酸基を1個有し、前記酸素原子を含んでいてもよい炭化水素部位における炭化水素が飽和脂肪族炭化水素のヒドロキシ炭化水素基である請求項3~5のいずれか一項に記載の抗菌剤。
    In the formula (I), at least one of R 1 has one hydroxyl group, and the hydrocarbon in the hydrocarbon moiety optionally containing an oxygen atom is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group. ,
    In the formula (II), at least one of R 3 has one hydroxyl group, and the hydrocarbon in the hydrocarbon moiety optionally containing an oxygen atom is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group. The antibacterial agent according to any one of claims 3-5.
  7.  前記式(I)において、R1のうち少なくとも1つが、水酸基を2個以上有し、前記酸素原子を含んでいてもよい炭化水素部位の炭化水素が飽和脂肪族炭化水素のヒドロキシ炭化水素基であり、
     前記式(II)において、R3のうち少なくとも1つが、水酸基を2個以上有し、前記酸素原子を含んでいてもよい炭化水素部位の炭化水素が飽和脂肪族炭化水素のヒドロキシ炭化水素基である請求項3~5のいずれか一項に記載の抗菌剤。
    In the above formula (I), at least one of R 1 has two or more hydroxyl groups, and the hydrocarbon in the hydrocarbon moiety which may contain an oxygen atom is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group. can be,
    In the formula (II), at least one of R 3 has two or more hydroxyl groups, and the hydrocarbon in the hydrocarbon moiety which may contain an oxygen atom is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group. The antibacterial agent according to any one of claims 3-5.
  8.  前記式(I)において、R1のうち少なくとも1つが、水酸基を1個以上有し、炭化水素部位が炭素数3~22の分岐鎖状で、前記酸素原子を含んでいてもよい炭化水素部位の炭化水素が飽和脂肪族炭化水素のヒドロキシ炭化水素基であり、
     前記式(II)において、R3のうち少なくとも1つが、水酸基を1個以上有し、炭化水素部位が炭素数3~22の分岐鎖状で、前記酸素原子を含んでいてもよい炭化水素部位の炭化水素が飽和脂肪族炭化水素のヒドロキシ炭化水素基である請求項3~5のいずれか一項に記載の抗菌剤。
    In the formula (I), at least one of R 1 has one or more hydroxyl groups, the hydrocarbon moiety is a branched chain having 3 to 22 carbon atoms, and the hydrocarbon moiety may contain an oxygen atom. is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group,
    In the formula (II), at least one of R 3 has one or more hydroxyl groups, the hydrocarbon moiety is a branched chain having 3 to 22 carbon atoms, and the hydrocarbon moiety may contain an oxygen atom. is a hydroxy hydrocarbon group of a saturated aliphatic hydrocarbon.
  9.  前記式(II)において、X-が水酸化物イオンである請求項3~8のいずれか一項に記載の抗菌剤。 The antibacterial agent according to any one of claims 3 to 8, wherein in formula (II), X - is a hydroxide ion.
  10.  前記成分(A)は、前記式(I)で表される請求項3~8のいずれか一項に記載の抗菌剤。 The antibacterial agent according to any one of claims 3 to 8, wherein the component (A) is represented by the formula (I).
  11.  請求項1~10のいずれか一項に記載の成分(B)のカチオン性残基を有していてもよい請求項1~10のいずれか一項に記載の成分(A)由来のカチオンと、前記成分(B)のアニオン性残基に由来するアニオンが形成する有機アンモニウム塩を含有する抗菌剤。 With a cation derived from the component (A) according to any one of claims 1 to 10, which may have a cationic residue of the component (B) according to any one of claims 1 to 10 and an antibacterial agent containing an organic ammonium salt formed by an anion derived from the anionic residue of component (B).
  12.  前記カチオンがアンモニウムカチオンである請求項11に記載の抗菌剤。 The antibacterial agent according to claim 11, wherein the cation is an ammonium cation.
  13.  前記成分(A)と成分(B)が形成する有機アンモニウム塩のカチオンが、下記式(III):
    Figure JPOXMLDOC01-appb-C000003
    (式中、R5はそれぞれ独立に、水酸基を1個以上有し、炭化水素部位が炭素数1~22の直鎖状もしくは分岐鎖状で、該炭化水素部位が酸素原子を含んでいてもよいヒドロキシ炭化水素基を示し、R6はそれぞれ独立に、水素原子又は炭素数1~22の有機基を示し、oは0~4の整数を示す。)で表される請求項11又は12に記載の抗菌剤。
    The cation of the organic ammonium salt formed by the component (A) and the component (B) has the following formula (III):
    Figure JPOXMLDOC01-appb-C000003
    (In the formula, each R 5 independently has one or more hydroxyl groups, the hydrocarbon moiety is linear or branched with 1 to 22 carbon atoms, and the hydrocarbon moiety contains an oxygen atom. represents a good hydroxy hydrocarbon group, each R 6 independently represents a hydrogen atom or an organic group having 1 to 22 carbon atoms, and o represents an integer of 0 to 4. Antibacterial agent as described.
  14.  前記式(III)において、oは1~4の整数である請求項13に記載の抗菌剤。 The antibacterial agent according to claim 13, wherein o is an integer of 1 to 4 in the formula (III).
  15.  前記式(III)において、全てのR6が水素原子である請求項13又は14に記載の抗菌剤。 15. The antibacterial agent according to claim 13 or 14, wherein in formula (III), all R6 are hydrogen atoms.
  16.  前記式(III)において、R5のうち少なくとも1つが、水酸基を1個有し、前記酸素原子を含んでいてもよい炭化水素部位における炭化水素が飽和脂肪族炭化水素のヒドロキシ炭化水素基である請求項13~15のいずれか一項に記載の抗菌剤。 In formula (III), at least one of R 5 has one hydroxyl group, and the hydrocarbon in the hydrocarbon moiety optionally containing an oxygen atom is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group. The antibacterial agent according to any one of claims 13-15.
  17.  前記式(III)において、R5のうち少なくとも1つが、水酸基を2個以上有し、前記酸素原子を含んでいてもよい炭化水素部位の炭化水素が飽和脂肪族炭化水素のヒドロキシ炭化水素基である請求項13~15のいずれか一項に記載の抗菌剤。 In the above formula (III), at least one of R 5 has two or more hydroxyl groups, and the hydrocarbon in the hydrocarbon moiety optionally containing an oxygen atom is a saturated aliphatic hydrocarbon hydroxy hydrocarbon group. The antibacterial agent according to any one of claims 13-15.
  18.  前記式(III)において、R5のうち少なくとも1つが、水酸基を1個以上有し、炭化水素部位が炭素数3~22の分岐鎖状で、前記酸素原子を含んでいてもよい炭化水素部位の炭化水素が飽和脂肪族炭化水素のヒドロキシ炭化水素基である請求項13~15のいずれか一項に記載の抗菌剤。 In the formula (III), at least one of R 5 has one or more hydroxyl groups, the hydrocarbon moiety is a branched chain having 3 to 22 carbon atoms, and the hydrocarbon moiety may contain an oxygen atom. is a hydroxy hydrocarbon group of a saturated aliphatic hydrocarbon.
  19.  前記式(III)で表されるカチオンのR6のうち少なくとも1つが水素原子の場合、その水素原子に対応するプロトンが前記成分(B)に由来する請求項13~18のいずれか一項に記載の抗菌剤。 When at least one of R 6 of the cation represented by the formula (III) is a hydrogen atom, the proton corresponding to the hydrogen atom is derived from the component (B). Antibacterial agent as described.
  20.  成分(B)がカルボン酸である請求項1~19のいずれか一項に記載の抗菌剤。 The antibacterial agent according to any one of claims 1 to 19, wherein the component (B) is a carboxylic acid.
  21.  成分(B)が炭化水素部位に水酸基及びカルボキシ基を有するカルボン酸である請求項1~20のいずれか一項に記載の抗菌剤。 The antibacterial agent according to any one of claims 1 to 20, wherein component (B) is a carboxylic acid having a hydroxyl group and a carboxy group in the hydrocarbon moiety.
  22.  前記成分(A)及び前記成分(B)が有するアミノ基の合計数とカルボキシ基の合計数の比(アミノ基の合計数/カルボキシ基の合計数)が1未満である請求項1~21のいずれか一項に記載の抗菌剤。 The ratio of the total number of amino groups to the total number of carboxy groups (total number of amino groups/total number of carboxy groups) of said component (A) and said component (B) is less than 1. The antibacterial agent according to any one of the clauses.
  23.  前記成分(A)と(B)との混合物又は(A)と(B)との塩は、無水物及び/又は水和物が25℃で液体である請求項1~22のいずれか一項に記載の抗菌剤。 23. Any one of claims 1 to 22, wherein the mixture of components (A) and (B) or the salt of (A) and (B) is an anhydride and/or hydrate liquid at 25°C. Antibacterial agent according to.
  24.  請求項1~23のいずれか一項に記載の抗菌剤を添加した抗菌性組成物。 An antibacterial composition to which the antibacterial agent according to any one of claims 1 to 23 is added.
  25.  請求項1~23のいずれか一項に記載の抗菌剤を添加した抗ウイルス性組成物。 An antiviral composition to which the antibacterial agent according to any one of claims 1 to 23 is added.
PCT/JP2022/018557 2021-04-23 2022-04-22 Antibacterial agent, antibacterial composition using same and antiviral composition WO2022225049A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023515539A JPWO2022225049A1 (en) 2021-04-23 2022-04-22

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021-073005 2021-04-23
JP2021073005 2021-04-23

Publications (1)

Publication Number Publication Date
WO2022225049A1 true WO2022225049A1 (en) 2022-10-27

Family

ID=83723092

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2022/018557 WO2022225049A1 (en) 2021-04-23 2022-04-22 Antibacterial agent, antibacterial composition using same and antiviral composition

Country Status (2)

Country Link
JP (1) JPWO2022225049A1 (en)
WO (1) WO2022225049A1 (en)

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5198324A (en) * 1975-02-25 1976-08-30 Satsukin shodoku oyobi bofusoseibutsu
JPS5296734A (en) * 1976-02-05 1977-08-13 Tokyo Yuuki Kagaku Kougiyou Kk Nonnmedical expellent for noxious organism
JPH08511543A (en) * 1993-06-09 1996-12-03 ロンザ インコーポレイテッド Quaternary ammonium and waterproof / preservative composition
JPH1143405A (en) * 1996-06-25 1999-02-16 Sanyo Chem Ind Ltd Antimicrobial processing agent for fiber having low irritation property
JP2003081709A (en) * 2001-09-13 2003-03-19 Asahi Denka Kogyo Kk Bactericidal disinfectant composition and bactericidal disinfectant material
JP2007504153A (en) * 2003-08-28 2007-03-01 ピュア バイオサイエンス Silver dihydrogen citrate composition containing a second antibacterial agent
JP2014019659A (en) * 2012-07-13 2014-02-03 Niitaka:Kk Disinfection liquid and disinfection method
JP2015071589A (en) * 2013-09-09 2015-04-16 吉田製薬株式会社 Disinfectant
JP2017528463A (en) * 2014-09-09 2017-09-28 ロンザ インコーポレーテッド Disinfecting composition containing a quaternary ammonium compound
JP2019023185A (en) * 2017-07-21 2019-02-14 ミヨシ油脂株式会社 Water-and-moisture-retentive agent
JP2020502055A (en) * 2016-12-13 2020-01-23 ユニリーバー・ナームローゼ・ベンノートシヤープ Biocidal composition for use in laundry washing processes
WO2020166678A1 (en) * 2019-02-13 2020-08-20 ミヨシ油脂株式会社 Cosmetic ingredient, cosmetic, and production method for cosmetic
JP2021138652A (en) * 2020-03-05 2021-09-16 日油株式会社 Disinfectant composition
JP2022058054A (en) * 2020-09-30 2022-04-11 シーバイエス株式会社 Skin disinfectant composition

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5198324A (en) * 1975-02-25 1976-08-30 Satsukin shodoku oyobi bofusoseibutsu
JPS5296734A (en) * 1976-02-05 1977-08-13 Tokyo Yuuki Kagaku Kougiyou Kk Nonnmedical expellent for noxious organism
JPH08511543A (en) * 1993-06-09 1996-12-03 ロンザ インコーポレイテッド Quaternary ammonium and waterproof / preservative composition
JPH1143405A (en) * 1996-06-25 1999-02-16 Sanyo Chem Ind Ltd Antimicrobial processing agent for fiber having low irritation property
JP2003081709A (en) * 2001-09-13 2003-03-19 Asahi Denka Kogyo Kk Bactericidal disinfectant composition and bactericidal disinfectant material
JP2007504153A (en) * 2003-08-28 2007-03-01 ピュア バイオサイエンス Silver dihydrogen citrate composition containing a second antibacterial agent
JP2014019659A (en) * 2012-07-13 2014-02-03 Niitaka:Kk Disinfection liquid and disinfection method
JP2015071589A (en) * 2013-09-09 2015-04-16 吉田製薬株式会社 Disinfectant
JP2017528463A (en) * 2014-09-09 2017-09-28 ロンザ インコーポレーテッド Disinfecting composition containing a quaternary ammonium compound
JP2020502055A (en) * 2016-12-13 2020-01-23 ユニリーバー・ナームローゼ・ベンノートシヤープ Biocidal composition for use in laundry washing processes
JP2019023185A (en) * 2017-07-21 2019-02-14 ミヨシ油脂株式会社 Water-and-moisture-retentive agent
WO2020166678A1 (en) * 2019-02-13 2020-08-20 ミヨシ油脂株式会社 Cosmetic ingredient, cosmetic, and production method for cosmetic
JP2021138652A (en) * 2020-03-05 2021-09-16 日油株式会社 Disinfectant composition
JP2022058054A (en) * 2020-09-30 2022-04-11 シーバイエス株式会社 Skin disinfectant composition

Also Published As

Publication number Publication date
JPWO2022225049A1 (en) 2022-10-27

Similar Documents

Publication Publication Date Title
US8604073B2 (en) Antimicrobial composition
JP3204962B2 (en) Quaternary ammonium polymer trihalides and uses thereof
CA2645037C (en) Pharmaceuticals containing fluoroquinolones
US20170247409A1 (en) Abietane-type diterpenoids
JP2015521617A5 (en)
EP2127650A3 (en) Carbapenem antibacterials with gram-negative activity and processes for their preparation
CA2644981C (en) Pharmaceutical formulation comprising fluoroquinolones
WO2022225049A1 (en) Antibacterial agent, antibacterial composition using same and antiviral composition
US9603928B2 (en) Medicinal composition for promoting synthesis of protoporphyrin IX
JP2019119725A (en) Bacteria repellent composition, bacteria repellent coating and method for forming the same, and article having bacteria repellent coating
US20170251666A1 (en) One-part solid glutaraldehyde-quaternary ammonium inclusion or occlusion complexes and their uses
JPH032105A (en) Stabilizer composition and stabilized aqueous system
ES2689562T3 (en) Liquid antiseptic composition and method to produce it
JP2540777B2 (en) Liquid disinfectant
JP6241779B2 (en) Preservative and composition for external use, and coloring reduction method
JPH0643285B2 (en) Microbial growth inhibitory composition
US20120289575A1 (en) Topical antimicrobial compositions
JP4621401B2 (en) Stabilized isothiazolone composition and method for stabilizing isothiazolone
WO2022225048A1 (en) Formulation using amino acid and carboxylic acid, organic salt, and composition comprising same and use thereof
WO2022225046A1 (en) Composition suitable for gel formation and thickening characteristics
NZ256962A (en) Pharmaceutical complex of a calcium lactate salt of antibacterial quinolone or naphthyridine derivatives
KR20170003745A (en) Chlorhexidine antiseptic for smallanimal
KR100840125B1 (en) High concentration water-solution composition including antibiotic compound
KR101350442B1 (en) A stable antimicrobial and antiseptic aqueous composition containing chlorhexidine
JPWO2007074904A1 (en) Aqueous pharmaceutical composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22791820

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2023515539

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 22791820

Country of ref document: EP

Kind code of ref document: A1